# Patent

## Title
Small Streptococcus pyogenes antigens and their use

## Abstract

The present invention relates to a peptide consisting of one antigen of Streptococcus pyogenes (S. pyogenes) of any of the SEQ ID NOS: 1 to 7 or a functional active variant thereof, optionally further consisting of additional amino acid residue(s); a nucleic acid coding for the same; a pharmaceutical composition, especially a vaccine, comprising said peptide or said nucleic acid; an antibody or functional active fragment thereof specifically binding to the antigen; a hybridoma cell line which produces said antibody; a method for producing said antibody; a pharmaceutical composition comprising said antibody; the use of said peptide or said nucleic acid for the manufacture of a medicament for the immunization or treatment of a subject; the use of said antibody or functional fragment thereof for the manufacture of a medicament for the treatment of an infection; a method of diagnosing a S. pyogenes infection; a method for identifying a ligand capable of binding to said peptide; and the use of said peptide for the isolation and/or purification and/or identification of an interaction partner of the peptide.

## Background
CROSS REFERENCE TO RELATED APPLICATIONS
This application is the U.S. National Stage of International Application No. PCT/EP2007/006027, filed Jul. 6, 2007, which claims benefit of European Application No. 06014166.0, filed Jul. 7, 2006, each of which is hereby incorporated by reference.
The present invention relates to a peptide consisting of one antigen of Streptococcus pyogenes (S. pyogenes) of any of the SEQ ID NOS: 1 to 7 or a functional active variant thereof, optionally further consisting of additional amino acid residue(s); a nucleic acid coding for the same; a pharmaceutical composition, especially a vaccine, comprising said peptide or said nucleic acid; an antibody or functional active fragment thereof specifically binding to the antigen; a hybridoma cell line which produces said antibody; a method for producing said antibody; a pharmaceutical composition comprising said antibody; the use of said peptide or said nucleic acid for the manufacture of a medicament for the immunization or treatment of a subject; the use of said antibody or functional fragment thereof for the manufacture of a medicament for the treatment of an infection; a method of diagnosing a S. pyogenes infection; a method for identifying a ligand capable of binding to said peptide; and the use of said peptide for the isolation and/or purification and/or identification of an interaction partner of the peptide.
Streptococcus pyogenes, also called group A streptococcus (GAS), is an important gram-positive extracellular bacterial pathogen and commonly infects humans. GAS colonizes the throat or skin and is responsible for a number of suppurative infections and non-suppurative sequelae. It is primarily a disease of children and causes a variety of infections including bacterial pharyngitis, scarlet fever, impetigo and sepsis in humans. Decades of epidemiological studies have led to the concept of distinct throat and skin strains, where certain serotypes are often associated with throat or skin infections, respectively (Cunningham, M. (2000). Clin Microbiol Rev 13: 470-511). GAS has been discovered responsible for streptococcal toxic shock syndrome associated necrotizing fasciitis which is recently resurgent in the USA (Cone, L., et al. (1987). New Engl J Med 317: 146-9; Stevens, D. (1992). Clin Infect Dis 14: 2-11) and has been described as the “flesh eating” bacterium which invades skin and soft tissues leading to tissue or limb destruction.
Several post-streptococcal sequelae may occur in humans subsequent to infection, such as acute rheumatic fever, acute glomerulonephritis and reactive arthritis. Acute rheumatic fever and rheumatic heart disease are of these the most serious autoimmune sequelae and have led to disability and death of children worldwide. S. pyogenes can also causes severe acute diseases such as scarlet fever and necrotizing fasciitis and has been associated with Tourette's syndrome, tics and movement and attention disorders.
Group A streptococci are the most common bacterial cause of sore throat and pharyngitis and account for at least 16% of all office calls in a general medical practice, season dependent (Hope-Simpson, R. (1981). J Hvg (Lond) 87: 109-29). It primarily affects children in school-age between 5 to 15 years of age (Cunningham, supra). All ages are susceptible to spread of the organism under crowded conditions, for example in schools. GAS are not considered normal flora though, but pharyngeal carriage of group A streptococci can occur without clinical symptoms.
Group A streptococci can be distinguished by the Lancefield classification scheme of serologic typing based on their carbohydrate or classified into M protein serotypes based on a surface protein that can be extracted by boiling bacteria with hydrochloric acid. This has led to the identification of more than 80 serotypes, which can also be typed by a molecular approach (emm genes). Molecular typing has identified more than 150 individual emm types. Certain M protein serotypes of S. pyogenes are mainly associated with pharyngitis and rheumatic fever, while others mainly seem to cause pyoderma and acute glomerulonephritis (Cunningham, supra).
Also implicated in causing pharyngitis and occasionally toxic shock are group C and G streptococci, which must be distinguished after throat culture (Hope-Simpson, supra; Bisno, A., et al. (1987). Infect Immun 55: 753-7).
Currently, streptococcal infections can only be treated by antibiotic therapy. However, 25-30% of those treated with antibiotics show recurrent disease and/or shed the organism in mucosal secretions. There is at present no preventive treatment (vaccine) available to avoid streptococcal infections.
Thus, there remains a need for an effective treatment to prevent or ameliorate streptococcal infections. A vaccine could not only prevent infections by streptococci, but more specifically prevent or ameliorate colonization of host tissues, thereby reducing the incidence of pharyngitis and other suppurative infections. Elimination of non-suppurative sequelae such as rheumatic fever, acute glomerulonephritis, sepsis, toxic shock and necrotizing fasciitis would be a direct consequence of reducing the incidence of acute infection and carriage of the organism. Vaccines capable of showing cross-protection against other streptococci would also be useful to prevent or ameliorate infections caused by all other beta-hemolytic streptococcal species, namely groups A, B, C and G.
A vaccine can contain a whole variety of different antigens. Examples of antigens are whole-killed or attenuated organisms, subfractions of these organisms/tissues, proteins, or, in their most simple form, peptides. Antigens can also be recognized by the immune system in form of glycosylated proteins or peptides and may also be or contain polysaccharides or lipids. Short peptides can be used since for example cytotoxic T-cells (CTL) recognize antigens in form of short usually 8-11 amino acids long peptides in conjunction with major histocompatibility complex (MHC). B-cells can recognize linear epitopes as short as 4-5 amino acids, as well as three-dimensional structures (conformational epitopes).
In some circumstances, adjuvants may be useful for sustaining antigen-specific immune responses. Primarily, adjuvants are acting, but are not restricted in their mode of action, on so-called antigen presenting cells (APCs). These cells usually first encounter the antigen(s) followed by presentation of processed or unmodified antigen to immune effector cells. Intermediate cell types may also be involved. Only effector cells with the appropriate specificity are activated in a productive immune response. The adjuvant may also locally retain antigens and co-injected other factors. In addition the adjuvant may act as a chemoattractant for other immune cells or may act locally and/or systemically as a stimulating agent for the immune system.
Approaches to develop a group A streptococcal vaccine have focused mainly on the cell surface M protein of S. pyogenes (Bessen, D., et al. (1988). Infect Immun 56: 2666-2672; Bronze, M., et al. (1988). J Immunol 141: 2767-2770). Since more than 80 different M serotypes of S. pyogenes exist and new serotypes continually arise (Fischetti, V. (1989). Clin Microbiol Rev 2: 285-314), inoculation with a limited number of serotype-specific M protein or M protein derived peptides will not likely be effective in protecting against all other M serotypes. Furthermore, it has been shown that the conserved region of the M protein contains an amino acid sequence, which is immunologically cross-reactive with human heart tissue, which is thought to account for heart valve damage associated with rheumatic fever (Fenderson, P., et al. (1989). J Immunol 142: 2475-2481).
There are other proteins under consideration for vaccine development, such as the erythrogenic toxins, streptococcal pyrogenic exotoxin A and streptococcal pyrogenic exotoxin B (Lee, P. K. (1989). J Clin Microbiol 27: 1890-2). Immunity to these toxins could possibly prevent the deadly symptoms of streptococcal toxic shock, but it may not prevent colonization by group A streptococci.
The use of the above described proteins as antigens for a potential vaccine as well as a number of additional candidates (Ji, Y., et al. (1997). Infect Immun 65: 2080-2087; Guzman, C., et al. (1999). J Infect Dis 179: 901-6) resulted mainly from a selection based on easiness of identification or chance of availability. There is a demand to identify efficient and relevant antigens for S. pyogenes. 
WO 2004/078907 describes a method for identification, isolation and production of hyperimmune serum reactive antigens from Streptococcus pyogenes. 
The antigens described herein focus on regions shown in the present application to be protective. A suitable antigen size to obtain protection varies based on different factors such as the type of protective epitope (e.g., conformational versus linear) and the number of protective epitopes providing a level of protection. Large antigens containing regions not providing useful protection may be disadvantageous in the context of immunization. First, providing of smaller antigens eases production of the protein in recombinant form. It is generally accepted that it is more difficult to produce larger proteins. Smaller proteins may be produced in a more economic manner, thus saving costs, particularly in the health care system. Second, reducing the size of antigenic proteins used for vaccination may lead to safer products. Eliminating extra sequences in antigenic proteins is desirable, since this reduces the probability of inducing antibodies which can cause cross-reactions with human tissues. Third, proteins used for vaccination may contain more than one antigen, the antigens directed either against the same disease or against different diseases, in order to obtain a more effective vaccination or vaccination against several diseases. However, if the single antigens are too large a combination into one protein is not feasible.
Accordingly, one problem underlying the present invention was to provide alternative means for the development of medicaments such as vaccines against S. pyogenes infection, particularly smaller proteins.
Surprisingly, the object has been solved by a peptide consisting of one antigen of S. pyogenes of the SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6 or SEQ ID NO: 7 or a functional active variant of one antigen of S. pyogenes of the SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6 or SEQ ID NO: 7. These peptides are referred to as antigenic peptides.
The sequences of SEQ ID NOS: 1 to 7 are characterized in table 1 of the present specification. The underlying amino acid sequences are disclosed in the attached sequence data. The peptides of SEQ ID NOS: 1 to 7 have been shown to induce an immune response and/or to show protection against S. pyogenes in a sepsis and/or lethality model (see Example 1). Functional active variants are obtained by changing the sequence of the antigen as defined below and are characterized by having a biological activity similar to that displayed by the antigen of any of the sequences of SEQ ID NO: 1 to 7 from which it is derived, including the ability to induce immune responses and/or to show protection against S. pyogenes e.g. in a sepsis and/or lethality model.
In some embodiments of the invention the peptide of the invention consists of one antigen of S. pyogenes of the SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6 or SEQ ID NO: 7 or a functional active variant of one antigen of S. pyogenes of the SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6 or SEQ ID NO: 7; and

    a) 1 to 350 additional amino acid residue(s), preferably 1 to 200, more preferably 1 to 150, even more preferably at most 1 to 100, still more preferably at most 1 to 50, most preferably 1, 2, 3, 4, 5, 10, 15, 20 or 25 additional amino acids residue(s) if the antigen is SEQ ID NO: 1; or
    b) 1 to 200 additional amino acid residue(s), preferably 1 to 150, more preferably 1 to 100, even more preferably at most 1 to 50, still more preferably at most 1 to 25, most preferably 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 additional amino acids residue(s) if the antigen is SEQ ID NO: 2; or
    c) 1 to 100 additional amino acid residue(s), preferably 1 to 75, more preferably 1 to 50, even more preferably at most 1 to 25, still more preferably at most 1 to 10, most preferably 1, 2, 3, 4 or 5 additional amino acids residue(s) if the antigen is that of SEQ ID NO: 3; or
    d) 1 to 150 additional amino acid residue(s), preferably 1 to 100, more preferably 1 to 75, even more preferably at most 1 to 50, still more preferably at most 1 to 25, most preferably 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 additional amino acids residue(s) if the antigen is that of SEQ ID NO: 4; or
    e) 1 to 450 additional amino acid residue(s), preferably 1 to 300, more preferably 1 to 150, even more preferably at most 1 to 100, still more preferably at most 1 to 50, most preferably 1, 2, 3, 4, 5, 10, 20, 30 or 40 additional amino acids residue(s) if the antigen is SEQ ID NO: 5; or
    f) 1 to 250 additional amino acid residue(s), preferably 1 to 200, more preferably 1 to 150, even more preferably at most 1 to 100, still more preferably at most 1 to 50, most preferably 1, 2, 3, 4, 5, 10, 15, 20 or 25 additional amino acids residue(s) if the antigen is SEQ ID NO: 6 or SEQ ID NO: 7.


The antigen of S. pyogenes can be any of the antigens as defined above, namely as defined in any of the SEQ ID NOS: 1, 2, 3, 4, 5, 6 or 7, or a functional active variant thereof, wherein the functional active variant is as defined below.
The antigen or the functional active variant thereof may have added at least one additional amino acid residue heterologous or homologous to the peptide. Homologous refers to any amino acid or amino acid sequence which is identical to the amino acid sequence of the S. pyogenes protein from which the antigen is derived, wherein the sequences of SEQ ID NO: 1 to 7 are derived from the following proteins:














derived from protein




(as disclosed in e.g. WO 2004/078907



Sequence
or in the attached sequence data)








SEQ ID NO: 1
Spy0269



SEQ ID NO: 2
Spy0292



SEQ ID NO: 3
Spy0292



SEQ ID NO: 4
Spy0416



SEQ ID NO: 5
Spy0416



SEQ ID NO: 6
Spy0416



SEQ ID NO: 7
Spy0872









In one embodiment the antigen or the functional active variant thereof having one or more additional amino acid residues (see above, particularly as defined in items (a) to (f)) further encompasses at least one amino acid residue heterologous to the antigen. The feature “heterologous amino acid” or “amino acid heterologous to the antigen or protein” refers to any amino acid which is different from that amino acid located adjacent to the antigen or protein in any naturally occurring protein of S. pyogenes, particularly from that of S. pyogenes SF370 (serotype MD. Therefore, the protein of the invention encompassing at least one heterologous amino acid refers to a protein which is different from any naturally occurring protein of S. pyogenes or fragment thereof, particularly which is different from that of S. pyogenes SF370 (serotype M1). The proteins from which the antigens of the invention are derived as well as a reference for their sequences are listed above.
In certain embodiments, the peptide consists of the antigen, optionally the at least one additional amino acid residue as defined above, and at least one additional heterologous amino acid sequence comprising a marker protein.
The additional sequence or amino acid residue(s) as defined above consists of (an) amino acid residue(s), which may be any amino acid, which may be either an L- and/or a D-amino acid, naturally occurring and otherwise. Preferably the amino acid is any naturally occurring amino acid such as alanine, cysteine, aspartic acid, glutamic acid, phenylalanine, glycine, histidine, isoleucine, lysine, leucine, methionine, asparagine, proline, glutamine, arginine, serine, threonine, valine, tryptophan or tyrosine.
However, the amino acid residue(s) may also be (a) modified or unusual amino acid(s). Examples of those are 2-aminoadipic acid, 3-aminoadipic acid, beta-alanine, 2-aminobutyric acid, 4-aminobutyric acid, 6-aminocaproic acid, 2-aminoheptanoic acid, 2-aminoisobutyric acid, 3-aminoisobutyric acid, 2-aminopimelic acid, 2,4-diaminobutyric acid, desmosine, 2,2′-diaminopimelic acid, 2,3-diaminopropionic acid, N-ethylglycine, N-ethylasparagine, hydroxylysine, allo-hydroxylysine, 3-hydroxyproline, 4-hydroxyproline, isodesmosine, allo-isoleucine, N-methylglycine, N-methylisoleucine, 6-N-Methyllysine, N-methylvaline, norvaline, norleucine or ornithine.
Additionally, the amino acid(s) may be subject to modifications such as posttranslational modifications. Examples of modifications include acetylation, amidation, blocking, formylation, γ-carboxyglutamic acid hydroxylation, glycosilation, methylation, phosphorylation and sulfatation.
If more than one additional or heterologous amino acid residue is present in the peptide, the amino acid residues may be the same or different from one another.
The antigenic peptide may be flanked by the amino acid residue(s) C-terminally, N-terminally, or C- and N-terminally.
In a further embodiment the peptide is as described above in the different embodiments, and contains a region that is essentially identical to any of the antigens of the SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6 or SEQ ID NO: 7, but differs from the antigens of any of the of the SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6 or SEQ ID NO: 7, in that is it derived from a homologous sequence of a different serotype of S. pyogenes, particularly wherein the serotype is M2, M3, M4, M5, M6, M11, M12, M14, M19, M22, M24, M25, M28, M44, M49, M57, M59, M60, M61, M76, M83, M84, M87, M89 or M118, especially S. pyogenes SF370.
Accordingly, the present invention also relates to antigens of different S. pyogenes isolates. Such homologues may easily be identified and isolated based on the nucleic acid and amino acid sequences disclosed herein. A homologous antigen of a different serotype may be identified by e.g. sequence alignment. The homologous antigen sequence may vary from the antigen of any of the sequences of SEQ ID NO: 1 to 7 by one or more amino acid substitutions, deletions and/or additions. Preferably the homologous antigen sequence has the sequence of any of the homologous variants identified in the attached listing of amino acid sequences.
Examples of homologous sequences of a different serotype are detailed in the attached sequence data. Particularly, sequences homologous to the respective peptide of the invention are those listed below:












Full length amino acid

Homologous


sequence
Peptide of the invention
amino acid sequences


(SEQ ID NO)
(SEQ ID NO)
(SEQ ID NOS)

















57
1
58 to 67


68
2
69 to 78


68
3
79 to 88


89
4
90 to 99


89
5
100 to 109


89
6
110 to 119


120
7
121 to 130









There are more than 150 emm types distinguished to date and the typing is based on the variable region at the 5′ end of the emm gene (see e.g. Vitali, L., et al. (2002) J. Clin. Microbiol. 40: 679-681). The presence of a homologous antigen can accordingly be determined for every emm type. In addition it is possible to determine the variability of a particular antigen in the various emm types as described for the sic gene (Hoe N., et al. (2001) J. Inf. Dis. 183: 633-9). The influence of the various M serotypes on the kind of disease it causes is summarized in a recent review (Cunningham, supra). In particular, two groups of serotypes can be distinguished:

    1) Those causing Pharyngitis and Scarlet fever (e.g. M types 1, 3, 5, 6, 14, 18, 19, 24)
    2) Those causing Pyoderma and Streptococcal skin infections (e.g. M types 2, 49, 57, 59, 60, 61)


This can serve as the basis to identify the relevance of an antigen for the use as a vaccine or in general as a drug targeting a specific disease.
The information e.g. from the homepage of the Centers for Disease Control and Prevention (CDC) gives a dendrogram showing the relatedness of various emm types. Further relevant references are Vitali et al., supra (molecular emm typing method), Enright et al., Infection and Immunity 69: 2416-2427. (2001) (alternative molecular typing method (MLST)), Hoe et al., supra (example for the variation of one antigen (sic) in many different serotypes) and Cunningham, supra (review on GAS pathogenesis). All emm types are completely listed and are available at publicly available databases (e.g., through the CDC).
In another embodiment of the present invention the variant is a fragment. The fragment is characterized by being derived from the antigen as defined above by one or more amino acid deletions. The deletion(s) may be C-terminally, N-terminally and/or internally. Preferably the fragment is obtained by at most 10, 20, 30, 40, 50, 60, 80, 100, 150 or 200, more preferably by at most 10, 20, 30, 40 or 50, even more preferably at most 5, 10 or 15, still more preferably at most 5 or 10, most preferably 1, 2, 3, 4 or 5 amino acid deletion(s). The functional active fragment of the invention is characterized by having a biological activity similar to that displayed by the complete antigen, including the ability to induce immunization and/or to show protection against S. pyogenes e.g. in a sepsis and/or lethality model. The fragment of an antigen is functional active in the context of the present invention, if the activity of the fragment amounts to at least 10%, preferably at least 25%, more preferably at least 50%, even more preferably at least 70%, still more preferably at least 80%, especially at least 90%, particularly at least 95%, most preferably at least 99% of the activity of the antigen without sequence alteration. These fragments may be designed or obtained in any desired length, including as small as about 50 to 80 amino acids in length.
The functional active fragment may be also characterized by other structural features. Accordingly, in one preferred embodiment of the invention the functional active fragments consists of at least 60%, preferably at least 70%, more preferably at least 80%, still more preferably at least 90%, even more preferably at least 95%, most preferably 99% of the amino acids of the antigen of any of the SEQ ID NOS: 1 to 7. The functional active fragment as defined above may be derived from the peptide by one or more amino acid deletions. The deletions may be C-terminally, N-terminally and/or internally.
Another preferred embodiment of the invention relates to a peptide as defined above in the previous embodiments, wherein the antigen is a functional active variant of an antigen of any of the SEQ ID NOS: 1 to 7 and wherein the variant has at least 50% sequence identity to the antigen of any of the SEQ ID NOS: 1 to 7. In a more preferred embodiment the functional active variant has a sequence identity of at least 60%, preferably at least 70%, more preferably at least 80%, still more preferably at least 90%, even more preferably at least 95%, most preferably 99% to the antigen of any of the SEQ ID NOS: 1 to 7.
The percentage of sequence identity can be determined e.g. by sequence alignment. Methods of alignment of sequences for comparison are well known in the art. Various programs and alignment algorithms have been described e.g. in Smith and Waterman, Adv. Appl. Math. 2: 482, 1981 or Pearson and Lipman, Proc. Natl. Acad. Sci. U.S.A. 85: 2444-2448, 1988.
The NCBI Basic Local Alignment Search Tool (BLAST) (Altschul et al., J. Mol. Biol. 215: 403-410, 1990) is available from several sources, including the National Center for Biotechnology Information (NCBI, Bethesda, Md.) and on the Internet, for use in connection with the sequence analysis programs blastp, blastn, blastx, tblastn and tblastx. Variants of an antigen of any of the sequences of SEQ ID NOS: 1 to 7 are typically characterized using the NCBI Blast 2.0, gapped blastp set to default parameters. For comparisons of amino acid sequences of at least 35 amino acids, the Blast 2 sequences function is employed using the default BLOSUM62 matrix set to default parameters, (gap existence cost of 11, and a per residue gap cost of 1). When aligning short peptides (fewer than around 35 amino acids), the alignment is performed using the Blast 2 sequences function, employing the PAM30 matrix set to default parameters (open gap 9, extension gap 1 penalties). Methods for determining sequence identity over such short windows such as 15 amino acids or less are described at the website that is maintained by the National Center for Biotechnology Information in Bethesda, Md.
The functional active variant of an antigen is obtained by sequence alterations in the antigen, wherein the antigen with the sequence alterations retains a function of the unaltered antigen, e.g. having a biological activity similar to that displayed by the complete antigen, including the ability to induce an immune response and/or to show protection against S. pyogenes e.g. in a sepsis and/or lethality model. Such sequence alterations can include, but are not limited to, conservative substitutions, deletions, mutations and insertions. These characteristics of the functional active variant can be assessed e.g. as detailed in Example 1. In the context of the present invention a variant specifically has a biological activity similar to that displayed by the antigen without alteration, including the ability to induce an immune response and/or to show protection against S. pyogenes e.g. in a sepsis and/or lethality model if the activity of the variant amounts to at least 10%, preferably at least 25%, more preferably at least 50%, even more preferably at least 70%, still more preferably at least 80%, especially at least 90%, particularly at least 95%, most preferably at least 99% of the activity of the antigen without sequence alterations.
The term “functional active variant” includes naturally-occurring allelic variants, as well as mutants or any other non-naturally occurring variants. As is known in the art, an allelic variant is an alternate form of a (poly)peptide that is characterized as having a substitution, deletion, or addition of one or more amino acids that does essentially not alter the biological function of the polypeptide. By “biological function” is meant a function of the polypeptide in the cells in which it naturally occurs, even if the function is not necessary for the growth or survival of the cells. For example, the biological function of a porin is to allow the entry into cells of compounds present in the extracellular medium. The biological function is distinct from the antigenic function. A polypeptide can have more than one biological function.
Within any species of the living world, allelic variation is the rule. For example, any bacterial species, e.g. S. pyogenes, is usually represented by a variety of strains (characterized by clonal reproduction) that differ from each other by minor allelic variations. Indeed, a polypeptide that fulfils the same biological function in different strains can have an amino acid sequence that is not identical in each of the strains. Such an allelic variation is equally reflected at the polynucleotide level.
Allelic variation is very common within the S. pyogenes species. Such allelic variation is also the basis for the molecular typing of group A streptococcal strains by emm typing as described above (see, e.g. Facklam, R. et al. (1999) Emerg Infect Dis. 5: 247-53 Further, genes such as sic are subject to allelic variation (Hoe N., et al. (2001) J. Inf. Dis. 183: 633-9). However, proteins with large allelic variation are in general not suitable candidates for a vaccine, as immunization would not protect against infection with all strains, or alternative immunization would possibly induce the emergence of new allelic variants not covered by the vaccine.
In a preferred embodiment, the functional active variant or fragment derived from the antigen by amino acid exchanges, deletions or insertions may also conserve, or more preferably improve, the activity (as defined above). Furthermore, these peptides may also cover epitopes, which trigger the same or preferably an improved T cell response. These epitope are referred to as “heteroclitic”. They have a similar or preferably greater affinity to MHC/HLA molecules, and the ability to stimulate the T cell receptors (TCR) directed to the original epitope in a similar or preferably stronger manner. Heteroclitic epitopes can be obtained by rational design i.e. taking into account the contribution of individual residues to binding to MHC/HLA as for instance described by (Rammensee, H. et al., 1999, Immunogenetics. 50: 213-219), combined with a systematic exchange of residues potentially interacting with the TCR and testing the resulting sequences with T cells directed against the original epitope. Such a design is possible for a skilled man in the art without much experimentation.
In a still more preferred embodiment of the invention the functional active variant of an antigen of any of the SEQ ID NOS: 1 to 7 having at least 50% sequence identity to the antigen of any of the SEQ ID NOS: 1 to 7, especially at least 60%, preferably at least 70%, more preferably at least 80%, still more preferably at least 90%, even more preferably at least 95%, most preferably 99% to the antigen of any of the SEQ ID NOS: 1 to 7 is derived from the antigen of any of the sequences of SEQ ID NOS: 1 to 7 by conservative substitutions. Conservative substitutions are those that take place within a family of amino acids that are related in their side chains and chemical properties. Examples of such families are amino acids with basic side chains, with acidic side chains, with non-polar aliphatic side chains, with non-polar aromatic side chains, with uncharged polar side chains, with small side chains, with large side chains etc. In one embodiment, one conservative substitution is included in the peptide. In another embodiment, two conservative substitutions or less are included in the peptide. In a further embodiment, three conservative substitutions or less are included in the peptide.
Examples of conservative amino acid substitutions include, but are not limited to, those listed below:













Original Residue
Conservative Substitutions








Ala
Ser



Arg
Lys



Asn
Gln; His



Asp
Glu



Cys
Ser



Gln
Asn



Glu
Asp



His
Asn; Gln



Ile
Leu, Val



Leu
Ile; Val



Lys
Arg; Gln; Asn



Met
Leu; Ile



Phe
Met; Leu; Tyr



Ser
Thr



Thr
Ser



Trp
Tyr



Tyr
Trp; Phe



Val
Ile; Leu









Examples of suitable variants of the peptide of the invention obtained by one or more amino acid exchange(s), deletion(s) and/or insertion(s) may be derived from data provided in tables 5 to 7 and 9. Particularly, tables 5 to 7 and 9 list naturally occurring amino acid alterations (substitutions, insertions, deletions) at particular positions in comparison to S. pyrogenes SF370.
With respect to a variant of a peptide having (i.e. consisting of or comprising as defined above, particularly as defined in the above items (a) to (f)) SEQ ID NO: 1, the variant of the invention may differ from the peptide having SEQ ID NO: 1 by one or more of the alterations identified in table 5.
With respect to a variant of a peptide having (i.e. consisting of or comprising as defined above, particularly as defined in the above items (a) to (f)) SEQ ID NO: 2, the variant of the invention may differ from the peptide having SEQ ID NO: 2 by one or more of the alterations identified in table 6.
With respect to a variant of a peptide having (i.e. consisting of or comprising as defined above, particularly as defined in the above items (a) to (f)) SEQ ID NO: 3, the variant of the invention may differ from the peptide having SEQ ID NO: 3 by one or more of the alterations identified in table 6.
With respect to a variant of a peptide having (i.e. consisting of or comprising as defined above, particularly as defined in the above items (a) to (f)) SEQ ID NO: 4, the variant of the invention may differ from the peptide having SEQ ID NO: 4 by one or more of the alterations identified in table 7.
With respect to a variant of a peptide having (i.e. consisting of or comprising as defined above, particularly as defined in the above items (a) to (f)) SEQ ID NO: 5, the variant of the invention may differ from the peptide having SEQ ID NO: 5 by one or more of the alterations identified in table 7.
With respect to a variant of a peptide having (i.e. consisting of or comprising as defined above, particularly as defined in the above items (a) to (f)) SEQ ID NO: 6, the variant of the invention may differ from the peptide having SEQ ID NO: 6 by one or more of the alterations identified in table 7.
With respect to a variant of a peptide having (i.e. consisting of or comprising as defined above, particularly as defined in the above items (a) to (f)) SEQ ID NO: 7, the variant of the invention may differ from the peptide having SEQ ID NO: 7 by one or more of the alterations identified in table 9.
It should be understood that variants obtained from a peptide of the invention by one or more sequence alterations in accordance with tables 5 to 7 and 9 are preferred.
A further aspect of the present invention describes a peptide comprising an amino acid sequence with at least 95% sequence identity to at least one of SEQ ID NO: 1, 2, 3, 4, 5, 6 or 7. In different embodiment the peptide comprises, consists, or consists essentially of a region of at least 95%, at least 97% or at least 99% identical to SEQ ID NO: 1, 2, 3, 4, 5, 6 or 7, or differs by 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20 amino acid alteration(s). In one embodiment the term “consist” may be as defined in the above items (a) to (f)). Preferably, the peptide does not contain a full-length naturally occurring Spy0269, Spy0292, Spy0416A (amino acids 33-867), or Spy0872.
SEQ ID NO: 1, 2, 3, 4, 5, 6 or 7 provide core sequences useful for producing a protective immune response. SEQ ID NO: 1 provides an amino acid core from amino acids 37-488 of Spy0269. SEQ ID NO: 2 provides a core region of amino acids 23-184 of Spy0292. SEQ ID NO: 3 provides a core of amino acids 23-300 of Spy0292, which is a longer-length sequence containing the shorter-length core sequence of 23-184 of Spy0292 provided in SEQ ID NO: 2. Surprisingly, the shorter fragment Spy0292-1 (SEQ ID NO: 2) shows even greater protection in the mouse model compared to the longer fragment Spy0292-3 (SEQ ID NO: 3), as depicted in FIG. 1. As described above, smaller peptides are in general advantageous over larger ones, since they may be produced in a more economic manner, they reduce the probability of inducing antibodies which can cause cross-reactions with human tissues, and they facilitate the preparation of combination vaccines comprising more than one antigen. SEQ ID NO: 4, 5, and 6 provide different Spy0416A core sequences of varying activity. SEQ ID NO: 5 provides a common core of amino acids 148-458 of Spy0416A and has the lowest activity. SEQ ID NO: 6 provides a core sequence containing amino acids 72-558 of Spy0416A with greater activity than the shorter core. SEQ ID NO: 4 provides an amino acid core containing amino acids 34-677 of Spy0416, also with activity greater than the 148-458 core.
Based on the guidance provided herein different peptides can be designed taking into account the core sequences provided in SEQ ID NOs: 1-7. Such guidance includes structurally related peptides containing (1) internal alterations; (2) additional amino acid groups at the amino and/or carboxyl terminus; and/or (3) additional modification(s) as described herein.
For structurally related peptides, each amino acid alteration is independently either an addition, substitution, or deletion. In a further embodiment, the amino terminus is methionine. The presence of methionine may be useful for recombinant expression. In some cases, the methionine may be initially present as a result of translation and subsequently cleaved. Additional examples and embodiments, including broader embodiments and some further descriptions applicable for structurally related peptides such as functional variants are provided above, particularly in the description of functional active variants.
In another subject of the invention the peptide as described above comprises or consists of at least 2, preferably at least 3, more preferably at least 4 antigens as defined above. If two ore more peptides derived from the same full length sequence (e.g Spy0292 or Spy0416) are combined into one peptide, these sequences do preferably not overlap. In one embodiment the term “consist” may be as defined in the above items (a) to (f)).
In another embodiment of the invention the peptide as defined above may be modified by one or more of a variety of chemical techniques to produce derivatives having essentially the same activity (as defined above for fragments and variants) as the modified peptides, and optionally having other desirable properties. For example, carboxylic acid groups of the protein, whether C-terminal or side chain, may be provided in the form of a salt of a pharmaceutically-acceptable cation or esterified to form an ester, or converted to an amide. Amino groups of the peptide, whether amino-terminal or side chain, may be in the form of a pharmaceutically-acceptable acid addition salt, such as the HCl, HBr, acetic, benzoic, toluene sulfonic, maleic, tartaric and other organic salts, or may be converted to an amide. Hydroxyl groups of the peptide side chains may be converted to alkoxy or to an ester using well recognized techniques. Phenyl and phenolic rings of the peptide side chains may be substituted with one or more halogen atoms, such as fluorine, chlorine, bromine or iodine, or with alkyl, alkoxy, carboxylic acids and esters thereof, or amides of such carboxylic acids. Thiols can be protected with any one of a number of well recognized protecting groups, such as acetamide groups.
Peptides of this invention may be in combination with outer surface proteins or other proteins or antigens of other proteins. In such combination, the antigen may be in the form of a fusion protein. The antigen of the invention may be optionally fused to a selected peptide or protein derived from other microorganisms. For example, an antigen or polypeptide of this invention may be fused at its N-terminus or C-terminus to a polypeptide from another pathogen or to more than one polypeptide in sequence. Peptides which may be useful for this purpose include polypeptides identified by the prior art.
In an embodiment of the invention the peptide of the invention is fused to an epitope tag which provides an epitope to which an anti-tag substance can selectively bind. The epitope tag is generally placed at the amino- or carboxyl-terminus of the peptide but may be incorporated as an internal insertion or substitution as the biological activity permits. The presence of such epitope-tagged forms of a peptide can be detected using a substance such as an antibody against the tagged peptide. Also, provision of the epitope tag enables the peptide to be readily purified by affinity purification using an anti-tag antibody or another type of affinity matrix that binds to the epitope tag. Various tag polypeptides and their respective antibodies are well known in the art. Examples include poly-histidine (poly-his), poly-histidine-glycine (poly-his-gly) tags, the HA tag polypeptide, the c-myc tag, the Strep tag and the FLAG tag.
Fusions also may include the peptides or antigens of this invention fused or coupled to moieties other than amino acids, including lipids and carbohydrates. Further, antigens of this invention may be employed in combination with other vaccinal agents described by the prior art, as well as with other species of vaccinal agents derived from other microorganisms. Such proteins are useful in the prevention, treatment and diagnosis of diseases caused by a wide spectrum of Streptococcus isolates.
These fusion proteins are constructed for use in the methods and compositions of this invention. These fusion proteins or multimeric proteins may be produced recombinantly, or may be synthesized chemically.
The peptides of the invention may be prepared by any of a number of conventional techniques. Desired peptides may be chemically synthesized. An alternative approach involves generating the fragments of known peptides by enzymatic digestion, e.g., by treating the protein with an enzyme known to cleave proteins at sites defined by particular amino acid residues, or by digesting the DNA with suitable restriction enzymes, expressing the digested DNA and isolating the desired fragment. Yet another suitable technique involves isolating and amplifying a DNA fragment encoding a desired peptide fragment, by polymerase chain reaction (PCR). Oligonucleotides that define the desired termini of the DNA fragment are employed as the 5′ and 3′ primers in the PCR. Techniques for making mutations, such as deletions, insertions and substitutions, at predetermined sites in DNA, and therefore in proteins, having a known sequence are well known. One of skill in the art using conventional techniques, such as PCR, may readily use the antigens and peptides provided herein to identify and isolate other similar proteins. Such methods are routine and not considered to require undue experimentation, given the information provided herein. For example, variations can be made using oligonucleotide-mediated site-directed mutagenesis (Carter et al., Nucl. Acids Res., 13: 4431 (1985); Zoller et al., Nucl. Acids Res. 10: 6487 (1987)), cassette mutagenesis (Wells et al., Gene, 34: 315 (1985)), restriction selection mutagenesis (Wells et al., Philos. Trans. R. Soc. London SerA, 317: 415 (1986)), PCR mutagenesis, or other known techniques can be performed on the cloned DNA to produce the peptide of the invention.
Another subject of the present invention relates to a nucleic acid encoding a peptide of the invention, i.e. any peptide as defined above, or a nucleic acid complementary thereto. Nucleic acid molecules of the present invention may be in the form of RNA, such as mRNA or cRNA, or in the form of DNA, including, for instance, cDNA and genomic DNA e.g. obtained by cloning or produced by chemical synthetic techniques or by a combination thereof. The DNA may be double-stranded or single-stranded. Single-stranded DNA may be the coding strand, also known as the sense strand, or it may be the non-coding strand, also referred to as the anti-sense strand. Nucleic acid molecule as used herein also refers to, among other, single- and double-stranded DNA, DNA that is a mixture of single- and double-stranded RNA, and RNA that is a mixture of single- and double-stranded regions, hybrid molecules comprising DNA and RNA that may be single-stranded or, more typically, double-stranded, or a mixture of single- and double-stranded regions.
The nucleic acid may be a fragment of a nucleic acid occurring naturally in S. pyogenes, especially in S. pyogenes serotype M1, M2, M3, M4, M5, M6, M11, M12, M14, M19, M22, M24, M25, M28, M44, M49, M57, M59, M60, M61, M76, M83, M84, M87, M89 or M118, particularly S. pyogenes SF370. Preferably the nucleic acid has a sequence as defined in any of the sequences of SEQ ID NOS: 11 to 17 or of any of the homologous variants identified in the attached listing of nucleic acid sequence data. Examples of homologous sequences of a different serotype are those listed below:














Homologous


Full length nucleic
Nucleic acid
nucleic acid


acid sequence
of the invention
sequences


(SEQ ID NO)
(SEQ ID NO)
(SEQ ID NOS)







133
11
134 to 143


144
12
145 to 154


144
13
155 to 164


165
14
166 to 175


165
15
176 to 185


165
16
186 to 195


196
17
197 to 206









The nucleic acid also includes sequences that are a result of the degeneration of the genetic code. There are 20 natural amino acids, most of which are specified by more than one codon. Therefore, all nucleotide sequences are included in the invention which result in the peptide as defined above.
Additionally, the nucleic acid may contain one or more modified bases. Such nucleic acids may also contain modifications e.g. in the ribose-phosphate backbone to increase stability and half life of such molecules in physiological environments. Thus, DNAs or RNAs with backbones modified for stability or for other reasons are “nucleic acid molecule” as that feature is intended herein. Moreover, DNAs or RNAs comprising unusual bases, such as inosine, or modified bases, such as tritylated bases, to name just two examples, are nucleic acid molecule within the context of the present invention. It will be appreciated that a great variety of modifications have been made to DNA and RNA that serve many useful purposes known to those of skill in the art. The term nucleic acid molecule as it is employed herein embraces such chemically, enzymatically or metabolically modified forms of nucleic acid molecule, as well as the chemical forms of DNA and RNA characteristic of viruses and cells, including simple and complex cells, inter alia. For example, nucleotide substitutions can be made which do not affect the polypeptide encoded by the nucleic acid, and thus any nucleic acid molecule which encodes an antigen or fragment or functional active variant thereof as defined above is encompassed by the present invention.
Furthermore, any of the nucleic acid molecules encoding an antigen of the invention or fragment or functional active variant thereof can be functionally linked, using standard techniques such as standard cloning techniques, to any desired regulatory sequences, whether a S. pyogenes regulatory sequence or a heterologous regulatory sequence, heterologous leader sequence, heterologous marker sequence or a heterologous coding sequence to create a fusion protein.
The nucleic acid of the invention may be originally formed in vitro or in a cell in culture, in general, by the manipulation of nucleic acids by endonucleases and/or exonucleases and/or polymerases and/or ligases and/or recombinases or other methods known to the skilled practitioner to produce the nucleic acids.
In one embodiment of the invention the nucleic acid is located in a vector. A vector may additionally include nucleic acid sequences that permit it to replicate in the host cell, such as an origin of replication, one or more desired genes and/or selectable marker genes and other genetic elements known in the art such as regulatory elements directing transcription, translation and/or secretion of the encoded protein. The vector may be used to transduce, transform or infect a cell, thereby causing the cell to express inserted nucleic acids and/or proteins other than those native to the cell. The vector optionally includes materials to aid in achieving entry of the nucleic acid into the cell, such as a viral particle, liposome, protein coating or the like. Numerous types of appropriate expression vectors are known in the art for protein expression, by standard molecular biology techniques. Such vectors are selected from among conventional vector types including insects, e.g., baculovirus expression, or yeast, fungal, bacterial or viral expression systems. Other appropriate expression vectors, of which numerous types are known in the art, can also be used for this purpose. Methods for obtaining such expression vectors are well-known (see, e.g. Sambrook et al, Molecular Cloning. A Laboratory Manual, 2′′ edition, Cold Spring Harbor Laboratory, New York (1989)). In one embodiment, the vector is a viral vector. Viral vectors include, but are not limited to, retroviral and adenoviral vectors.
Suitable host cells or cell lines for transfection by this method include bacterial cells. For example, the various strains of E. coli are well-known as host cells in the field of biotechnology. Various strains of B. subtilis, Pseudomonas, Streptomyces, and other bacilli and the like may also be employed in this method. Many strains of yeast cells known to those skilled in the art are also available as host cells for expression of the peptides of the present invention. Other fungal cells or insect cells such as Spodoptera frugipedera (Sf9) cells may also be employed as expression systems. Alternatively, mammalian cells, such as human 293 cells, Chinese hamster ovary cells (CHO), the monkey COS-1 cell line or murine 3T3 cells derived from Swiss, BALB/c or NIH mice may be used. Still other suitable host cells, as well as methods for transfection, culture, amplification, screening, production, and purification are known in the art.
A peptide of the invention may be produced by expressing a nucleic acid of the invention in a suitable host cell. The host cells can be transfected, e.g. by conventional means such as electroporation with at least one expression vector containing a nucleic acid of the invention under the control of a transcriptional regulatory sequence. The transfected or transformed host cell is then cultured under conditions that allow expression of the protein. The expressed protein is recovered, isolated, and optionally purified from the cell (or from the culture medium, if expressed extracellularly) by appropriate means known to one of skill in the art. For example, the proteins are isolated in soluble form following cell lysis, or extracted using known techniques, e.g. in guanidine chloride. If desired, the peptides or fragments of the invention are produced as a fusion protein. Such fusion proteins are those described above. Alternatively, for example, it may be desirable to produce fusion proteins to enhance expression of the protein in a selected host cell or to improve purification. The molecules comprising the peptides and antigens of this invention may be further purified using any of a variety of conventional methods including, but not limited to: liquid chromatography such as normal or reversed phase, using HPLC, FPLC and the like; affinity chromatography (such as with inorganic ligands or monoclonal antibodies); size to exclusion chromatography; immobilized metal chelate chromatography; gel electro-phoresis; and the like. One of skill in the art may select the most appropriate isolation and purification techniques without departing from the scope of this invention. Such purification provides the antigen in a form substantially free from other proteinaceous and non-proteinaceous materials of the microorganism.
Another subject of the invention is a pharmaceutical composition, especially a vaccine, comprising

    (i) at least one peptide according to the invention, and/or
    (ii) at least one peptide comprising or consisting of the sequence of any of the SEQ ID NO: 8, SEQ ID NO: 9, or SEQ ID NO: 10, or a functional active variant thereof, and
    (iii) optionally a pharmaceutically acceptable carrier or excipient.


The variants of the peptides of (ii) are as defined and may be obtained as the peptides of (i) (see above description of the peptides of the invention). Preferred alterations of the sequences of SEQ ID NO: 8 or 10 are those listed in tables 8 and 9, respectively.
The peptides of (i) and (ii) are referred to as pharmaceutical peptides of the invention.
With respect to the peptide of (ii), these proteins have been shown for the first time to be capable to provide protection against lethal S. pyogenes challenge (see Example 1), particularly in a physiologically highly relevant intranasal challenge model. Especially protein Spy0895 (SEQ ID NO: 9) shows particular promise as a vaccine candidate, because it provided protection against group A streptococcal infection in all three models listed in Table 1.
A pharmaceutical peptide of the invention may be used for methods for immunizing or treating humans and/or animals with the disease caused by infection with S. pyogenes. Therefore, the pharmaceutical peptide may be used within a pharmaceutical composition. The pharmaceutical composition of the present invention may further encompass pharmaceutically acceptable carriers and/or excipients. The pharmaceutically acceptable carriers and/or excipients useful in this invention are conventional and may include buffers, stabilizers, diluents, preservatives, and solubilizers. Remington's Pharmaceutical Sciences, by E. W. Martin, Mack Publishing Co., Easton, Pa., 15th Edition (1975), describes compositions and formulations suitable for pharmaceutical delivery of the (poly)peptides herein disclosed. In general, the nature of the carrier or excipients will depend on the particular mode of administration being employed. For instance, parenteral formulations usually comprise injectable fluids that include pharmaceutically and physiologically acceptable fluids such as water, physiological saline, balanced salt solutions, aqueous dextrose, glycerol or the like as a vehicle. For solid compositions (e.g. powder, pill, tablet, or capsule forms), conventional non-toxic solid carriers can include, for example, pharmaceutical grades of mannitol, lactose, starch, or magnesium stearate. In addition to biologically neutral carriers, pharmaceutical compositions to be administered can contain minor amounts of non-toxic auxiliary substances, such as wetting or emulsifying agents, preservatives, and pH buffering agents and the like, for example sodium acetate or sorbitan monolaurate.
In a preferred embodiment the pharmaceutical composition further comprises an immunostimulatory substance such as an adjuvant. The adjuvant can be selected based on the method of administration and may include mineral oil-based adjuvants such as Freund's complete and incomplete adjuvant, Montanide incomplete Seppic adjuvant such as ISA, oil in water emulsion adjuvants such as the Ribi adjuvant system, syntax adjuvant formulation containing muramyl dipeptide, IC31TM (Intercell; a synthetic adjuvant comprising the peptide motif KLK [WO 02/32451] and an oligonucleotide [WO 01/93905]), or aluminum salt adjuvants. Preferably, the adjuvant is a mineral oil-based adjuvant, most preferably ISA206 (SEPPIC, Paris, France).
In other embodiments the immunostimulatory substance is selected from the group comprising polycationic polymers, especially polycationic peptides such as polyarginine, immunostimulatory deoxynucleotides (ODNs), especially Oligo(dIdC)13, peptides containing at least two LysLeuLys motifs, especially KLKLLLLLKLK (SEQ ID NO: 55), neuroactive compounds, especially human growth hormone, alum, adjuvants or combinations thereof. In further embodiments, the combination is either a polycationic polymer and immunostimulatory deoxynucleotides or of a peptide containing at least two LysLeuLys motifs and immunostimulatory deoxynucleotides. In a still another embodiment the polycationic polymer is a polycationic peptide.
The term “Oligo(dIdC)13” as used in the present invention means a phosphodiester backboned single-stranded DNA molecule containing 13 deoxy (inosine-cytosine) motifs, also defined by the term [oligo-d(IC)13]. The exact sequence is 5′-dIdCdIdCdIdCdIdCdIdCdIdCdIdCdIdCdIdCdIdCdIdCdIdCdIdC-3′. Oligo(dIdC)13 can also be defined by the terms (oligo-dIC26); oligo-dIC26-mer; oligo-deoxy IC, 26-mer; or oligo-dIC, 26-mer, as specified for example in WO 01/93903 and WO 01/93905.
In an embodiment the immunostimulatory substance is at least one immunostimulatory nucleic acid. Immunostimulatory nucleic acids are e.g. neutral or artificial CpG containing nucleic acids, short stretches of nucleic acids derived from non-vertebrates or in form of short oligonucleotides (ODNs) containing non-methylated cytosine-guanine dinucleotides (CpG) in a defined base context (e.g. as described in WO 96/02555). Alternatively, also nucleic acids based on inosine and cytidine as e.g. described in WO 01/93903, or deoxynucleic acids containing deoxy-inosine and/or deoxyuridine residues (described in WO 01/93905 and WO 02/095027) may preferably be used as immunostimulatory nucleic acids in the present invention. Preferably, mixtures of different immunostimulatory nucleic acids are used in the present invention. Additionally, the aforementioned polycationic compounds may be combined with any of the immunostimulatory nucleic acids as aforementioned. Preferably, such combinations are according to the ones described in WO 01/93905, WO 02/32451, WO 01/54720, WO 01/93903, WO 02/13857, WO 02/095027 and WO 03/047602.
In addition or alternatively, such pharmaceutical or vaccine composition may comprise a neuroactive compound. Preferably, the neuroactive compound is human growth factor, e.g. described in WO 01/24822. Also preferably, the neuroactive compound is combined with any of the polycationic compounds and/or immunostimulatory nucleic acids as defined above.
The composition may be used e.g. for immunization or treatment of a subject. The pharmaceutical composition encompasses at least one pharmaceutical peptide of the invention; however, it may also contain a cocktail (i.e., a simple mixture) containing different pharmaceutical peptides (including fragments and other variants) of the invention, optionally mixed with different antigenic proteins or peptides of other pathogens. Such mixtures of these peptides, polypeptides, proteins or fragments or variants thereof are useful e.g. in the generation of desired antibodies to a wide spectrum of Streptococci isolates. The pharmaceutical peptide(s) of the present invention may also be used in the form of a pharmaceutically acceptable salt. Suitable acids and bases which are capable of forming salts with the peptides of the present invention are well known to those of skill in the art, and include inorganic and organic acids and bases.
Still another subject of the invention is a pharmaceutical composition containing a nucleic acid selected from the group consisting of:

    (i) a nucleic acid of the invention and/or a nucleic acid complementary thereto, and/or
    (ii) a nucleic acid coding for the peptide comprising or consisting of the sequence of any of the SEQ ID NO: 8, SEQ ID NO: 9, or SEQ ID NO: 10, particularly a DNA sequence of any of the SEQ ID NO: 18, SEQ ID NO: 19, or SEQ ID NO: 20, or a functional active variant thereof or a nucleic acid complementary thereto or the corresponding RNA sequence, and
    (iii) optionally a pharmaceutically acceptable carrier or excipient.


The variants of the nucleic acids of (ii) are as defined and may be obtained as the nucleic acids of (i) (see above description of the nucleic acids of the invention). The nucleic acids of (i) and (ii) are referred to as pharmaceutical nucleic acids of the invention.
The pharmaceutical nucleic acid sequences, alone or in combination with other nucleic acid sequences encoding antigens or antibodies or directed to other pathogenic microorganisms, may further be used as components of a pharmaceutical composition. The composition may be used for immunizing or treating humans and/or animals being susceptible to or having a disease caused by infection with S. pyogenes, particularly S. pyogenes serotype M1, M2, M3, M4, M5, M6, M11, M12, M14, M19, M22, M24, M25, M28, M44, M49, M57, M59, M60, M61, M76, M83, M84, M87, M89 or M118, especially S. pyogenes SF370. The pharmaceutically acceptable carrier or excipient may be as defined above.
In another embodiment, the pharmaceutical nucleic acids of this invention, alone or in combination with nucleic acid sequences encoding other antigens or antibodies from other pathogenic microorganisms, may further be used in compositions directed to actively induce a protective immune response in a subject to the pathogen. These components of the present invention are useful in methods for inducing a protective immune response in humans and/or animals against infection with S. pyogenes, particularly with S. pyogenes serotype M1, M2, M3, M4, M5, M6, M11, M12, M14, M19, M22, M24, M25, M28, M44, M49, M57, M59, M60, M61, M76, M83, M84, M87, M89 or M118, especially S. pyogenes SF370.
For use in the preparation of the therapeutic or vaccine compositions, nucleic acid delivery compositions and methods are useful, which are known to those of skill in the art. The pharmaceutical nucleic acid of the invention may be employed in the methods of this invention or in the compositions described herein as DNA sequences, either administered as naked DNA, or associated with a pharmaceutically acceptable carrier and provide for in vivo expression of the antigen, peptide or polypeptide. So-called “naked DNA” may be used to express the antigen, peptide or polypeptide of the invention in vivo in a patient. (See, e.g., J. Cohen, Science, 259: 1691-1692, which describes similar uses of “naked DNA”). For example, “naked DNA” associated with regulatory sequences may be administered therapeutically or as part of the vaccine composition e.g., by injection.
Alternatively, a nucleic acid, especially a pharmaceutical nucleic acid according to the invention, encoding an antigen or peptide of the invention or a nucleic acid complementary thereto may be used within a pharmaceutical composition, e.g. in order to express the antigen or (pharmaceutical) peptide of the invention in vivo, e.g., to induce antibodies.
A preferred embodiment of the invention relates to a pharmaceutical composition, wherein the pharmaceutical nucleic acid according to the invention is comprised in a vector and/or a cell. Vectors and cells suitable in the context of the present invention are described above. Vectors are particularly employed for a DNA vaccine. An appropriate vector for delivery may be readily selected by one of skill in the art. Exemplary vectors for in vivo gene delivery are readily available from a variety of academic and commercial sources, and include, e.g., adeno-associated virus (International patent application No. PCT/US91/03440), adenovirus vectors (M. Kay et al, Proc. Natl. Acad. Sci. USA, 91: 2353 (1994); S. Ishibashi et al, J. Clin. Invest., 92: 883 (1993)), or other viral vectors, e.g., various poxviruses, vaccinia, etc. Recombinant viral vectors, such as retroviruses or adenoviruses, are preferred for integrating the exogenous DNA into the chromosome of the cell.
Another subject of the invention relates to an antibody or functional active fragment thereof which binds specifically to the antigen of the invention. The present invention includes, for example, monoclonal and polyclonal antibodies, chimeric, single chain, and humanized antibodies, as well as Fab fragments, or the product of a Fab expression library.
While S. pyogenes infections are primarily a disease of children and cause non-severe diseases such as bacterial pharyngitis and impetigo, GAS are also responsible for streptococcal toxic shock syndrome associated necrotizing fasciitis (Cone, L., et al. (1987). New Engl J Med 317: 146-9; Stevens, D. (1992). Clin Infect Dis 14: 2-11) and several post-streptococcal sequelae such as acute rheumatic fever, acute glomerulonephritis and reactive arthritis. It would be very beneficial to provide monoclonal or polyclonal antibody therapies which target antigenic proteins of S. pyogenes and have the potential to support a therapy of an infection or eliminate the pathogen and the disease altogether.
In a preferred embodiment the antibody is a monoclonal, polyclonal, chimeric or humanized antibody or functional active variant thereof. In another preferred embodiment the functional active fragment comprises a Fab fragment.
Antibodies generated against the antigens, fragments or variants thereof of the present invention can be obtained by direct injection of the antigens, fragments or variants thereof into an animal or by administering the antigens, fragments or variants thereof to an animal, preferably a non-human. The antibody so obtained will then bind the antigens, fragments or variants. Such antibodies can then be used to isolate reactive antigens, fragments or variants thereof from tissue expressing those.
For preparation of monoclonal antibodies, any technique known in the art, which provides antibodies produced by continuous cell line cultures, e.g. a hybridoma cell line, can be used.
Techniques described for the production of single chain antibodies (U.S. Pat. No. 4,946,778) can be adapted to produce single chain antibodies to the antigens, fragments or variants thereof according to this invention. Also, transgenic mice or other organisms such as other mammals may be used to express humanized antibodies to antigens, fragments or variants thereof according to this invention.
Still another subject of the invention relates to a hybridoma cell line which produces the antibody of the invention.
Hybridoma cell lines expressing desirable monoclonal antibodies are generated by well-known conventional techniques. The hybridoma cell can be generated by fusing a normal-activated, antibody-producing B cell with a myeloma cell. In the context of the present invention the hybridoma cell is able to produce an antibody specifically binding to the antigen of the invention.
Similarly, desirable high titre antibodies are generated by applying known recombinant techniques to the monoclonal or polyclonal antibodies developed to these antigens (see, e.g., PCT Patent Application No. PCT/GB85/00392; British Patent Application Publication No. GB2188638A; Amit et al., Science, 233: 747-753 (1986); Queen et al., Proc. Natl. Acad. Sci. USA, 86: 10029-10033 (1989); PCT Patent Application No. WO90/07861; Riechmann et al., Nature, 332: 323-327 (1988); Huse et al., Science, 246: 1275-1281 (1988)).
The present invention also provides a method for producing an antibody according to the invention, characterized by the following steps:

    (a) administering an effective amount of the peptide according to the invention to an animal; and
    (b) isolating the antibody produced by the animal in response to the administration of step (a) from the animal.


Another subject of the invention relates to a method for producing an antibody according to the invention, characterized by the following steps:

    (a) contacting a B cell with an effective amount of the peptide according to the invention;
    (b) fusing the B cell of step (a) with a myeloma cell to obtain a hybridoma cell; and
    (c) isolating the antibody produced by the cultivated hybridoma cell.


More particularly, the antibody may be produced by initiating an immune response in a non-human animal by administrating a peptide of the invention to an animal, removing an antibody containing body fluid from said animal, and producing the antibody by subjecting said antibody containing body fluid to further purification steps. Alternatively, the antibody may be produced by initiating an immune response in a non-human animal by administrating an antigen, fragment or variant thereof, as defined in the present invention, to said animal, removing the spleen or spleen cells from said animal and/or producing hybridoma cells of said spleen or spleen cells, selecting and cloning hybridoma cells specific for said antigen, fragment or variant thereof and producing the antibody by cultivation of said cloned hybridoma cells.
In a preferred embodiment the antibody produced according to a method of the invention is additionally purified. Methods of purification are known to the skilled artisan.
The antibody may be used in methods for preventing or treating an infection. Accordingly, still another subject of the invention relates to a pharmaceutical composition, especially a vaccine, comprising an antibody of the invention. The pharmaceutical composition may encompass further components as detailed above. The composition may further encompass substances increasing their capacity to stimulate T cells. These include T helper cell epitopes, lipids or liposomes or preferred modifications as described in WO01/78767. Another way to increase the T cell stimulating capacity of epitopes is their formulation with immune stimulating substances for instance cytokines or chemokines like interleukin-2, -7, -12, -18, class I and II interferons (IFN), especially IFN-gamma, GM-CSF, TNF-alpha, flt3-ligand and others.
A further subject of the invention relates to a pharmaceutical composition comprising the pharmaceutical peptide of the invention or the pharmaceutical nucleic acid of the invention or an antibody of the invention or functional fragment thereof for the immunization of a subject against an infection or the treatment of a subject having an infection, wherein the infection is preferably a S. pyogenes infection. In another aspect of the invention a pharmaceutical peptide of the invention or a pharmaceutical nucleic acid of the invention or an antibody of the invention or functional fragment thereof is used for the manufacture of a medicament for the immunization of a subject against an infection or the treatment of a subject having an infection, wherein the infection is preferably a S. pyogenes infection, more preferably an infection with S. pyogenes serotype M1, M2, M3, M4, M5, M6, M11, M12, M14, M19, M22, M24, M25, M28, M44, M49, M57, M59, M60, M61, M76, M83, M84, M87, M89 or M118, especially S. pyogenes SF370. Alternatively, a pharmaceutical peptide or a pharmaceutical nucleic acid of the invention or an antibody of the invention or functional fragment thereof is used in a method of immunizing or treating a subject in need thereof, wherein an effective amount of the pharmaceutical peptide or the pharmaceutical nucleic acid of the invention or an antibody of the invention or functional fragment thereof is administered to the subject. The subject may be immunized in order to prevent an infection, particularly a S. pyogenes infection, or may be treated to ameliorate or cure an infection, particularly a S. pyogenes infection. The determination of the effective amount to be administered is within the knowledge of the skilled practitioner. Exemplary amounts are mentioned below.
The pharmaceutical peptides or the pharmaceutical nucleic acids of the invention are generally useful for inducing an immune response in a subject. The vaccine used for immunization may be administered to a subject susceptible to infection by S. pyogenes, preferably mammals, and still more preferably humans. Potential modes of administration include oral, intranasal, intramuscular, intra-lymph node, intradermal, intraperitoneal, subcutaneous, and combinations thereof, but most preferably intramuscular injection. The volume of the dose for intramuscular administration is preferably up to about 5 mL, for example, between 0.3 mL and 3 mL, between 1 mL and 3 mL, about 0.5 to 1 mL, or about 2 mL. The amount of protein comprising the antigen in each dose should be enough to confer effective immunity to decrease the risk of developing clinical signs, e.g. resulting from S. pyogenes infection. In different embodiments, the unit dose of protein should be up to about 5 μg protein/kg body weight, between about 0.2 to 3 μg, between about 0.3 to 1.5 μg, between about 0.4 to 0.8 μg, or about 0.6 μg. In alternative embodiments unit doses of protein could be up to about 6 μg protein/kg body weight, between about 0.05 to 5 μg, or between about 0.1 to 4 μg. In different embodiments, the dose is administered 1 to 3 times, e.g. with an interval of 1 to 3 weeks. Representative amounts of protein per dose are from approximately 1 μg to approximately 1 mg, more preferably from approximately 5 μg to approximately 500 μg, still more preferably from approximately 10 μg to approximately 250 μg and most preferably from approximately 25 μg to approximately 100 μg.
In still another aspect of the invention the antibody of the invention or functional fragment thereof is used for the manufacture of a medicament for the treatment of an infection, preferably a S. pyogenes infection, more preferably an infection with S. pyogenes serotype M1, M2, M3, M4, M5, M6, M11, M12, M14, M19, M22, M24, M25, M28, M44, M49, M57, M59, M60, M61, M76, M83, M84, M87, M89 or M118, especially S. pyogenes SF370. Alternatively, the antibody of the invention is used in a method of treating a subject in need thereof, wherein an effective amount of the antibody of the invention is administered to the subject. The subject may be treated to ameliorate or cure an infection, particularly a S. pyogenes infection. The determination of the effective amount to be administered is within the knowledge of the skilled practitioner.
The treatment involves administering an effective amount of an antibody of the invention to a subject, preferably a mammal, more preferably a human. Thus, antibodies against the antigens, fragments or variants thereof of the present invention may be employed to inhibit and/or treat infections, particularly bacterial infections and especially infections arising from S. pyogenes, especially S. pyogenes serotype M1, M2, M3, M4, M5, M6, M11, M12, M14, M19, M22, M24, M25, M28, M44, M49, M57, M59, M60, M61, M76, M83, M84, M87, M89 or M118, especially S. pyogenes SF370.
An “effective amount” of a pharmaceutical peptide, a pharmaceutical nucleic acid or an antibody of the invention may be calculated as that amount capable of exhibiting an in vivo effect, e.g. preventing or ameliorating a sign or symptom of infection, particularly S. pyogenes infection, especially of S. pyogenes serotype M1, M2, M3, M4, M5, M6, M11, M12, M14, M19, M22, M24, M25, M28, M44, M49, M57, M59, M60, M61, M76, M83, M84, M87, M89 or M118, especially S. pyogenes SF370. Such amounts may be determined by one of skill in the art. Preferably, such a composition is administered parenterally, preferably intramuscularly or subcutaneously. However, it may also be formulated to be administered by any other suitable route, including orally or topically. The selection of the route of delivery and dosage of such therapeutic compositions is within the skill of the art.
Treatment in the context of the present invention refers to both therapeutic treatment and prophylactic or preventative measures, wherein the object is to prevent or slow down (lessen) the targeted pathologic condition or disorder. Those in need of treatment include those already with the disorder as well as those prone to have the disorder or those in whom the disorder is to be prevented.
Another subject of the invention relates to a method of diagnosing a S. pyogenes infection comprising the steps of:

    (a) contacting a sample obtained from a subject with the peptide according to the invention; and
    (b) detecting the presence of an antibody against S. pyogenes in the sample.


The peptides of the invention may be used for the detection of the S. pyogenes, particularly S. pyogenes serotype M1, M2, M3, M4, M5, M6, M11, M12, M14, M19, M22, M24, M25, M28, M44, M49, M57, M59, M60, M61, M76, M83, M84, M87, M89 or M118, especially S. pyogenes SF370. Preferably such detection is for diagnosis, more preferable for the diagnosis of a disease, most preferably for the diagnosis of a S. pyogenes infection. The peptides or polypeptides may be used to detect the presence of a S. pyogenes-specific antibody or fragment thereof e.g. in a sample obtained from a subject. The sample may be e.g. a blood sample. Alternatively, the presence of a S. pyogenes-specific antigen can be detected using an antibody of the invention.
Accordingly, an alternative method of diagnosing a S. pyogenes infection comprises the steps of:

    (a) contacting a sample obtained from a subject with the antibody according to the invention; and
    (b) detecting the presence of an antigen of S. pyogenes in the sample.


The present invention also relates to diagnostic assays such as quantitative and diagnostic assays for detecting levels of the peptides or antibodies of the present invention in cells and tissues or body fluids, including determination of normal and abnormal levels. Assay techniques that can be used to determine levels of a peptide or an antibody, in a sample derived from a host are well known to those of skill in the art. Such assay methods include radioimmunoassays, competitive-binding assays, Western Blot analysis and ELISA assays. Among these, ELISAs frequently are preferred. An ELISA assay initially comprises preparing an antibody specific to the peptide, particularly the antigen, preferably a monoclonal antibody. In addition, a reporter antibody generally is prepared which binds to the monoclonal antibody. The reporter antibody is attached to a detectable reagent such as radioactive, fluorescent or enzymatic reagent, such as horseradish peroxidase enzyme.
The peptides or antibodies of the present invention may also be used for the purpose of or in connection with an array. More particularly, at least one of the peptides or antibodies of the present invention may be immobilized on a support. Said support typically comprises a variety of antigens and fragments thereof whereby the variety may be created by using one or several of the peptides or antibodies of the present invention. The characterizing feature of such array as well as of any array in general is the fact that at a distinct or predefined region or position on said support or a surface thereof, a distinct polypeptide is immobilized. Because of this any activity at a distinct position or region of an array can be correlated with a specific polypeptide. The number of different peptides or antibodies of the present invention immobilized on a support may range from as little as 10 to several 1000 different peptides or antibodies of the present invention.
The manufacture of such arrays is known to the one skilled in the art and, for example, described in U.S. Pat. No. 5,744,309. The array preferably comprises a planar, porous or non-porous solid support having at least a first surface. Preferred support materials are, among others, glass or cellulose. It is also within the present invention that the array is used for any of the diagnostic applications described herein. Apart from the peptides or antibodies of the present invention also the nucleic acid molecules according to the present invention to may be used for the generation of an array as described above.
Another aspect of the invention relates to a method for identifying a ligand capable of binding to a peptide according to the invention comprising:

    (a) providing a test system comprising the peptide,
    (b) contacting the test system with a test compound, and
    (c) detecting a signal generated in response to the binding of the test compound to the peptide.


More particularly, the method may be carried out by contacting an isolated or immobilized peptide according to the invention with a candidate ligand under conditions to permit binding of the candidate ligand to the peptide, wherein the test system comprises a component capable of providing a detectable signal in response to the binding of the candidate ligand to said peptide; and detecting the presence or absence of a signal generated in response to the binding of the ligand to the peptide. The ligand may be an agonist or an antagonist.
Test systems for detection binding of a ligand are known to the skilled artisan and include e.g. binding assays with labeled ligand such as radioligands, fluorescence-labeled ligands or enzyme-labeled ligands.
The test compound can be any test compound either naturally occurring or chemically synthesized. Naturally occurring test compounds include in particular antibodies, preferably those showing similarity to the antibodies of the invention. In one preferred embodiment of the invention the test compound is provided in the form of a chemical compound library. Chemical compound libraries include a plurality of chemical compounds and have been assembled from any of multiple sources, including chemically synthesized molecules and natural products, or have been generated by combinatorial chemistry techniques. They are especially suitable for high throughput screening. They may be comprised of chemical compounds of a particular structure or compounds of a particular creature such as a plant.
The method for identifying a ligand may also include the following steps:

    (a) providing a peptide according to the invention,
    (b) providing an interaction partner to the peptide especially an antibody according to the invention,
    (c) allowing interaction of the peptide to said interaction partner to form a interaction complex,
    (d) providing a test compound,
    (e) allowing a competition reaction to occur between the test compound and the interaction complex, and
    (f) determining whether the test compound inhibits or reduces the interaction activities of the peptide with the interaction partner.


The ligands identified may be employed, for instance, to inhibit diseases arising from infection with Streptococcus, especially S. pyogenes and may therefore be formulated in a pharmaceutical composition.
In a last aspect, the peptide according to the invention is used for the isolation and/or purification and/or identification of a ligand of the peptide, wherein the isolation and/or purification and/or identification of the ligand may be carried out as detailed above or as known to the person skilled in the art. In a preferred embodiment of the invention an affinity device may be used. The affinity device may comprise as least a support material and any peptide according to the present invention, which is attached to the support material. Because of the specificity of the peptides according to the present invention for their target cells or target molecules or their interaction partners, the peptides allow a selective removal of their interaction partner(s) from any kind of sample applied to the support material provided that the conditions for binding are met. The sample may be a biological or medical sample, including but not limited to, fermentation broth, cell debris, cell preparation, tissue preparation, organ preparation, blood, urine, lymph liquid, liquor and the like. The peptide may be attached to the matrix in a covalent or non-covalent manner. Suitable support material is known to the one skilled in the art and can be selected from the group comprising cellulose, silicon, glass, aluminium, paramagnetic beads, starch and dextrane.



The present invention is further illustrated by the following figures, examples and the sequence data, from which further features, embodiments and advantages may be taken. It is to be understood that the present examples are given by way of illustration only and not by way of limitation of the disclosure.
FIG. 1 shows the protection achieved by active immunization with selected S. pyogenes antigens and sub-constructs in a mouse lethality model.
FIG. 2 shows the protection achieved by active immunization with selected S. pyogenes antigens and sub-constructs in a mouse lethality model.
FIG. 3 shows the protection achieved by active immunization with selected S. pyogenes antigens and sub-constructs in a mouse lethality model.
FIG. 4 shows the protection achieved by active immunization with selected S. pyogenes antigens in a mouse lethality model.



Table 1 shows the recombinant proteins of S. pyogenes and fragments thereof assessed for protection in murine models of infection.
Table 2 shows the oligonucleotides used for the cloning of genes encoding antigenic proteins and fragments thereof of S. pyogenes. 
Table 3 shows the S. pyogenes strains used for the gene conservation study.
Table 4 shows the oligonucleotides used for PCR and sequencing of the S. pyogenes genes.
Table 5 shows the variable amino acid positions of Spy0269 from S. pyogenes strains.
Table 6 shows the variable amino acid positions of Spy0292 from S. pyogenes strains.
Table 7 shows the variable amino acid positions of Spy0416 from S. pyogenes strains.
Table 8 shows the variable amino acid positions of Spy0488 from S. pyogenes strains.
Table 9 shows the variable amino acid positions of Spy0872 from S. pyogenes strains.
Table 10 shows the variable amino acid positions of Spy0895 from S. pyogenes strains.
Table 11 shows the variable amino acid positions of Spy1536 from S. pyogenes strains.
Table 12 shows the variable amino acid positions of Spy1666 from S. pyogenes strains.
FIGURES
FIG. 1: Protection achieved by active immunization with selected S. pyogenes antigens and sub-constructs in a mouse lethality model. CD-1 mice (10 mice per group) were immunized subcutaneously with recombinant antigens cloned from an emm type 1 S. pyogenes strain (SF370) and challenged with the MA-A20 (emm type 23) strain. Survival was monitored for 14 days post-challenge. Mice were immunized subcutaneously with 50 μg recombinant protein adjuvanted with CFA/IFA. (A) Spy0292, and its sub-constructs Spy0292-1 and Spy0292-3; Spy0488; (B) Spy0872 and its sub-construct Spy0872-2. Anesthetized mice were challenged intranasally with 108 cfu S. pyogenes MA-A20. Adjuvant control mice were used as negative controls, while M1 (Spy2018) served as positive control. Numbers of surviving mice are plotted as percentage of total mice.
FIG. 2: Protection achieved by active immunization with selected S. pyogenes antigens and sub-constructs in a mouse lethality model. CD-1 mice (10 mice per group) were immunized subcutaneously with recombinant antigens cloned from an emm type 1 S. pyogenes strain (SF370) and challenged with the MA-A20 (emm type 23) strain. Survival was monitored for 14 days post-challenge. Mice were immunized subcutaneously with 50 μg recombinant protein adjuvanted with CFA/IFA. (A) Spy0269 and its sub-construct Spy0269-1; (B) Spy0416A and 3 sub-constructs (Spy0416A-1, Spy0416A-6 and Spy0416A-7) and Spy0416B. Anesthetized mice were challenged intranasally with 108 cfu S. pyogenes MA-A20. Adjuvant control mice were used as negative controls, while M1 protein (Spy2018) served as positive control. Numbers of surviving mice are plotted as percentage of total mice.
FIG. 3: Protection achieved by active immunization with selected S. pyogenes antigens or sub-constructs in a mouse lethality model. CD-1 mice (10 mice per group) were immunized subcutaneously with recombinant antigens cloned from an emm type 1 S. pyogenes strain (SF370) and challenged with the MA-A20 (emm type 23) strain. Survival was monitored for 14 days post-challenge. Mice were immunized subcutaneously with 50 μg recombinant protein adjuvanted with aluminum hydroxide. (A) Spy1727, Spy0269-1, Spy0872-2, and Spy0416A-1; (B) Spy1666, Spy1536, Spy0895, and Spy0292-1. Anesthetized mice were challenged intranasally with 108 cfu S. pyogenes MA-A20. Adjuvant control mice were used as negative controls, while M1 protein (Spy2018) served as positive control. Numbers of surviving mice are plotted as percentage of total mice.
FIG. 4: Protection achieved by active immunization with selected S. pyogenes antigens in a mouse lethality model. BALB/c mice (10 mice per group) were immunized intranasally with recombinant antigens cloned from an emm type 1 S. pyogenes strain (SF370) and challenged either with (A) MA-A20 (emm type 23) strain or with (B) MA-A147 (emm type 11/106) strain. Survival was monitored for 14 days post-challenge. Mice were immunized intranasally with 30-50 μg recombinant protein adjuvanted with IC31TM. (A) Spy1536 and Spy0895; (B) Spy1727 and Spy1536. Anesthetized mice were challenged intranasally with 106 cfu S. pyogenes MA-A20 or 108 cfu S. pyogenes MA-A147. Adjuvant control mice were used as negative controls, while M1 protein (Spy2018) served as positive control. Numbers of surviving mice are plotted as percentage of total mice.
EXAMPLES
Example 1
Group A Streptococcal Antigens and Fragments Thereof Inducing Protective Immune Responses Against Lethal Sepsis in Intranasal Challenge Models
Experimental Procedures
Cloning and Expression of Recombinant Pneumococcal Proteins
Cloning of Genes/DNA Fragments:
The gene/DNA fragment of interest (see Table 1) was amplified from genomic DNA of Streptococcus pyogenes SF370 (serotype M1) by PCR using gene specific primers (see Table 2). Apart from the gene specific part, the primers had restriction sites that aided in a directional cloning of the amplified PCR product. The gene annealing (specific) part of the primer ranged between 15-30 bases in length. The PCR products obtained were digested with the appropriate restriction enzymes and cloned into the pET28b (+) vector (Novagen) for His-tagged proteins. The constructs including full length and fragments of the selected antigens are listed in Table 1. Once the recombinant plasmid was confirmed to contain the gene of interest, E. coli BL21 Star® cells (Invitrogen) that served as expression host were transformed.
Expression and Purification of Proteins:
E. coli BL21 Star® cells harboring the recombinant plasmid were grown into log phase in the required culture volume. Once an OD600nm of 0.6 was reached the culture was induced with 0.5 mM IPTG (isopropyl-beta-D-thiogalactopyranoside) at 37° C. for 3 hours. The cells were harvested by centrifugation, lysed by a combination of the freeze-thaw method followed by disruption of cells with BugBuster® (Novagen). The lysate was separated by centrifugation into soluble (supernatant) and insoluble (pellet) fractions. Depending on the location of the protein different purification strategies were applied.
A) If the His-tagged protein was in the soluble fraction, protein purification was done by binding the supernatant to Ni-Sepharose beads (Ni-SepharoseTM 6 Fast Flow, GE Healthcare). Due to the presence of the hexa Histidine (6×HIS) at the C terminus of the expressed protein, it bound to the Ni-Sepharose while the other contaminating proteins were washed from the column by wash buffer. The protein was eluted by 500 mM Imidazole in 20 mM NaH2PO4, 0.5 mM NaCl buffer at pH 7.4. The eluate was concentrated, assayed by Bradford for protein concentration and checked by SDS-PAGE and Western blot.
B) If the protein was present in the insoluble fraction the pellet was solubilized in suitable buffer containing 8 M urea and applied onto the Ni-NTA column under denaturing conditions (in buffer containing 8 M urea) using the same materials and procedure as mentioned above. Contaminating proteins were washed from the column by wash buffer without urea. Refolding of the His-tagged protein was performed while the protein was immobilized on the Ni-NTA matrix. After renaturation, proteins were eluted by the addition of 500 mM Imidazole. The eluate was dialyzed to remove traces of urea and concentrated if the volume was large, checked by SDS-PAGE and measured by the Bradford method.
Animal Protection Studies
Animals:
CD-1 or BALB/c female mice (6-8 weeks) were used.
Active Immunization (Subcutaneous Route):
50 μg of recombinant proteins buffered in PBS were injected subcutaneously into CD-1 mice (volume 100 μL), adjuvanted with Complete Freund adjuvant (CFA, final concentration: 50%), aluminium hydroxide (ALUM, final concentration: 1%) or IC31TM (final concentration: 100 nmol L-KLKLLLLLKLK (SEQ ID NO: 55), 4 nmol oligodexoynucleotide ODN 1 a (dIdC)13 in PBS) (Intercell AG, Vienna, Austria). Animals were boosted twice with the same amount of protein and adjuvant (except for CFA where Incomplete Freund adjuvant (IFA) was used for the booster immunizations; final concentration: 50%), at days 14 and 28. The published (Dale et al., J. Immunol. 151: 2188 (1993)) protective M1 or M23 protein antigens were used as positive controls, while mice immunized with adjuvant only served as negative controls. Antibody titers were measured at day 35 by ELISA using the respective recombinant proteins.
Active Immunization (Intranasal Route):
30-50 μg of recombinant proteins buffered in PBS were injected intranasally into BALB/c mice (volume 20 μL), adjuvanted with IC31TM (final concentration: 10 nmol L-KLKLLLLLKLK (SEQ ID NO: 55), 0.4 nmol oligodexoynucleotide ODN1a (dIdC)13 in PBS) (Intercell AG, Vienna, Austria). Animals were boosted three times with the same amount of protein and adjuvant at days 7, 14 and 28. The published protective M1 or M23 protein antigens were used as positive controls, while mice immunized with adjuvant only served as negative controls. Antibody titers were measured at day 35 by ELISA using the respective recombinant proteins.
Bacterial Challenge:
Freshly grown S. pyogenes strains MA-A20 or MA-A147 were used. 1 mL bacterial suspension from an o/n culture of the respective S. pyogenes strain was added to 50 mL THY culture medium. Optical density was measured until the bacterial suspension reached an OD600nm between 0.4 and 0.6. Bacterial counts were determined using an individually established growth curve. Bacterial cells were spun down and adjusted with PBS to obtain the desired cfu count. In order to determine the viable cell numbers present in the bacterial inoculum, cfus were determined via plating on blood agar plates. 106-108 cfus were applied intranasally (20 μL) into individually anesthetized mice. Protection by immunization was measured by a bacteraemia/sepsis model where survival rates were followed for 2 to 3 weeks post-challenge and survival was expressed in percentage of the total number of animals (10 mice/group).
Results
Group A streptococcal antigens and/or their fragments were identified showing protection in an intranasal mouse sepsis/lethality model. As the target indication for a preventive vaccine in humans is pharyngitis, an intranasal challenge model for the evaluation of candidate antigens is believed to be physiologically more relevant than an intravenous or intraperitoneal model, which have been described previously (Guzman et al., J. Inf. Dis. 179: 901 (1999); Stalhammar-Carlemalm et al., Mol. Microbiol. 33: 208 (1999)). Therefore protection was assessed in three distinct models, all applying the bacterial challenge via the intranasal route. Protection was observed for 9 distinct proteins in the intranasal challenge model, some of which were tested as a fragment of the full length recombinant protein.
Since protection against streptococcal challenge is mediated by antibodies, immunizations were first performed using CFA/IFA as adjuvant in order to obtain very high levels of antibodies. Subsequently, experiments were also performed with Alum and IC31TM as adjuvants, as these adjuvants are suited for use in humans and would be a preferred choice for a vaccine to prevent group A streptococcal infections in humans. As can be seen for the experiment depicted in FIG. 1, fragment Spy0292-1 performed as well as full length Spy0292 protein for protection, while Spy0292-3 showed lower levels of protection. This clearly indicates that one region useful for protection lies within the sequence encompassing the Spy0292-1 protein.
Similar results were obtained for the proteins, Spy0269 (good protection also observed with Spy0269-1), Spy0416 (good protection also observed with Spy0416A-1, Spy0416A-6 and Spy0416A-7), and Spy0872 (good protection also observed with Spy0872-2).
For the proteins Spy0488, Spy0895, and Spy1727 full length recombinant proteins were used (Table 1), as these proteins have been shown for the first time to be capable to provide protection against lethal S. pyogenes challenge. Especially protein Spy0895 shows promise as a vaccine candidate, because it provided protection against group A streptococcal infection in all three models listed in Table 1.
Spy1536 and Spy1666 have been shown to provide protection in an intravenous challenge model before (WO 2004/078907), but importantly it could now be shown that they also provide protection in the physiologically more relevant intranasal challenge model. Spy1536 was most consistent in providing significant protection in all three models of GAS infection. Besides these two antigens, Spy0895 and Spy1536, several antigens showed protection in at least 2 models: Spy0269-1, Spy0292-1, Spy0416A-1, Spy0872-2, Spy1666 and Spy1727. Importantly, several antigens showed a level of protection that was as high as the level seen for the positive control protein M1 (e.g. Spy0416A-1, Spy0488, Spy0895; Table 1).
These data clearly provide evidence, that the selected proteins are promising candidates for vaccine development. In addition, proteins Spy0269, Spy0292, Spy0416, and Spy0872 have been shown to possess amino acid sequences that are dispensable for protection, since sub-fragments were capable to provide the same or even superior levels of protection than the full length recombinant protein.







TABLE 1







Recombinant proteins of S. pyogenes and fragments thereof assessed for


protection in murine models of infection.
















Amino








Length1
acids1
SEQ
Calculated

Base pairs1


ORF/Protein
(aa)
(from-to)
ID No
MW (kDa)2
Vector
(from-to)
Protection3

















Spy0269
837
36-873
57
92.34
pET28b
106-2619
10% (30%, 60%)A


Spy0269-1
452
37-488
1
50.85
pET28b
109-1464
50% (10%, 50%)B,A,C


Spy0292
388
23-410
68
44.91
pET28b
 67-1233
60% (10%, 90%)A,C


Spy0292-1
162
23-184
2
19.41
pET28b
67-554
56% (10%, 90%)A,B


Spy0292-3
278
23-300
3
32.39
pET28b
67-900
30% (10%, 90%)A


Spy0416A
834
34-867
89
95.80
pET28b
100-2601
20% (10%, 63%)A


Spy0416A-1
644
34-677
4
74.70
pET28b
100-2031
80% (20%, 80%)C,A


Spy0416A-6
311
148-458 
5
38.77
pET28b
442-1374
40% (10%, 63%)A


Spy0416A-7
487
72-558
6
57.68
pET28b
214-1674
63% (10%, 63%)A


Spy0416B
882
736-1617
56
103.08
pET28b
2206-4851 
20% (10%, 63%)A


Spy0488
331
 1-331
8
37.84
pET28b
 1-993
90% (20%, 80)C,A


Spy0872
613
28-640
120
68.38
pET28b
 82-1920
20% (0%, 60%)A


Spy0872-2
290
351-640
7
33.02
pET28b
1051-1920 
60% (0%, 60%)A,C,B


Spy0895
261
 2-262
9
32.15
pET28b
 4-786
90% (20%, 80%)C,A,B


Spy1536
314
32-345
131
35.27
pET28b
 94-1035
70% (20%, 80%)C,A,B


Spy1666
315
23-337
132
37.02
pET28b
 67-1011
60% (20%, 80%)C,B


Spy1727
263
 1-263
10
32.43
pET28b
 1-789
70% (20%, 80%)C,B





1Length, amino acids and base pairs are calculated for the S. pyogenes gene specific sequence only.


2The calculated molecular weight includes amino acids derived from the vector and the His6-tag.


3Protection is based on the animal model as indicated:


As.c. immunization using CFA/IFA as adjuvant, i.n. challenge with S. pyogenes A20


Bs.c. immunization using ALUM as adjuvant and i.n. challenge with S. pyogenes A20


Cintranasal immunization using IC31 TM or a mucosal adjuvant and intranasal challenge with either S. pyogenes A20 or A147.


Brackets show protection in the respective model with the negative (PBS + adjuvant only) and positive control (M protein). If protection was seen in more than one model, the protection data of the model listed first are shown.














TABLE 2







Oligonucleotides used for the cloning of genes encoding antigenic proteins



and fragments thereof of S. pyogenes.
















Restriction



ORF-protein
Plasmid name
Primer1
Name
enzyme





SPy0269
pET28b-SPy0269
TAGTAGCCATGGGCGATGATAGAGCCTCA
210-2129
NcoI





GGA SEQ ID NO: 21




TAGTAGGCGGCCGCCTTAGATTCCTTACG
210-2196
NotI




GAACCT SEQ ID NO: 22


 


SPy0269-1
pET28b-SPy0269-1
TAGTAGCCATGGGCGATGATAGAGCCTCA
210-2129
NcoI




GGA SEQ ID NO: 23




TAGTAGGCGGCCGCAACAGGCGCATTAGG
210-2719
NotI




G SEQ ID NO: 24


 


SPy0292
pET28b-SPy0292
TAGTAGCCATGGGCGAAGAGTATTCGGTA
210-2131
NcoI




ACTGC SEQ ID NO: 25




TAGTAGGCGGCCGCTAAAGAGGTATTGAC
210-2197
NotI




ATACCT SEQ ID NO: 26


 


SPy0292-1
pET28b-SPy0292-1
TAGTAGCCATGGGCGAAGAGTATTCGGTA
210-2131
NcoI




ACTGC SEQ ID NO: 27




TAGTAGGCGGCCGCGCAAAAACAATTTTC
210-2954
NotI




ATCATC SEQ ID NO: 28


 


SPy0292-3
pET28b-SPy0292-3
TAGTAGCCATGGGCGAAGAGTATTCGGTA
210-2131
NcoI




ACTGC SEQ ID NO: 29




TAGTAGGCGGCCGCTTCAATTAACTGGAC
210-2956
NotI




TTTTTG SEQ ID NO: 30


 


SPy0416A
pET28b-SPy0416A
TAGTAGGAATTCGGCAGATGAGCTAAGCA
210-2246
EcoRI




CAATG SEQ ID NO: 31




TAGTAGCTCGAGCTCTGAACCAAGAGTGA
210-2247
XhoI




CAAG SEQ ID NO: 32


 


SPy0416A-1
pET28b-SPy0416A-1
TAGTAGGAATTCGGCAGATGAGCTAAGCA
210-2246
EcoRI




CAATG SEQ ID NO: 33




TAGTAGCTCGAGTGCCCCTTGCTGACGCG
210-2663
XhoI




GTG SEQ ID NO: 34


 


SPy0416A-6
pET28b-SPy0416A-6
TAGTAGGAATTCGGCAGTTATTGACACAGG
210-2715
EcoRI




G SEQ ID NO: 35




TAGTAGCTCGAGTAGGCTATCTTTTATGTC
210-2717
XhoI




SEQ ID NO: 36


 


SPy0416A-7
pET28b-SPy0416A-7
TAGTAGGAATTCGTCACAAATCACTCTCAA
210-2716
EcoRI




G SEQ ID NO: 37




TAGTAGCTCGAGACTTCCTGTACCATTGCC
210-2718
XhoI




SEQ ID NO: 38


 


SPy0416B
pET28b-SPy0416B
TAGTAGGAATTCGCATGTAGACCCACAAA
210-2248
EcoRI




AGGGC SEQ ID NO: 39




TAGTAGCTCGAGCGTTGATGGTAGGGCTTT
210-2249
XhoI




TGC SEQ ID NO: 40


 


SPy0488
pET28b-SPy0488
TAGTAGCCATGGGCTTGCGGCAGATTCAG
210-2139
NcoI




TCCATT SEQ ID NO: 41




TAGTAGGCGGCCGCACTTTTTAACCTGTCC
210-2199
NotI




TCAGC SEQ ID NO: 42


 


SPy0872
pET28b-SPy0872
TAGTAGCCATGGGCGATCAAGTTGATGTG
210-2143
NcoI




CAATTC SEQ ID NO: 43




TAGTAGGCGGCCGCTGTTATTGGAAGAGT
210-2144
NotI




GGAACT SEQ ID NO: 44


 


SPy0872-2
pET28b-SPy0872-2
TAGTAGCCATGGGCGCTATAATAAATCATG
210-2962
NcoI




CT SEQ ID NO: 45




TAGTAGGCGGCCGCTGTTATTGGAAGAGT
210-2144
NotI




GGAACT SEQ ID NO: 46


 


SPy0895
pET28b-SPy0895
TAGTAGCCATGGGCACTAATAATCAAACA
210-2145
NcoI




CTA SEQ ID NO: 47




TAGTAGGCGGCCGCGACAATAGATTGTCT
210-2201
NotI




CCAAAG SEQ ID NO: 48


 


SPy1536
pET28b-SPy1536
TAGTAGCCATGGGCATTGAAATGCCTGGA
210-2161
NcoI




GGCG SEQ ID NO: 49




TAGTAGGCGGCCGCTTTGCGAAGATAAAC
210-2207
NotI




CAGTGC SEQ ID NO: 50


 


SPy1666
pET28b-SPy1666
TAGTAGCCATGGGCACAAAAGAATTTCATC
210-2165
NcoI




ACGTG SEQ ID NO: 51




TAGTAGGCGGCCGCTTTCCGAATTTTTTTG
210-2209
NotI




GCAAC SEQ ID NO: 52


 


SPy1727
pET28b-SPy1727
TAGTAGCCATGGGCGTGACAACGACGGAAA
210-2167
NcoI




CAAG SEQ ID NO: 53




TAGTAGGCGGCCGCTTTCTTTCTAAATATT
210-2210
NotI




TCTCT SEQ ID NO: 54


 





1Primer, letters in bold indicate gene-specific sequences, letters underlined indicate the restriction enzyme sites, letters in normal font indicate sequences necessary for cloning, but not present in the final plasmid construct used for expression. The first primer always refers to the sense and the second primer to the anti-sense oligonucleotide in relation to the encoded gene used for amplification.






Example 2
Group A Streptococcal Antigens And Variants Thereof
Experimental Procedures
Preparation of Streptococcal Genomic DNA
5 mL Todd-Hewitt Broth medium were inoculated with the respective strain of S. pyogenes (as listed in Table 3) from a frozen stab and grown without shaking at 37° C. overnight. 4 mL of the culture were then harvested by centrifuging at 13,000 rpm in a biofuge fresco (Haereus) for 5 min and the supernatant was removed. DNA was isolated from the bacterial cell pellets following the protocol of Wizard® Genomic DNA Purification Kit (Promega). The DNA pellets were finally dried on air and dissolved in 70 μl ddH2O.
PCR and Sequence Analyses of S. pyogenes Genes
In order to determine the sequence of an antigen from diverse S. pyogenes strains, PCR was performed with primers specific for the gene of interest. S. pyogenes strains used for these analyses are shown in Table 3. Oligonucleotide sequences as primers for PCR were designed for the selected antigens in order to be able to amplify the full gene. Sequencing was performed with dedicated primers using the PCR products as templates. The sequences of the oligonucleotides are listed in Table 4. Genomic DNA of all S. pyogenes strains was prepared as described above. PCR was performed in a reaction volume of 25 μl using Taq polymerase (1 U), 200 nM dNTPs, 10 pMol of each oligonucleotide and the kit according to the manufacturer's instructions (Invitrogen, The Netherlands). As standard, 30 cycles (1×: 5 min. 95° C., 30×: 30 sec. 95° C., 30 sec. 56° C., 120 sec. 72° C., 1×4 min. 72° C.) were performed, unless conditions had to be adapted for individual primer pairs. PCR samples were sequenced with the oligonucleotides as listed in Table 10. Sequencing was performed at Agowa (Germany).







TABLE 3







S. pyogenes clinical isolates utilized for the present study.










No.
Strain
Country of origin
Serotype













1
Schmitz 1/94
Netherlands
1


2
Schmitz 1/12
Portugal
1


3
Schmitz 1/5
Portugal
1


4
Schmitz 2/14
Germany
1


5
Schmitz 1/74
England
3


6
Schmitz 1/35
Spain
3


7
Schmitz 1/41
France
3


8
RDN 78
unknown
3.1


9
Schmitz 1/17
Portugal
4


10
Schmitz 1/156
Switzerland
4


11
Schmitz 1/22
Spain
4


12
RDN 60
unknown
5


13
Schmitz 1/174
Austria
6


14
Schmitz 1/97
Belgium
6


15
Schmitz 1/29
Spain
9


16
Schmitz 1/92
Netherlands
11


17
Schmitz 1/39
Spain
12


18
Schmitz 1/248
Poland
12


19
Schmitz 1/59
England
12


20
RDN 02
unknown
19


21
Schmitz 1/76
England
22


22
Schmitz 1/177
Austria
22


23
Schmitz 1/43
France
22


24
Schmitz 2/32
Germany
22


25
RDN 136
unknown
22.2


26
Schmitz 1/136
Germany
25


27
Schmitz 1/56
France
28


28
Schmitz 1/108
Belgium
28


29
Schmitz 1/85
Netherlands
28


30
Schmitz 2/50
Germany
28


31
Schmitz 1/194
Italy
44


32
Schmitz 1/234
Turkey
44


33
Schmitz 1/103
Belgium
44


34
Schmitz 1/253
Poland
49


35
Schmitz 1/141
Germany
49


36
Schmitz 1/123
Germany
49


37
Schmitz 2/30
Germany
66 or 90


38
Schmitz 1/144
Germany
76


39
Schmitz 1/99
Belgium
78


40
RDN 120
unknown
81


41
Schmitz 1/142
Germany
83


42
Schmitz 1/176
Austria
83


43
Schmitz 1/25
Spain
83


44
RDN 75
unknown
85


45
Schmitz 2/46
Germany
89


46
Schmitz 2/9
Germany
90


47
Schmitz 2/23
Germany
90


48
RDN 116
unknown
94


49
Schmitz 1/55
France
118


50
Schmitz 1/68
England
118


51
Schmitz 1/3
Portugal
118
















TABLE 4







Oligonucleotides used for sequence conservation analyses.


















Position




Primer



relative to


ORF
name
Orientation
Sequence
SEQ ID NO:
gene





Spy0269
210-4752
sense
TGACCTTCAAATCATTGCTGA
209
−103 to −82




210-4759
antisense
TTTTGCACTTCTGGTGTCAA
210
1014 to 1034



210-4754
sense
TTGCCAAAGCTAGTCCAGGT
211
 931 to 951



210-4761
antisense
AGTATTATCAATGCGCTCACG
212
2028 to 2049



210-4756
sense
AAAAGCTCATTTGCAATATCTAAGG
213
1967 to 1992



210-4763
antisense
GCTGGTGAATCTGATTTTTCAA
214
2875 to 2897


 


Spy0292
210-4575
sense
TCTTGTGAGGTAAGTCATTACCTTAG
215
 −79 to −53



210-4576
antisense
TTCATCATCTGGTTCTGTATTAGG
216
 516 to 540



210-4577
sense
GGTCGTCAATTCAACTGGC
217
 464 to 483



210-4578
antisense
GCGATCATTGTGGATGATTTC
218
1031 to 1052



210-4579
sense
AAACTGTCAAACTTGTAGCCC
219
 946 to 967



210-4580
antisense
TGTTAGGATTGGCCTAGTTTG
220
1304 to 1325


 


Spy0416
210-4588
sense
TGAGTTAATGATTAACATTAAACTGGT
221
 −56 to −29



210-4591
antisense
TGACATAAGCAAATTGATGCG
222
1387 to 1408



210-4592
sense
CCATCTATTCAGAGTCTGTCGAC
223
1327 to 1350



210-4595
antisense
CCTTGTCACTAGCATGGTAGAC
224
2802 to 2824



210-4596
sense
TTGCAGCCTTCAAAGGTG
225
2749 to 2767



210-4599
antisense
AAGACACATTACCAGCTCTATCTTC
226
4128 to 4153



210-4600
sense
CAGATGGTTCTTACACCATTTC
227
4063 to 4085



210-4603
antisense
AATCTCAAAGAAAGGTCAGACTG
228
4982 to 5005


 


Spy0488
210-5497
sense
AAAGCTCGTCATTTTATATGATTT
229
−195 to −171



210-4767
antisense
TTTAATGAGAGTTGTCATTCGTTCA
230
 497 to 522



210-4765
sense
TTTTCTTGTTCAACCGCAAG
231
 404 to 424



210-4766
antisense
GCGCTCACAGCTACTTCAGA
232
1052 to 1072


 


Spy0872
210-4581
sense
CAAAATCATAGTAAACTTGATCTATAACG
233
 −55 to −26



210-4584
antisense
GAAGAATTAGTTGCAGTTCCG
234
1103 to 1124



210-4585
sense
GTTGCTGTAGCACCAGGTATC
235
1005 to 1026



210-4587
antisense
CCAGCACGAATTAGATCATCTAG
236
2111 to 2134


 


Spy0985
210-4768
sense
CTGAAGAGCGCCAAACAACT
237
 −63 to −43



210-4771
antisense
TCGAAGAAGTAACCTTTGATTAATGT
238
 864 to 890


 


Spy1536
210-4772
sense
GCTCTAGTCGTGTGAGAGAGCTAA
239
 −90 to −66



210-4775
antisense
TGTCTATCTGGTTCAACCGTTTT
240
1089 to 1112


 


Spy1666
210-4780
sense
GTGGCTAAGTCAGTGCTTGCT
241
 −80 to-59



210-4783
antisense
AAGTTTTTATTCGTTTTTGCAAGG
242
1055 to 1079


 


Spy1727
210-4776
sense
GATCATTGACTAAGTAGCCTAAAACAA
243
 −76 to −49



210-4779
antisense
CCAAAAACGTCATGCCAAC
244
 879 to 898





Shown are the ORF and primer names, orientation of the primer relative to the gene, the sequence, and the position relative to the gene. Oligonucleotides were used for both PCR amplification of the gene or gene fragment and subsequent sequence analyses.






Results

Gene Conservation Analysis of Selected Streptococcal Antigens

The PCR and sequencing of the 9 selected genes was performed as described under Methods. Table 3 shows the strains used for sequencing, while Table 4 lists the oligonucleotides employed for the PCR and sequencing analyses.
Sequence Analyses of Spy0269
Sequences were obtained from all 51 strains. The level of amino acid sequence identity ranged from 98.7% to 100% as compared to the sequence of Spy0269 from S. pyogenes SF370. Table 5 lists all 36 amino acid positions which showed a distinct amino acid as compared to Spy0269 from S. pyogenes SF370.







TABLE 5







Gene conservation of Spy0269.













Position

Amino acid


Strains with the
Strains with the


in SF370
Alignment
in SF370
AA
AA
respective
respective


gene
position
gene
change1
change2
change1
change2
















30
30
V
I

Schm1_142,








Schm1_177,







Schm1_43,







RDN75


68
68
D
E

Schm1_76,







Schm1_92,







Schm1_142,







Schm1_176,







Schm1_177,







Schm1_25,







Schm1_43,







Schm2_32,







RDN136,







RDN75


73
73
T
A

Schm1_142,







Schm1_177,







Schm1_43


80
80
E
K

Schm1_55,







Schm1_68,







Schm1_3,







Schm2_23,







Schm2_30


83
83
E
K

Schm1_17,







Schm1_59,







Schm1_97


94
94
E
K

Schm1_142,







Schm1_177,







Schm1_43


97
97
H
N

Schm1_99,







Schm2_14,







Schm2_46


150
150
A
V

Schm1_74,







Schm1_35,







Schm1_141,







Schm1_174,







Schm1_41,







Schm2_9,







Schm2_50,







RDN60, RDN78,







RDN75


230
230
A
G

Schm1_35


249
249
E
D

Schm1_103


276
276
A
V

Schm1_56,







Schm1_108


279
279
G
D

Schm1_55,







Schm1_68,







Schm1_3,







Schm2_23,







Schm2_30


307
307
A
G

Schm1_92


482
482
H
R

Schm1_17,







Schm1_56,







Schm1_76,







Schm1_92,







Schm1_142,







Schm1_253,







Schm1_108,







Schm1_141,







Schm1_174,







Schm1_176,







Schm1_177,







Schm1_25,







Schm1_43,







Schm1_59,







Schm1_97,







Schm1_99,







Schm1_123,







Schm1_136,







Schm2_14,







Schm2_32,







Schm2_46,







Schm2_50,







RDN60, RDN02,







RDN136,







RDN120,







RDN116


485
485
N
K

Schm1_39,







Schm1_55,







Schm1_68,







Schm1_156,







Schm1_248,







Schm1_3,







Schm1_22,







Schm1_29,







Schm2_23,







Schm2_30,







RDN75


537
537
G
S

Schm1_76,







Schm1_92,







Schm1_142,







Schm1_176,







Schm1_177,







Schm1_25,







Schm1_43,







Schm2_32,







RDN136


577
577
Q
E

Schm1_39,







Schm1_76,







Schm1_92,







Schm1_142,







Schm1_141,







Schm1_156,







Schm1_174,







Schm1_176,







Schm1_177,







Schm1_248,







Schm1_22,







Schm1_25,







Schm1_29,







Schm1_43,







Schm2_32,







Schm2_50,







RDN60,







RDN136


602
602
G
R

Schm2_46


605
605
R
K

Schm1_174


610
610
A
V

Schm1_74,







Schm1_76,







Schm1_35,







Schm1_176,







Schm1_25,







Schm1_41,







Schm2_9,







Schm2_32,







RDN136,







RDN78


636
636
L
M

Schm1_74,







Schm1_76,







Schm1_35,







Schm1_176,







Schm1_25,







Schm1_41,







Schm2_9,







Schm2_32,







RDN136,







RDN78


640
640
E
K

Schm1_74,







Schm1_76,







Schm1_35,







Schm1_176,







Schm1_25,







Schm1_41,







Schm2_9,







Schm2_32,







RDN136,







RDN78


641
641
A
V

Schm1_56,







Schm1_108


650
650
V
E

Schm2_9


666
666
F
L

Schm1_22


700
700
A
T

Schm1_17,







Schm1_39,







Schm1_55,







Schm1_56,







Schm1_253,







Schm1_68,







Schm1_108,







Schm1_156,







Schm1_248,







Schm1_3,







Schm1_22,







Schm1_29,







Schm1_59,







Schm1_97,







Schm1_123,







Schm1_136,







Schm2_23,







Schm2_30,







RDN02,







RDN120,







RDN116


703
703
A
V

Schm2_50,







RDN60


710
710
S
G

Schm1_17,







Schm1_59,







Schm1_97


733
733
E
G

Schm1_56,







Schm1_108


750
750
A
P

Schm1_22


752
752
P
S

Schm1_55,







Schm1_74,







Schm1_76,







Schm1_92,







Schm1_142,







Schm1_144,







Schm1_194,







Schm1_35,







Schm1_68,







Schm1_176,







Schm1_177,







Schm1_234,







Schm1_3,







Schm1_25,







Schm1_41,







Schm1_43,







Schm1_99,







Schm1_103,







Schm2_9,







Schm2_14,







Schm2_23,







Schm2_30,







Schm2_32,







Schm2_46,







RDN136,







RDN78


758
758
P
L

Schm1_92


764
764
I
V

Schm1_74,







Schm1_76,







Schm1_92,







Schm1_142,







Schm1_144,







Schm1_194,







Schm1_35,







Schm1_176,







Schm1_177,







Schm1_234,







Schm1_25,







Schm1_41,







Schm1_43,







Schm1_99,







Schm1_103,







Schm2_9,







Schm2_14,







Schm2_32,







Schm2_46,







RDN136,







RDN78


765
765
D
E

Schm1_74,







Schm1_76,







Schm1_92,







Schm1_142,







Schm1_144,







Schm1_194,







Schm1_35,







Schm1_176,







Schm1_177,







Schm1_234,







Schm1_25,







Schm1_41,







Schm1_43,







Schm1_99,







Schm1_103,







Schm2_9,







Schm2_14,







Schm2_32,







Schm2_46,







RDN136,







RDN78


794
794
L
F
H
Schm1_22
Schm2_23,








Schm2_30


873
873
K
R

Schm1_55,







Schm1_74,







Schm1_76,







Schm1_92,







Schm1_142,







Schm1_144,







Schm1_194,







Schm1_35,







Schm1_68,







Schm1_141,







Schm1_174,







Schm1_176,







Schm1_177,







Schm1_234,







Schm1_3,







Schm1_25,







Schm1_41,







Schm1_43,







Schm1_99,







Schm1_103,







Schm2_9,







Schm2_14,







Schm2_23,







Schm2_30,







Schm2_32,







Schm2_46,







Schm2_50,







RDN60,







RDN136,







RDN78, RDN75





1observed amino acid at respective position in any of the sequenced genes of the respective S. pyogenes strains.






Sequence Analyses of Spy0292

Sequences were obtained from all 51 strains. The level of amino acid sequence identity ranged from 97.3% to 100% as compared to the sequence of Spy0292 from S. pyogenes SF370. Table 6 lists all 36 amino acid positions which showed a distinct amino acid as compared to Spy0292 from S. pyogenes SF370.







TABLE 6







Gene conservation of Spy0292.

















Amino








Position

acid



Strains
Strains
Strains


in

in



with
with
with


SF370
Alignment
SF370
AA
AA
AA
respective
respective
respective


gene
position
gene
change1
change2
change3
change1
change2
change3


















21
21
S
N


Schm1_136




32
32
A
V


RDN02


45
45
E
K


RDN60


48
48
A
T


Schm1_56,








Schm1_108,








Schm1_85


50
50
E
K


RDN75


57
57
V
I


Schm2_50


58
58
S
T


Schm2_50


65
65
L
M


Schm1_141,








Schm1_156,








Schm1_174


68
68
K
Q
N

Schm2_30
Schm2_50


88
88
Y
D


Schm2_30


89
89
E
D


Schm2_30


93
93
N
Y


Schm2_50


95
95
T
S


Schm2_30


96
96
I
M


Schm2_30


101
101
L
P


Schm2_30


121
121
N
I


Schm2_50


122
122
S
T


Schm2_50


128
128
A
P
S

RDN60
RDN60


137
137
K
N


Schm2_30


141
141
K
E
Q

Schm1_17
Schm2_50


147
147
R
L
W
I
Schm1_17
Schm2_50
RDN60


148
148
Q
L


Schm2_30,








RDN60


152
152
S
F


RDN120


154
154
A
T


Schm1_55,








Schm1_68,








Schm1_3,








Schm1_29,








Schm2_23,








Schm2_30


165
165
H
L


RDN60


188
188
L
F


Schm1_174


189
189
A
P


Schm1_174


190
190
I
V


Schm1_253,








Schm1_123


214
214
A
D


Schm1_39,








Schm1_55,








Schm1_56,








Schm1_76,








Schm1_92,








Schm1_142,








Schm1_144,








Schm1_108,








Schm1_141,








Schm1_156,








Schm1_174,








Schm1_176,








Schm1_177,








Schm1_234,








Schm1_248,








Schm1_25,








Schm1_43,








Schm1_59,








Schm1_85,








Schm1_99,








Schm1_103,








Schm2_32,








Schm2_46,








Schm2_50,








RDN60,








RDN02,








RDN136,








RDN120


240
240
V
I


Schm1_92,








RDN120


266
266
L
I


Schm1_144,








Schm1_234,








Schm1_103


309
309
Y
S


Schm1_17,








Schm1_39,








Schm1_55,








Schm1_56,








Schm1_74,








Schm1_76,








Schm1_92,








Schm1_142,








Schm1_144,








Schm1_35,








Schm1_68,








Schm1_108,








Schm1_141,








Schm1_156,








Schm1_174,








Schm1_176,








Schm1_177,








Schm1_234,








Schm1_248,








Schm1_3,








Schm1_22,








Schm1_25,








Schm1_29,








Schm1_41,








Schm1_43,








Schm1_59,








Schm1_85,








Schm1_97,








Schm1_99,








Schm1_103,








Schm1_136,








Schm2_9,








Schm2_23,








Schm2_30,








Schm2_32,








Schm2_46,








Schm2_50,








RDN60,








RDN02,








RDN136,








RDN78,








RDN120,








RDN75,








RDN116


314
314
P
S


Schm1_17,








Schm1_22,








Schm1_97


351
351
A
P


Schm1_177


371
371
G
A


Schm1_234


386
386
Q
H


Schm1_234





1observed amino acid at respective position in any of the sequenced genes of the respective S. pyogenes strains.


2second possible amino acid observed at the respective position.


3third possible amino acid observed at the respective position.






Sequence Analyses of Spy0416

Sequences were obtained from all 50 strains excluding strain Schmitz 1/74. The level of amino acid sequence identity ranged from 98.1% to 100% as compared to the sequence of Spy0416 from S. pyogenes SF370. Table 7 lists all 103 amino acid positions which showed a distinct amino acid as compared to Spy0416 from S. pyogenes SF370. The gene showed in addition an insertion of 2 amino acids after position 31, as well as several deletions of amino acids at the indicated positions (e.g. strains Schmitz 1/17 and Schmitz 1/39).







TABLE 7







Gene conservation of Spy0416.















Amino






Position

acid in


Strains with
Strains with


in SF370
Alignment
SF370


respective
respective


gene
position
gene
AA change1
AA change2
change1
change2
















21
21
I
V

Schm1_99,








Schm2_46


27
27
V
M

Schm1_17,







Schm1_39,







Schm1_55,







Schm1_56,







Schm1_76,







Schm1_142,







Schm1_253,







Schm1_35,







Schm1_68,







Schm1_108,







Schm1_141,







Schm1_156,







Schm1_174,







Schm1_176,







Schm1_177,







Schm1_248,







Schm1_3,







Schm1_22,







Schm1_25,







Schm1_29,







Schm1_41,







Schm1_43,







Schm1_59,







Schm1_85,







Schm1_97,







Schm1_99,







Schm1_123,







Schm1_136,







Schm2_9,







Schm2_14,







Schm2_23,







Schm2_30,







Schm2_32,







Schm2_46,







Schm2_50,







RDN60,







RDN136,







RDN78,







RDN120,







RDN75,







RDN116


29
29
T
M

Schm1_17,







Schm1_39,







Schm1_76,







Schm1_142,







Schm1_35,







Schm1_141,







Schm1_156,







Schm1_174,







Schm1_176,







Schm1_177,







Schm1_248,







Schm1_22,







Schm1_25,







Schm1_41,







Schm1_43,







Schm1_59,







Schm1_97,







Schm1_136,







Schm2_9,







Schm2_14,







RDN136,







RDN78, RDN75


Insertion
32
—
T

Schm1_17,







Schm1_39,







Schm1_76,







Schm1_142,







Schm1_35,







Schm1_141,







Schm1_156,







Schm1_174,







Schm1_176,







Schm1_177,







Schm1_248,







Schm1_22,







Schm1_25,







Schm1_41,







Schm1_43,







Schm1_59,







Schm1_97,







Schm1_136,







Schm2_9,







Schm2_14,







RDN136,







RDN78


Insertion
33
—
T

Schm1_17,







Schm1_22,







Schm1_97


38
40
S
T

Schm1_17,







Schm1_39,







Schm1_55,







Schm1_56,







Schm1_76,







Schm1_142,







Schm1_253,







Schm1_35,







Schm1_68,







Schm1_108,







Schm1_141,







Schm1_156,







Schm1_174,







Schm1_176,







Schm1_177,







Schm1_248,







Schm1_3,







Schm1_22,







Schm1_25,







Schm1_29,







Schm1_41,







Schm1_43,







Schm1_59,







Schm1_85,







Schm1_97,







Schm1_99,







Schm1_103,







Schm1_123,







Schm1_136,







Schm2_9,







Schm2_14,







Schm2_23,







Schm2_30,







Schm2_32,







Schm2_46,







Schm2_50,







RDN136,







RDN78,







RDN116


40
42
M
T

Schm1_17,







Schm1_39,







Schm1_55,







Schm1_56,







Schm1_76,







Schm1_142,







Schm1_253,







Schm1_35,







Schm1_68,







Schm1_108,







Schm1_141,







Schm1_156,







Schm1_174,







Schm1_176,







Schm1_177,







Schm1_248,







Schm1_3,







Schm1_22,







Schm1_25,







Schm1_29,







Schm1_41,







Schm1_43,







Schm1_59,







Schm1_85,







Schm1_97,







Schm1_99,







Schm1_103,







Schm1_123,







Schm1_136,







Schm2_9,







Schm2_14,







Schm2_23,







Schm2_30,







Schm2_32,







Schm2_46,







Schm2_50,







RDN136,







RDN78,







RDN116


49
51
A
T

Schm1_39,







Schm1_76,







Schm1_142,







Schm1_35,







Schm1_176,







Schm1_177,







Schm1_248,







Schm1_25,







Schm1_41,







Schm1_43,







Schm1_59,







Schm2_9,







Schm2_14,







Schm2_32,







RDN60,







RDN136,







RDN78


54
56
Q
P

Schm1_55,







Schm1_68,







Schm1_3,







Schm1_29,







Schm2_23,







Schm2_30


55
57
H
P

Schm1_55,







Schm1_253,







Schm1_68,







Schm1_3,







Schm1_29,







Schm1_99,







Schm1_123,







Schm2_23,







Schm2_30,







Schm2_32,







Schm2_46,







RDN116


67
69
K
Q

Schm1_17,







Schm1_55,







Schm1_56,







Schm1_253,







Schm1_68,







Schm1_108,







Schm1_3,







Schm1_22,







Schm1_29,







Schm1_85,







Schm1_97,







Schm1_99,







Schm1_123,







Schm1_136,







Schm2_23,







Schm2_30,







Schm2_32,







Schm2_46,







Schm2_50,







RDN120,







RDN116


68
70
S
P
T
Schm1_39,
Schm1_92







Schm1_55,







Schm1_76,







Schm1_142,







Schm1_35,







Schm1_68,







Schm1_141,







Schm1_156,







Schm1_174,







Schm1_176,







Schm1_177,







Schm1_248,







Schm1_3,







Schm1_25,







Schm1_29,







Schm1_41,







Schm1_43,







Schm1_59,







Schm2_9,







Schm2_14,







Schm2_23,







Schm2_30,







RDN136,







RDN78, RDN75


69
71
Q
P

Schm1_17,







Schm1_56,







Schm1_253,







Schm1_108,







Schm1_22,







Schm1_85,







Schm1_97,







Schm1_99,







Schm1_123,







Schm1_136,







Schm2_32,







Schm2_46,







Schm2_50,







RDN120,







RDN116


71
73
T
I

Schm1_253,







Schm1_123,







Schm2_32


74
76
I
V

Schm1_55,







Schm1_253,







Schm1_68,







Schm1_3,







Schm1_29,







Schm1_99,







Schm1_123,







Schm1_136,







Schm2_23,







Schm2_30,







Schm2_46


76
78
L
P

Schm1_17,







Schm1_55,







Schm1_56,







Schm1_92,







Schm1_144,







Schm1_194,







Schm1_253,







Schm1_68,







Schm1_108,







Schm1_141,







Schm1_156,







Schm1_174,







Schm1_234,







Schm1_3,







Schm1_22,







Schm1_29,







Schm1_85,







Schm1_97,







Schm1_99,







Schm1_123,







Schm1_136,







Schm2_23,







Schm2_30,







Schm2_46,







Schm2_50,







RDN60,







RDN02,







RDN116


77
79
K
E

Schm1_55,







Schm1_253,







Schm1_68,







Schm1_3,







Schm1_29,







Schm1_99,







Schm1_123,







Schm1_136,







Schm2_23,







Schm2_30,







Schm2_46


78
80
T
I

Schm1_56,







Schm1_108,







Schm1_85,







Schm2_50


85
87
S
P

Schm1_17,







Schm1_39,







Schm1_55,







Schm1_56,







Schm1_76,







Schm1_92,







Schm1_142,







Schm1_253,







Schm1_35,







Schm1_68,







Schm1_108,







Schm1_176,







Schm1_177,







Schm1_248,







Schm1_3,







Schm1_22,







Schm1_25,







Schm1_29,







Schm1_41,







Schm1_43,







Schm1_59,







Schm1_85,







Schm1_97,







Schm1_103,







Schm1_123,







Schm1_136,







Schm2_9,







Schm2_14,







Schm2_23,







Schm2_30,







Schm2_50,







RDN60,







RDN136,







RDN78


87
89
D
G

Schm1_17,







Schm1_39,







Schm1_55,







Schm1_56,







Schm1_76,







Schm1_92,







Schm1_142,







Schm1_253,







Schm1_35,







Schm1_68,







Schm1_108,







Schm1_176,







Schm1_177,







Schm1_248,







Schm1_3,







Schm1_22,







Schm1_25,







Schm1_29,







Schm1_41,







Schm1_43,







Schm1_59,







Schm1_85,







Schm1_97,







Schm1_103,







Schm1_123,







Schm1_136,







Schm2_9,







Schm2_14,







Schm2_23,







Schm2_30,







Schm2_50,







RDN60,







RDN136,







RDN78


91
93
E
K

Schm1_99,







Schm2_46,







RDN116


93
95
T
Deletion

RDN60


102
104
A
S

RDN120,







RDN75,







RDN116


104
106
S
P

Schm1_39,







Schm1_55,







Schm1_56,







Schm1_76,







Schm1_142,







Schm1_253,







Schm1_35,







Schm1_68,







Schm1_108,







Schm1_176,







Schm1_177,







Schm1_248,







Schm1_3,







Schm1_25,







Schm1_29,







Schm1_41,







Schm1_43,







Schm1_59,







Schm1_85,







Schm1_99,







Schm1_123,







Schm1_136,







Schm2_9,







Schm2_14,







Schm2_23,







Schm2_30,







Schm2_32,







Schm2_46,







Schm2_50,







RDN60,







RDN136,







RDN78,







RDN120,







RDN75,







RDN116


107
109
N
Deletion

Schm1_92


110
112
S
P

Schm1_17,







Schm1_39,







Schm1_56,







Schm1_76,







Schm1_92,







Schm1_142,







Schm1_253,







Schm1_35,







Schm1_108,







Schm1_141,







Schm1_156,







Schm1_174,







Schm1_176,







Schm1_177,







Schm1_248,







Schm1_22,







Schm1_25,







Schm1_41,







Schm1_43,







Schm1_59,







Schm1_85,







Schm1_97,







Schm1_99,







Schm1_103,







Schm1_123,







Schm1_136,







Schm2_9,







Schm2_14,







Schm2_32,







Schm2_46,







Schm2_50,







RDN60,







RDN136,







RDN78,







RDN120,







RDN75,







RDN116


183
185
A
V

RDN75


215
217
E
G

Schm1_17,







Schm1_92,







Schm1_22,







Schm1_97,







Schm1_99,







Schm2_46,







RDN116


228
230
A
Deletion

Schm1_17,







Schm1_56,







Schm1_92,







Schm1_108,







Schm1_22,







Schm1_85,







Schm1_97,







Schm2_50,







RDN120


229
231
E
Deletion
D
Schm1_17,
Schm1_144,







Schm1_56,
Schm1_194,







Schm1_92,
Schm1_253,







Schm1_108,
Schm1_234,







Schm1_22,
Schm1_99,







Schm1_85,
Schm1_123,







Schm1_97,
Schm1_136,







Schm2_50,
Schm2_46,







RDN120,
RDN02







RDN116


230
232
A
Deletion

RDN116


238
240
H
N

Schm1_17,







Schm1_92,







Schm1_22,







Schm1_97


273
275
D
E

Schm1_92,







Schm1_99,







Schm2_46,







RDN120,







RDN116


308
310
A
T

Schm1_56,







Schm1_108,







Schm1_85,







Schm2_50


320
322
I
V

Schm1_17,







Schm1_39,







Schm1_55,







Schm1_56,







Schm1_76,







Schm1_92,







Schm1_142,







Schm1_144,







Schm1_194,







Schm1_253,







Schm1_35,







Schm1_68,







Schm1_108,







Schm1_141,







Schm1_156,







Schm1_174,







Schm1_176,







Schm1_177,







Schm1_234,







Schm1_248,







Schm1_3,







Schm1_22,







Schm1_25,







Schm1_29,







Schm1_41,







Schm1_43,







Schm1_59,







Schm1_85,







Schm1_97,







Schm1_99,







Schm1_103,







Schm1_123,







Schm1_136,







Schm2_9,







Schm2_14,







Schm2_23,







Schm2_30,







Schm2_32,







Schm2_46,







Schm2_50,







RDN02,







RDN136,







RDN78,







RDN120,







RDN75,







RDN116


428
430
T
A

Schm1_142


429
431
V
A

Schm1_17,







Schm1_22,







Schm1_97


431
433
E
G

Schm1_253,







Schm1_123


434
436
N
S

RDN116


449
451
V
F

Schm1_177


453
455
D
N

Schm1_142,







Schm1_35,







Schm1_141,







Schm1_174,







Schm1_176,







Schm1_177,







Schm1_248,







Schm1_25,







Schm1_41,







Schm1_43,







Schm1_59,







Schm1_97,







Schm1_123,







Schm1_136,







Schm2_9,







RDN136


463
465
S
T

Schm1_177,







RDN136


478
480
N
K

Schm1_17,







Schm1_76,







Schm1_92,







Schm1_142,







Schm1_144,







Schm1_194,







Schm1_176,







Schm1_177,







Schm1_234,







Schm1_22,







Schm1_25,







Schm1_43,







Schm1_97,







RDN60,







RDN02,







RDN136,







RDN120,







RDN116


481
483
D
N

Schm1_55,







Schm1_68,







Schm1_3,







Schm1_29,







Schm1_136,







Schm2_23,







Schm2_30


484
486
G
D

Schm1_17,







Schm1_92,







Schm1_144,







Schm1_194,







Schm1_234,







Schm1_22,







Schm1_97,







RDN02


493
495
P
L

RDN120


512
514
V
L

Schm1_253,







Schm1_123


519
521
P
S

Schm1_253,







Schm1_123


530
532
A
S

Schm1_141,







Schm1_156,







Schm1_174


535
537
I
V

RDN120


547
549
A
V

Schm1_35,







Schm1_41,







Schm2_9


553
555
G
T

RDN116


560
562
E
V

RDN02,







RDN116


630
632
V
I

RDN75


668
670
T
M

RDN116


689
691
G
D

Schm1_39,







Schm1_248,







Schm1_59,







Schm2_14


706
708
I
V

RDN02


723
725
D
A

Schm1_39,







Schm1_55,







Schm1_56,







Schm1_92,







Schm1_144,







Schm1_194,







Schm1_253,







Schm1_35,







Schm1_68,







Schm1_108,







Schm1_141,







Schm1_156,







Schm1_174,







Schm1_234,







Schm1_248,







Schm1_3,







Schm1_29,







Schm1_41,







Schm1_59,







Schm1_85,







Schm1_103,







Schm1_123,







Schm1_136,







Schm2_9,







Schm2_23,







Schm2_30,







Schm2_50,







RDN60,







RDN02,







RDN78,







RDN120,







RDN116


734
736
T
A

RDN02


743
745
R
H

RDN116


749
751
H
R

Schm1_17,







Schm1_39,







Schm1_55,







Schm1_56,







Schm1_76,







Schm1_92,







Schm1_142,







Schm1_144,







Schm1_194,







Schm1_253,







Schm1_35,







Schm1_68,







Schm1_108,







Schm1_141,







Schm1_156,







Schm1_174,







Schm1_176,







Schm1_177,







Schm1_234,







Schm1_248,







Schm1_3,







Schm1_22,







Schm1_25,







Schm1_29,







Schm1_41,







Schm1_43,







Schm1_59,







Schm1_85,







Schm1_97,







Schm1_99,







Schm1_103,







Schm1_123,







Schm1_136,







Schm2_9,







Schm2_14,







Schm2_23,







Schm2_30,







Schm2_32,







Schm2_46,







RDN60,







RDN02,







RDN136,







RDN78,







RDN120,







RDN75,







RDN116


770
772
R
K

RDN60,







RDN120


804
806
D
A

Schm1_55,







Schm1_68,







Schm1_248,







Schm1_3,







Schm1_29,







Schm2_23,







Schm2_30,







RDN02,







RDN120,







RDN75


874
876
T
M

Schm1_35,







Schm1_41,







Schm1_103,







Schm1_136,







Schm2_9,







RDN78


876
878
S
C

Schm1_94


913
915
N
S

RDN60


951
953
P
S

Schm1_76,







Schm1_177,







Schm1_43


991
993
H
Y

Schm1_17,







Schm1_39,







Schm1_55,







Schm1_56,







Schm1_142,







Schm1_144,







Schm1_194,







Schm1_35,







Schm1_68,







Schm1_108,







Schm1_141,







Schm1_156,







Schm1_174,







Schm1_176,







Schm1_234,







Schm1_248,







Schm1_3,







Schm1_22,







Schm1_25,







Schm1_29,







Schm1_41,







Schm1_59,







Schm1_85,







Schm1_97,







Schm1_99,







Schm1_136,







Schm2_9,







Schm2_14,







Schm2_23,







Schm2_30,







Schm2_46,







Schm2_50,







RDN60,







RDN02,







RDN78,







RDN120,







RDN116


1053
1055
V
A

Schm1_94,







Schm1_12X,







Schm1_5


1078
1080
E
A

Schm1_92,







Schm1_142,







Schm1_176,







Schm1_25,







Schm1_99,







Schm2_23,







Schm2_30,







Schm2_46


1080
1082
N
S

Schm1_35,







Schm1_41,







Schm2_9,







RDN78


1227
1229
T
I

Schm1_76


1238
1240
V
A

Schm1_17,







Schm1_39,







Schm1_55,







Schm1_56,







Schm1_76,







Schm1_92,







Schm1_142,







Schm1_144,







Schm1_194,







Schm1_253,







Schm1_35,







Schm1_68,







Schm1_108,







Schm1_141,







Schm1_156,







Schm1_174,







Schm1_176,







Schm1_177,







Schm1_234,







Schm1_248,







Schm1_3,







Schm1_22,







Schm1_25,







Schm1_29,







Schm1_41,







Schm1_43,







Schm1_59,







Schm1_85,







Schm1_97,







Schm1_99,







Schm1_103,







Schm1_123,







Schm1_136,







Schm2_9,







Schm2_14,







Schm2_23,







Schm2_30,







Schm2_32,







Schm2_46,







Schm2_50,







RDN60,







RDN02,







RDN136,







RDN78,







RDN120,







RDN75,







RDN116


1241
1243
I
V

Schm1_253,







Schm1_123


1302
1304
D
G

Schm1_253,







Schm1_123


1313
1315
D
G

Schm1_17,







Schm1_39,







Schm1_55,







Schm1_56,







Schm1_76,







Schm1_92,







Schm1_94,







Schm1_142,







Schm1_144,







Schm1_253,







Schm1_12X,







Schm1_35,







Schm1_68,







Schm1_108,







Schm1_141,







Schm1_156,







Schm1_174,







Schm1_176,







Schm1_177,







Schm1_234,







Schm1_248,







Schm1_3,







Schm1_5,







Schm1_22,







Schm1_25,







Schm1_29,







Schm1_41,







Schm1_43,







Schm1_59,







Schm1_85,







Schm1_97,







Schm1_99,







Schm1_103,







Schm1_123,







Schm1_136,







Schm2_9,







Schm2_14,







Schm2_23,







Schm2_30,







Schm2_32,







Schm2_46,







Schm2_50,







RDN60,







RDN02,







RDN136,







RDN78,







RDN120,







RDN75,







RDN116


1322
1324
V
I

RDN120


1349
1351
V
M

RDN02


1355
1357
P
S

Schm1_234,







Schm1_136,







RDN75


1364
1366
R
E

Schm1_156


1365
1367
D
I

Schm1_156


1393
1395
A
V

Schm1_35,







Schm1_41,







Schm2_9,







RDN78


1425
1427
A
V

RDN02


1479
1481
N
K

RDN60


1483
1485
V
I

Schm1_141,







Schm1_156,







Schm1_174


1487
1489
I
M

Schm1_17,







Schm1_39,







Schm1_55,







Schm1_56,







Schm1_76,







Schm1_92,







Schm1_142,







Schm1_144,







Schm1_194,







Schm1_253,







Schm1_35,







Schm1_68,







Schm1_108,







Schm1_141,







Schm1_156,







Schm1_174,







Schm1_176,







Schm1_177,







Schm1_234,







Schm1_248,







Schm1_3,







Schm1_22,







Schm1_25,







Schm1_29,







Schm1_41,







Schm1_43,







Schm1_59,







Schm1_85,







Schm1_97,







Schm1_99,







Schm1_103,







Schm1_123,







Schm1_136,







Schm2_9,







Schm2_14,







Schm2_23,







Schm2_30,







Schm2_32,







Schm2_46,







Schm2_50,







RDN60,







RDN02,







RDN136,







RDN78,







RDN120,







RDN75,







RDN116


1505
1507
E
K

Schm2_50


1516
1518
D
G

Schm1_17,







Schm1_39,







Schm1_55,







Schm1_56,







Schm1_76,







Schm1_92,







Schm1_142,







Schm1_144,







Schm1_194,







Schm1_253,







Schm1_35,







Schm1_68,







Schm1_108,







Schm1_141,







Schm1_156,







Schm1_174,







Schm1_176,







Schm1_177,







Schm1_234,







Schm1_248,







Schm1_3,







Schm1_22,







Schm1_25,







Schm1_29,







Schm1_41,







Schm1_43,







Schm1_59,







Schm1_85,







Schm1_97,







Schm1_99,







Schm1_103,







Schm1_123,







Schm1_136,







Schm2_9,







Schm2_14,







Schm2_23,







Schm2_30,







Schm2_32,







Schm2_46,







Schm2_50,







RDN60,







RDN02,







RDN136,







RDN78,







RDN120,







RDN75,







RDN116


1522
1524
E
G

Schm1_99,







Schm2_32,







Schm2_46


1538
1540
G
D

Schm1_17,







Schm1_22,







Schm1_97


1545
1547
S
T

Schm2_50


1555
1557
N
D

Schm1_35,







Schm1_41,







Schm2_9,







RDN78


1560
1562
T
A

Schm1_17,







Schm1_144,







Schm1_194,







Schm1_35,







Schm1_234,







Schm1_22,







Schm1_41,







Schm1_97,







Schm1_99,







Schm1_103,







Schm1_136,







Schm2_9,







Schm2_32,







Schm2_46,







RDN78


1576
1578
G
R

Schm2_50


1580
1582
D
G

Schm1_144,







Schm1_194,







Schm1_234,







Schm1_136


1587
1589
V
A

Schm1_142,







Schm1_176,







Schm1_25


1591
1593
N
S

RDN75


1598
1600
A
V

Schm1_17,







Schm1_22,







Schm1_97


1605
1607
S
T

Schm1_17,







Schm1_39,







Schm1_55,







Schm1_56,







Schm1_76,







Schm1_92,







Schm1_142,







Schm1_144,







Schm1_194,







Schm1_253,







Schm1_35,







Schm1_68,







Schm1_108,







Schm1_141,







Schm1_156,







Schm1_174,







Schm1_176,







Schm1_177,







Schm1_234,







Schm1_248,







Schm1_3,







Schm1_22,







Schm1_25,







Schm1_29,







Schm1_41,







Schm1_43,







Schm1_59,







Schm1_85,







Schm1_97,







Schm1_99,







Schm1_103,







Schm1_123,







Schm1_136,







Schm2_9,







Schm2_14,







Schm2_23,







Schm2_30,







Schm2_32,







Schm2_46,







Schm2_50,







RDN60,







RDN02,







RDN136,







RDN78,







RDN120,







RDN75,







RDN116


1608
1610
S
P

Schm1_144,







Schm1_194,







Schm1_234,







Schm1_136


1609
1611
A
Deletion

Schm1_142,







Schm1_176,







Schm1_25,







RDN120


1610
1612
T
Deletion

Schm1_142,







Schm1_176,







Schm1_25,







RDN120


1617
1619
T
A

Schm1_17,







Schm1_39,







Schm1_56,







Schm1_92,







Schm1_35,







Schm1_108,







Schm1_141,







Schm1_156,







Schm1_174,







Schm1_248,







Schm1_22,







Schm1_41,







Schm1_59,







Schm1_85,







Schm1_97,







Schm1_99,







Schm2_9,







Schm2_14,







Schm2_23,







Schm2_30,







Schm2_46,







Schm2_50,







RDN60,







RDN78,







RDN116


1622
1624
G
S

Schm1_142,







Schm1_176,







Schm1_25,







RDN120


1642
1644
K
T

Schm1_144





1observed amino acid at respective position in any of the sequenced genes of the respective S. pyogenes strains.


2second possible amino acid observed at the respective position.


Deletion or insertion refers to a missing or additional amino acid relative to Spy0416 of S. pyogenes SF370.






Sequence Analyses of Spy0488

Sequences were obtained from all 51 strains. The level of amino acid sequence identity ranged from 85.4% to 100% as compared to the sequence of Spy0488 from S. pyogenes SF370. Table 8 lists all 49 amino acid positions which showed a distinct amino acid as compared to Spy0488 from S. pyogenes SF370. The genes from several strains (e.g. Schmitz 1/55) possessed furthermore a different N terminus, with an addition of 25 amino acids and a frame-shift for the first 16 amino acids relative to Spy0488 from S. pyogenes SF370.







TABLE 8







Gene conservation of Spy0488.















Amino



Strains


Position

acid in



with


in SF370
Alignment
SF370
AA

Strains with respective
respective


gene
position
gene
change1
AA change2
change1
change2
















Insertion
1
—
M

Schm1_39,








Schm1_55,







Schm1_56,







Schm1_74,







Schm1_76,







Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35,







Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3,







Schm1_22,







Schm1_25,







Schm1_29,







Schm1_41,







Schm1_43,







Schm1_59,







Schm1_85,







Schm1_97,







Schm1_99,







Schm1_103, Schm1_123,







Schm1_136,







Schm2_9,







Schm2_23,







Schm2_30,







Schm2_32,







Schm2_46,







Schm2_50,







RDN60,







RDN02,







RDN136,







RDN78,







RDN120,







RDN75,







RDN116


Insertion
2
—
M

Schm1_39,







Schm1_55,







Schm1_56,







Schm1_74,







Schm1_76,







Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35,







Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3,







Schm1_22,







Schm1_25,







Schm1_29,







Schm1_41,







Schm1_43,







Schm1_59,







Schm1_85,







Schm1_97,







Schm1_99,







Schm1_103, Schm1_123,







Schm1_136,







Schm2_9,







Schm2_23,







Schm2_30,







Schm2_32,







Schm2_46,







Schm2_50,







RDN60,







RDN02,







RDN136,







RDN78,







RDN120,







RDN75,







RDN116


Insertion
3
—
M

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


Insertion
4
—
L

Schm1_39 Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


Insertion
5
—
R

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


Insertion
6
—
D

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


Insertion
7
—
V

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


Insertion
8
—
K

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


Insertion
9
—
V

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


Insertion
10
—
K

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


Insertion
11
—
M
T
Schm1_39, Schm1_55,
Schm1_56,







Schm1_74, Schm1_76,
Schm1_108,







Schm1_92, Schm1_142,
Schm1_22,







Schm1_144, Schm1_194,
Schm1_85,







Schm1_253, Schm1_35,
Schm1_97,







Schm1_68, Schm1_141,
Schm2_50,







Schm1_156, Schm1_174,
RDN02,







Schm1_176, Schm1_177,
RDN116







Schm1_234, Schm1_248,







Schm1_3, Schm1_25,







Schm1_29, Schm1_41,







Schm1_43, Schm1_59,







Schm1_99, Schm1_103,







Schm1_123, Schm1_136,







Schm2_9, Schm2_23,







Schm2_30, Schm2_32,







Schm2_46, RDN60,







RDN136, RDN78, RDN120,







RDN75


Insertion
12
—
S

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


Insertion
13
—
S

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


Insertion
14
—
L

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


Insertion
15
—
L

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


Insertion
16
—
V

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


Insertion
17
—
G

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


Insertion
18
—
C

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


Insertion
19
—
A

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


Insertion
20
—
A

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


Insertion
21
—
T

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


Insertion
22
—
L

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


Insertion
23
—
L

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


Insertion
24
—
V

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


Insertion
25
—
S

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


2
27
R
S

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


3
28
Q
S
G
Schm1_39, Schm1_55,
Schm1_74,







Schm1_56, Schm1_76,
Schm1_92,







Schm1_142, Schm1_253,
Schm1_144,







Schm1_68, Schm1_108,
Schm1_194,







Schm1_141, Schm1_156,
Schm1_35,







Schm1_174, Schm1_176,
Schm1_234,







Schm1_177, Schm1_248,
Schm1_41,







Schm1_3, Schm1_22,
Schm1_103,







Schm1_25, Schm1_29,
Schm2_9,







Schm1_43, Schm1_59,
RDN78







Schm1_85, Schm1_97,







Schm1_99, Schm1_123,







Schm1_136, Schm2_23,







Schm2_30, Schm2_32,







Schm2_46, Schm2_50,







RDN60, RDN02, RDN136,







RDN120, RDN75, RDN116


4
29
I
T

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


5
30
Q
V

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


6
31
S
A

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


7
32
I
A

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


8
33
R
D

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


9
34
L
S

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


10
35
I
V

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


11
36
D
H

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


12
37
V
S

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


13
38
L
S

Schm1_39, Schm1_55,
RDN78







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN120,







RDN75, RDN116


14
39
E
D

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


15
40
L
R

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


16
41
A
R

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_142, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_176, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_25, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN78,







RDN120, RDN75, RDN116


30
55
S
F

Schm1_99, Schm1_136,







Schm2_46


35
60
S
Y

RDN75


50
75
A
T

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_144, Schm1_194,







Schm1_253, Schm1_35,







Schm1_68, Schm1_108,







Schm1_141, Schm1_156,







Schm1_174, Schm1_177,







Schm1_234, Schm1_248,







Schm1_3, Schm1_22,







Schm1_29, Schm1_41,







Schm1_43, Schm1_59,







Schm1_85, Schm1_97,







Schm1_99, Schm1_103,







Schm1_123, Schm1_136,







Schm2_9, Schm2_23,







Schm2_30, Schm2_32,







Schm2_46, Schm2_50,







RDN60, RDN02, RDN136,







RDN78, RDN120, RDN75,







RDN116


53
78
N
D

Schm1_253, Schm1_99,







Schm1_123, Schm1_136,







Schm2_46, RDN120


56
81
S
Y

Schm1_39, Schm1_55,







Schm1_56, Schm1_76,







Schm1_92, Schm1_144,







Schm1_194, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_177, Schm1_234,







Schm1_248, Schm1_3,







Schm1_22, Schm1_29,







Schm1_43, Schm1_59,







Schm1_85, Schm1_97,







Schm1_99, Schm1_103,







Schm1_136, Schm2_23,







Schm2_30, Schm2_32,







Schm2_46, Schm2_50,







RDN60, RDN02, RDN136,







RDN120, RDN75, RDN116


60
85
D
G

Schm1_248, Schm1_59


69
94
D
G

Schm1_39, Schm1_55,







Schm1_56, Schm1_76,







Schm1_92, Schm1_253,







Schm1_68, Schm1_108,







Schm1_141, Schm1_156,







Schm1_174, Schm1_177,







Schm1_248, Schm1_3,







Schm1_22, Schm1_29,







Schm1_43, Schm1_59,







Schm1_85, Schm1_97,







Schm1_99, Schm1_123,







Schm1_136, Schm2_23,







Schm2_30, Schm2_32,







Schm2_46, Schm2_50,







RDN60, RDN02, RDN136,







RDN120


75
100
Q
H

Schm2_32


76
101
I
T

Schm1_39, Schm1_55,







Schm1_56, Schm1_76,







Schm1_144, Schm1_194,







Schm1_253, Schm1_68,







Schm1_108, Schm1_141,







Schm1_156, Schm1_174,







Schm1_177, Schm1_234,







Schm1_248, Schm1_3,







Schm1_22, Schm1_29,







Schm1_43, Schm1_59,







Schm1_85, Schm1_97,







Schm1_99, Schm1_103,







Schm1_123, Schm1_136,







Schm2_23, Schm2_30,







Schm2_32, Schm2_46,







Schm2_50, RDN60,







RDN02, RDN136, RDN120


87
112
F
L

Schm1_253, Schm1_123


93
118
G
E

Schm1_99, Schm2_46


112
137
V
A

Schm1_253, Schm1_123


117
142
I
T

Schm1_39, Schm1_55,







Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_253, Schm1_35,







Schm1_68, Schm1_108,







Schm1_141, Schm1_156,







Schm1_174, Schm1_177,







Schm1_248, Schm1_3,







Schm1_22, Schm1_29,







Schm1_41, Schm1_43,







Schm1_59, Schm1_85,







Schm1_97, Schm1_99,







Schm1_123, Schm1_136,







Schm2_9, Schm2_23,







Schm2_30, Schm2_32,







Schm2_46, Schm2_50,







RDN60, RDN02, RDN136,







RDN78, RDN120, RDN75,







RDN116


127
152
H
Y

Schm1_39


157
182
D
G

RDN75


163
188
V
L

RDN75


174
199
K
T

Schm1_55, Schm1_68,







Schm1_3, Schm1_29,







Schm2_23, Schm2_30


183
208
G
R

RDN75


184
209
G
S

Schm1_56, Schm1_108,







Schm1_85, Schm2_50,







RDN02


188
213
F
L

Schm1_92, Schm1_144,







Schm1_194, Schm1_253,







Schm1_35, Schm1_234,







Schm1_41, Schm1_99,







Schm1_103, Schm1_123,







Schm1_136, Schm2_9,







Schm2_46, RDN78


198
223
P
S

Schm1_92


199
224
K
R

Schm1_56, Schm1_108,







Schm1_85, Schm2_50,







RDN02


201
226
R
G

Schm1_56, Schm1_74,







Schm1_76, Schm1_92,







Schm1_144, Schm1_194,







Schm1_253, Schm1_35,







Schm1_108, Schm1_177,







Schm1_234, Schm1_41,







Schm1_43, Schm1_85,







Schm1_99, Schm1_103,







Schm1_123, Schm1_136,







Schm2_9, Schm2_32,







Schm2_46, Schm2_50,







RDN02, RDN136, RDN78,







RDN120


202
227
Q
L

Schm1_144, Schm1_194,







Schm1_35, Schm1_234,







Schm1_41, Schm1_99,







Schm1_103, Schm1_136,







Schm2_9, Schm2_46,







RDN78


206
231
T
I

Schm1_56, Schm1_108,







Schm1_85, Schm2_50,







RDN02


209
234
D
A

Schm1_92, Schm1_144,







Schm1_194, Schm1_35,







Schm1_234, Schm1_41,







Schm1_99, Schm1_103,







Schm1_136, Schm2_9,







Schm2_46, RDN78


217
242
P
S

Schm1_56, Schm1_108,







Schm1_85, Schm2_50,







RDN02


221
246
W
C

Schm1_76, Schm1_177,







Schm1_43, RDN136


222
247
K
E

Schm1_56, Schm1_108,







Schm1_85, Schm2_50,







RDN02


232
257
A
T

Schm1_39, Schm1_22,







Schm1_97


235
260
S
F

Schm1_253, Schm1_123


238
263
T
I

Schm1_248, Schm1_59


258
283
A
V

Schm1_92


291
316
E
Q

Schm1_55, Schm1_68,







Schm1_3, Schm1_29,







Schm2_23, Schm2_30





1observed amino acid at respective position in any of the sequenced genes of the respective S. pyogenes strains.


2second possible amino acid observed at the respective position.


Insertion refers to an additional amino acid relative to Spy0488 of S. pyogenes SF370.






Sequence Analyses of Spy0872

Sequences were obtained from all 51 strains. The level of amino acid sequence identity ranged from 98.2% to 100% as compared to the sequence of Spy0872 from S. pyogenes SF370. Table 9 lists all 34 acid positions which showed a distinct amino acid as compared to Spy0872 from S. pyogenes SF370. The gene from strain Schmitz 1/22 showed in addition an insertion of 2 amino acids after position 587.







TABLE 9







Gene conservation of Spy0872.













Amino




Position

acid in




in SF370
Alignment
SF370
AA



gene
position
gene
change1
Strains with respective change1














67
67
G
C
Schm1_136


74
74
E
D
Schm1_76, Schm1_177, Schm1_43, RDN136


178
178
K
N
Schm1_7, Schm1_39, Schm1_55, Schm1_56,






Schm1_74, Schm1_76, Schm1_92, Schm1_142,






Schm1_144, Schm1_194, Schm1_253, Schm1_35,






Schm1_68, Schm1_108, Schm1_141, Schm1_156,






Schm1_174, Schm1_176, Schm1_177, Schm1_234,






Schm1_248, Schm1_3, Schm1_22, Schm1_25,






Schm1_29, Schm1_41, Schm1_43, Schm1_59,






Schm1_85, Schm1_97, Schm1_99, Schm1_103,






Schm1_123, Schm1_136, Schm2_9, Schm2_14,






Schm2_32, Schm2_46, Schm2_50, RDN60, RDN02,






RDN136, RDN78, RDN120, RDN75, RDN116


181
181
P
S
RDN60


222
222
H
Y
RDN120


228
228
V
A
Schm1_56, Schm1_108, Schm1_85, Schm2_50


253
253
V
I
Schm1_7, Schm1_39, Schm1_55, Schm1_56,






Schm1_76, Schm1_142, Schm1_144, Schm1_194,






Schm1_68, Schm1_108, Schm1_141, Schm1_156,






Schm1_174, Schm1_176, Schm1_177, Schm1_234,






Schm1_248, Schm1_3, Schm1_22, Schm1_25,






Schm1_29, Schm1_43, Schm1_59, Schm1_85,






Schm1_97, Schm1_99, Schm1_103, Schm2_14,






Schm2_32, Schm2_46, Schm2_50, RDN60, RDN136,






RDN120


328
328
I
M
Schm1_55, Schm1_56, Schm1_92, Schm1_68,






Schm1_108, Schm1_3, Schm1_29, Schm1_85,






Schm1_136, Schm2_23, Schm2_30, Schm2_50, RDN75


329
329
K
T
Schm1_55, Schm1_56, Schm1_92, Schm1_68,






Schm1_108, Schm1_3, Schm1_29, Schm1_85,






Schm1_136, Schm2_23, Schm2_30, Schm2_50, RDN75


336
336
V
I
Schm1_56, Schm1_108, Schm1_85, Schm2_50


337
337
A
T
Schm1_136, RDN75


340
340
P
L
RDN120


393
393
A
V
Schm1_7, Schm1_39, Schm1_55, Schm1_56,






Schm1_74, Schm1_76, Schm1_92, Schm1_142,






Schm1_144, Schm1_194, Schm1_253, Schm1_35,






Schm1_68, Schm1_108, Schm1_141, Schm1_156,






Schm1_174, Schm1_176, Schm1_177, Schm1_234,






Schm1_248, Schm1_3, Schm1_22, Schm1_25,






Schm1_29, Schm1_41, Schm1_43, Schm1_59,






Schm1_85, Schm1_97, Schm1_99, Schm1_103,






Schm1_123, Schm1_136, Schm2_9, Schm2_14,






Schm2_23, Schm2_30, Schm2_32, Schm2_46,






Schm2_50, RDN60, RDN02, RDN136, RDN78,






RDN120, RDN75, RDN116


412
412
M
I
RDN120


427
427
D
Y
Schm2_46


433
433
G
E
Schm1_7, Schm1_22, Schm1_97


444
444
I
T
RDN75


478
478
Y
F
Schm1_253, Schm1_123


490
490
T
I
Schm1_55, Schm1_68, Schm1_3, Schm1_29,






Schm2_23, Schm2_30


492
492
F
C
RDN02


532
532
A
T
Schm1_144, Schm1_194, Schm1_234, Schm1_103


535
535
I
V
Schm1_142, Schm1_176, Schm1_25, Schm2_46,






RDN116


553
553
E
Q
Schm1_142, Schm1_176, Schm1_25, Schm1_99,






Schm2_32, Schm2_46, RDN116


576
576
S
R
Schm1_142, Schm1_176, Schm1_25, Schm1_99,






Schm2_46, RDN116


580
580
V
I
Schm1_142, Schm1_176, Schm1_25, Schm1_99,






Schm2_46, RDN116


Insertion
588
—
I
Schm1_7, Schm1_22, Schm1_97


Insertion
589
—
I
Schm1_7, Schm1_22, Schm1_97


588
590
I
T
RDN78


598
600
G
D
Schm1_92


600
602
T
I
Schm1_7, Schm1_39, Schm1_55, Schm1_56,






Schm1_74, Schm1_76, Schm1_92, Schm1_142,






Schm1_144, Schm1_194, Schm1_253, Schm1_35,






Schm1_68, Schm1_108, Schm1_141, Schm1_156,






Schm1_174, Schm1_176, Schm1_177, Schm1_234,






Schm1_248, Schm1_3, Schm1_22, Schm1_25,






Schm1_29, Schm1_41, Schm1_43, Schm1_59,






Schm1_85, Schm1_97, Schm1_99, Schm1_103,






Schm1_123, Schm1_136, Schm2_9, Schm2_14,






Schm2_23, Schm2_30, Schm2_32, Schm2_46,






Schm2_50, RDN60, RDN02, RDN136, RDN78,






RDN120, RDN75, RDN116


605
607
V
I
Schm1_7, Schm1_39, Schm1_56, Schm1_76,






Schm1_144, Schm1_194, Schm1_253, Schm1_108,






Schm1_141, Schm1_156, Schm1_174, Schm1_177,






Schm1_234, Schm1_248, Schm1_22, Schm1_43,






Schm1_59, Schm1_85, Schm1_97, Schm1_103,






Schm1_123, Schm2_14, Schm2_50, RDN60, RDN02,






RDN136, RDN78, RDN120


620
622
L
F
Schm1_7, Schm1_142, Schm1_176, Schm1_22,






Schm1_25, Schm1_97, Schm1_99, Schm2_32,






Schm2_46, RDN116


625
627
T
I
Schm1_7, Schm1_22, Schm1_97


634
636
S
N
Schm1_7, Schm1_142, Schm1_176, Schm1_22,






Schm1_25, Schm1_97, Schm1_99, Schm2_46, RDN116


659
661
G
C
Schm1_253, Schm1_123


667
669
K
E
Schm1_144, Schm1_194, Schm1_234, Schm1_103,






RDN120





1observed amino acid at respective position in any of the sequenced genes of the respective S. pyogenes strains. Insertion refers to an additional amino acid relative to Spy0872 of S. pyogenes SF370.






Sequence Analyses of Spy0895

Sequences were obtained from all 51 strains. The level of amino acid sequence identity ranged from 98.9% to 100% as compared to the sequence of Spy0895 from S. pyogenes SF370. Table 10 lists all 13 amino acid positions which showed a distinct amino acid as compared to Spy0895 from S. pyogenes SF370.







TABLE 10







Gene conservation of Spy0895.











Position






in SF370
Alignment
Amino acid in
AA



gene
position
SF370 gene
change1
Strains with respective change1














19
19
A
V
Schm1_17, Schm1_22, Schm1_97


33
33
A
V
Schm1_17, Schm1_141, Schm1_156,






Schm1_174, Schm1_22, Schm1_97, RDN02


50
50
F
V
Schm1_253, Schm1_123


52
52
A
V
Schm1_17, Schm1_55, Schm1_68,






Schm1_141, Schm1_156, Schm1_174,






Schm1_3, Schm1_22, Schm1_29, Schm1_97,






Schm2_30


60
60
T
I
Schm1_56, Schm1_108, Schm1_85,






Schm2_50


71
71
L
I
Schm1_92, Schm1_144, Schm1_194,






Schm1_234, Schm1_103


138
138
H
Q
Schm1_92, Schm1_144, Schm1_194,






Schm1_234, Schm1_103


188
188
R
P
Schm1_174


238
238
R
C
Schm1_55, Schm1_76, Schm1_68,






Schm1_177, Schm1_3, Schm1_29,






Schm1_43, Schm2_30, RDN136


242
242
Y
C
Schm1_136


252
252
K
T
Schm1_56, Schm1_108, Schm1_85,






Schm2_50


255
255
S
G
Schm1_56, Schm1_108, Schm1_85,






Schm2_50


256
256
L
F
RDN60





1observed amino acid at respective position in any of the sequenced genes of the respective S. pyogenes strains.






Sequence Analyses of Spy1536

Sequences were obtained from all 51 strains. The level of amino acid sequence identity ranged from 99.1% to 100% as compared to the sequence of Spy1536 from S. pyogenes SF370. Table 11 lists all 8 amino acid positions which showed a distinct amino acid as compared to Spy1536 from S. pyogenes SF370. The gene from strain Schmitz 2/14 showed in addition an insertion of 3 amino acids after position 207.







TABLE 11







Gene conservation of Spy1536.













Amino




Position

acid in




in SF370
Alignment
SF370
AA
Strains


gene
position
gene
change1
with respective change1














5
5
K
N
Schm1_12, Schm2_9,






Schm1_136


92
92
G
R
Schm1_142


97
97
A
T
Schm1_5, Schm1_74


125
125
P
S
Schm1_123


126
126
V
A
Schm1_142


183
183
V
I
Schm1_94, RDN78,






Schm1_97, Schm1_59,






Schm1_76, RDN136,






Schm1_177, Schm2_32, 






Schm1_141, Schm1_144,






RDN120, Schm1_25,






Schm1_176, RDN75_85, 






Schm2_46, Schm2_23,






Schm1_55


Insertion
208
—
K
Schm2_14


Insertion
209
—
N
Schm2_14


Insertion
210
—
G
Schm2_14


333
336
V
I
Schm1_12, Schm1_35,






Schm2_9, Schm1_174,






Schm1_136, Schm1_234,






Schm1_68


337
340
Q
E
Schm1_43, Schm1_108





1observed amino acid at respective position in any of the sequenced genes of the respective S. pyogenes strains. Insertion refers to an additional amino acid relative to Spy1536 of S. pyogenes SF370.






Sequence Analyses of Spy1666

Sequences were obtained from 50 strains. The sequence from strain RDN120 was not determined. The level of amino acid sequence identity ranged from 98.2 to 100% as compared to the sequence of Spy1666 from S. pyogenes SF370. Table 12 lists all 18 amino acid positions which showed a distinct amino acid as compared to Spy1666 from S. pyogenes SF370.







TABLE 12







Gene conservation of Spy1666.













Amino




Position

acid in




in SF370
Alignment
SF370
AA



gene
position
gene
change1
Strains with respective change1














3
3
S
P
Schm1_17, Schm1_22, Schm1_97, Schm1_136,






Schm1_17, Schm1_22, Schm1_97, Schm1_136


11
11
L
V
Schm1_17, Schm1_22, Schm1_97, Schm1_136,






Schm1_17, Schm1_22, Schm1_97, Schm1_136


45
45
D
N
Schm1_17, Schm1_22, Schm1_97, Schm1_136,






Schm1_17, Schm1_22, Schm1_97, Schm1_136


67
67
G
S
Schm1_17, Schm1_22, Schm1_97, Schm1_136,






Schm1_17, Schm1_22, Schm1_97, Schm1_136


69
69
E
Q
Schm1_17, Schm1_22, Schm1_97, Schm1_136,






Schm1_17, Schm1_22, Schm1_97, Schm1_136


90
90
K
Q
Schm1_142, Schm1_176, Schm1_25, Schm2_46,






Schm1_142, Schm1_176, Schm1_25, Schm2_46


106
106
R
I
RDN136, RDN78, RDN136, RDN78


120
120
I
F
Schm1_136, Schm1_136


149
149
L
S
RDN78, RDN78


167
167
T
N
RDN75, RDN75


204
204
T
A
Schm1_253, Schm1_103, Schm1_123, Schm1_253,






Schm1_103, Schm1_123


217
217
P
S
Schm1_39, Schm1_248, Schm1_59, Schm1_39,






Schm1_248, Schm1_59


251
251
Q
H
Schm1_97, Schm1_97


252
252
D
E
Schm1_76, Schm1_141, Schm1_156, Schm1_174,






Schm1_177, Schm1_43, Schm2_32, RDN136,






Schm1_76, Schm1_141, Schm1_156, Schm1_174,






Schm1_177, Schm1_43, Schm2_32, RDN136


259
259
L
F
Schm1_92, RDN75, Schm1_92, RDN75


292
292
L
F
RDN116, RDN116


302
302
K
T
Schm1_17, Schm1_142, Schm1_176, Schm1_22,






Schm1_25, Schm1_97, Schm2_46, Schm1_17,






Schm1_142, Schm1_176, Schm1_22, Schm1_25,






Schm1_97, Schm2_46


319
319
T
A
Schm1_76, Schm1_141, Schm1_156, Schm1_174,






Schm1_177, Schm1_43, Schm2_32, RDN136,






Schm1_76, Schm1_141, Schm1_156, Schm1_174,






Schm1_177, Schm1_43, Schm2_32, RDN136





1observed amino acid at respective position in any of the sequenced genes of the respective S. pyogenes strains.






Sequence Analyses of Spy1727

No sequence variation was observed on the amino acid sequence level in any of the analyzed 51 gene sequences obtained from the listed S. pyogenes strains.










SEQUENCE DATA FOR AMINO ACID SEQUENCES
















1. Spy0269



1.1 Full length Spy0269


> Spy0269/SF370 (serotype 1); SEQ ID NO: 57


MDLEQTKPNQVKQKIALTSTIALLSASVGVSHQVKADDRASGETKASNTHDDSLPKPETIQEAKATIDAVEKT


 


LSQQKAELTELATALTKTTAEINHLKEQQDNEQKALTSAQEIYTNTLASSEETLLAQGAEHQRELTATETELH


 


NAQADQHSKETALSEQKASISAETTRAQDLVEQVKTSEQNIAKLNAMISNPDAITKAAQTANDNTKALSSELE


 


KAKADLENQKAKVKKQLTEELAAQKAALAEKEAELSRLKSSAPSTQDSIVGNNTMKAPQGYPLEELKKLEASG


 


YIGSASYNNYYKEHADQIIAKASPGNQLNQYQDIPADRNRFVDPDNLTPEVQNELAQFAAHMINSVRRQLGLP


 


PVTVTAGSQEFARLLSTSYKKTHGNTRPSFVYGQPGVSGHYGVGPHDKTIIEDSAGASGLIRNDDNMYENIGA


 


FNDVHTVNGIKRGIYDSIKYMLFTDHLHGNTYGHAINFLRVDKHNPNAPVYLGFSTSNVGSLNEHFVMFPESN


 


IANHQRFNKTPIKAVGSTKDYAQRVGTVSDTIAAIKGKVSSLENRLSAIHQEADIMAAQAKVSQLQGKLASTL


 


KQSDSLNLQVRQLNDTKGSLRTELLAAKAKQAQLEATRDQSLAKLASLKAALHQTEALAEQAAARVTALVAKK


 


AHLQYLRDFKLNPNRLQVIRERIDNTKQDLAKTTSSLLNAQEALAALQAKQSSLEATIATTEHQLTLLKTLAN


 


EKEYRHLDEDIATVPDLQVAPPLTGVKPLSYSKIDTTPLVQEMVKETKQLLEASARLAAENTSLVAEALVGQT


 


SEMVASNAIVSKITSSITQPSSKTSYGSGSSTTSNLISDVDESTQRALKAGVVMLAAVGLTGFRFRKESK


 


1.2 Antigenic fragment Spy0269-1


> Spy0269-1/SF370 (serotype 1); SEQ ID NO: 1


DDRASGETKASNTHDDSLPKPETIQEAKATIDAVEKTLSQQKAELTELATALTKTTAEINHLKEQQDNEQKAL


 


TSAQEIYTNTLASSEETLLAQGAEHQRELTATETELHNAQADQHSKETALSEQKASISAETTRAQDLVEQVKT


 


SEQNIAKLNAMISNPDAITKAAQTANDNTKALSSELEKAKADLENQKAKVKKQLTEELAAQKAALAEKEAELS


 


RLKSSAPSTQDSIVGNNTMKAPQGYPLEELKKLEASGYIGSASYNNYYKEHADQIIAKASPGNQLNQYQDIPA


 


DRNRFVDPDNLTPEVQNELAQFAAHMINSVRRQLGLPPVTVTAGSQEFARLLSTSYKKTHGNTRPSFVYGQPG


 


VSGHYGVGPHDKTIIEDSAGASGLIRNDDNMYENIGAFNDVHTVNGIKRGIYDSIKYMLFTDHLHGNTYGHAI


 


NFLRVDKHNPNAPV


 


1.3 Homologous sequences of other S. pyogenes isolates and/or serotypes


> Spy0269-1/Schmitz 2/14 (serotype 1); SEQ ID NO: 58


DDRASGETKASNTHDDSLPKPETIQEAKATIDAVEKTLSQQKAELTELATALTKTTAEINNLKEQQDNEQKAL


 


TSAQEIYTNTLASSEETLLAQGAEHQRELTATETELHNAQADQHSKETALSEQKASISAETTRAQDLVEQVKT


 


SEQNIAKLNAMISNPDAITKAAQTANDNTKALSSELEKAKADLENQKAKVKKQLTEELAAQKAALAEKEAELS


 


RLKSSAPSTQDSIVGNNTMKAPQGYPLEELKKLEASGYIGSASYNNYYKEHADQIIAKASPGNQLNQYQDIPA


 


DRNRFVDPDNLTPEVQNELAQFAAHMINSVRRQLGLPPVTVTAGSQEFARLLSTSYKKTHGNTRPSFVYGQPG


 


VSGHYGVGPHDKTIIEDSAGASGLIRNDDNMYENIGAFNDVHTVNGIKRGIYDSIKYMLFTDHLHGNTYGHAI


 


NFLRVDKRNPNAPV


 


> Spy0269-1/Schmitz 1/156 (serotype 4); SEQ ID NO: 59


DDRASGETKASNTHDDSLPKPETIQEAKATIDAVEKTLSQQKAELTELATALTKTTAEINHLKEQQDNEQKAL


 


TSAQEIYTNTLASSEETLLAQGAEHQRELTATETELHNAQADQHSKETALSEQKASISAETTRAQDLVEQVKT


 


SEQNIAKLNAMISNPDAITKAAQTANDNTKALSSELEKAKADLENQKAKVKKQLTEELAAQKAALAEKEAELS


 


RLKSSAPSTQDSIVGNNTMKAPQGYPLEELKKLEASGYIGSASYNNYYKEHADQIIAKASPGNQLNQYQDIPA


 


DRNRFVDPDNLTPEVQNELAQFAAHMINSVRRQLGLPPVTVTAGSQEFARLLSTSYKKTHGNTRPSFVYGQPG


 


VSGHYGVGPHDKTIIEDSAGASGLIRNDDNMYENIGAFNDVHTVNGIKRGIYDSIKYMLFTDHLHGNTYGHAI


 


NFLRVDKHNPKAPV


 


> Spy0269-1/Schmitz 1/59 (serotype 12); SEQ ID NO: 60


DDRASGETKASNTHDDSLPKPETIQEAKATIDAVEKTLSQQKAELTKLATALTKTTAEINHLKEQQDNEQKAL


 


TSAQEIYTNTLASSEETLLAQGAEHQRELTATETELHNAQADQHSKETALSEQKASISAETTRAQDLVEQVKT


 


SEQNIAKLNAMISNPDAITKAAQTANDNTKALSSELEKAKADLENQKAKVKKQLTEELAAQKAALAEKEAELS


 


RLKSSAPSTQDSIVGNNTMKAPQGYPLEELKKLEASGYIGSASYNNYYKEHADQIIAKASPGNQLNQYQDIPA


 


DRNRFVDPDNLTPEVQNELAQFAAHMINSVRRQLGLPPVTVTAGSQEFARLLSTSYKKTHGNTRPSFVYGQPG


 


VSGHYGVGPHDKTIIEDSAGASGLIRNDDNMYENIGAFNDVHTVNGIKRGIYDSIKYMLFTDHLHGNTYGHAI


 


NFLRVDKRNPNAPV


 


> Spy0269-1/Schmitz 1/177 (serotype 22); SEQ ID NO: 61


DDRASGETKASNTHDDSLPKPETIQEAKATIEAVEKALSQQKAELTELATALTKTTAKINHLKEQQDNEQKAL


 


TSAQEIYTNTLASSEETLLAQGAEHQRELTATETELHNAQADQHSKETALSEQKASISAETTRAQDLVEQVKT


 


SEQNIAKLNAMISNPDAITKAAQTANDNTKALSSELEKAKADLENQKAKVKKQLTEELAAQKAALAEKEAELS


 


RLKSSAPSTQDSIVGNNTMKAPQGYPLEELKKLEASGYIGSASYNNYYKEHADQIIAKASPGNQLNQYQDIPA


 


DRNRFVDPDNLTPEVQNELAQFAAHMINSVRRQLGLPPVTVTAGSQEFARLLSTSYKKTHGNTRPSFVYGQPG


 


VSGHYGVGPHDKTIIEDSAGASGLIRNDDNMYENIGAFNDVHTVNGIKRGIYDSIKYMLFTDHLHGNTYGHAI


 


NFLRVDKRNPNAPV


 


> Spy0269-1/Schmitz 1/43 (serotype 22); SEQ ID NO: 62


DDRASGETKASNTHDDSLPKPETIQEAKATIEAVEKALSQQKAELTELATALTKTTAKINHLKEQQDNEQKAL


 


TSAQEIYTNTLASSEETLLAQGAEHQRELTATETELHNAQADQHSKETALSEQKASISAETTRAQDLVEQVKT


 


SEQNIAKLNAMISNPDAITKAAQTANDNTKALSSELEKAKADLENQKAKVKKQLTEELAAQKAALAEKEAELS


 


RLKSSAPSTQDSIVGNNTMKAPQGYPLEELKKLEASGYIGSASYNNYYKEHADQIIAKASPGNQLNQYQDIPA


 


DRNRFVDPDNLTPEVQNELAQFAAHMINSVRRQLGLPPVTVTAGSQEFARLLSTSYKKTHGNTRPSFVYGQPG


 


VSGHYGVGPHDKTIIEDSAGASGLIRNDDNMYENIGAFNDVHTVNGIKRGIYDSIKYMLFTDHLHGNTYGHAI


 


NFLRVDKRNPNAPV


 


> Spy0269-1/Schmitz 1/136 (serotype 25); SEQ ID NO: 63


DDRASGETKASNTHDDSLPKPETIQEAKATIDAVEKTLSQQKAELTELATALTKTTAEINHLKEQQDNEQKAL


 


TSAQEIYTNTLASSEETLLAQGAEHQRELTATETELHNAQADQHSKETALSEQKASISAETTRAQDLVEQVKT


 


SEQNIAKLNAMISNPDAITKAAQTANDNTKALSSELEKAKADLENQKAKVKKQLTEELAAQKAALAEKEAELS


 


RLKSSAPSTQDSIVGNNTMKAPQGYPLEELKKLEASGYIGSASYNNYYKEHADQIIAKASPGNQLNQYQDIPA


 


DRNRFVDPDNLTPEVQNELAQFAAHMINSVRRQLGLPPVTVTAGSQEFARLLSTSYKKTHGNTRPSFVYGQPG


 


VSGHYGVGPHDKTIIEDSAGASGLIRNDDNMYENIGAFNDVHTVNGIKRGIYDSIKYMLFTDHLHGNTYGHAI


 


NFLRVDKRNPNAPV


 


> Spy0269-1/Schmitz 1/85 (serotype 28); SEQ ID NO: 64


DDRASGETKASNTHDDSLPKPETIQEAKATIDAVEKTLSQQKAELTELATALTKTTAEINHLKEQQDNEQKAL


 


TSAQEIYTNTLASSEETLLAQGAEHQRELTATETELHNAQADQHSKETALSEQKASISAETTRAQDLVEQVKT


 


SEQNIAKLNAMISNPDAITKAAQTANDNTKALSSELEKAKADLENQKAKVKKQLTEELAAQKAALAEKEAELS


 


RLKSSAPSTQDSIVGNNTMKAPQGYPLEELKKLEASGYIGSASYNNYYKEHADQIIAKASPGNQLNQYQDIPA


 


DRNRFVDPDNLTPEVQNELAQFAAHMINSVRRQLGLPPVTVTAGSQEFARLLSTSYKKTHGNTRPSFVYGQPG


 


VSGHYGVGPHDKTIIEDSAGASGLIRNDDNMYENIGAFNDVHTVNGIKRGIYDSIKYMLFTDHLHGNTYGHAI


 


NFLRVDKHNPNAPV


 


> Spy0269-1/Schmitz 2/50 (serotype 28); SEQ ID NO: 65


DDRASGETKASNTHDDSLPKPETIQEAKATIDAVEKTLSQQKAELTELATALTKTTAEINHLKEQQDNEQKAL


 


TSAQEIYTNTLASSEETLLAQGAEHQRELTATETELHNAQVDQHSKETALSEQKASISAETTRAQDLVEQVKT


 


SEQNIAKLNAMISNPDAITKAAQTANDNTKALSSELEKAKADLENQKAKVKKQLTEELAAQKAALAEKEAELS


 


RLKSSAPSTQDSIVGNNTMKAPQGYPLEELKKLEASGYIGSASYNNYYKEHADQIIAKASPGNQLNQYQDIPA


 


DRNRFVDPDNLTPEVQNELAQFAAHMINSVRRQLGLPPVTVTAGSQEFARLLSTSYKKTHGNTRPSFVYGQPG


 


VSGHYGVGPHDKTIIEDSAGASGLIRNDDNMYENIGAFNDVHTVNGIKRGIYDSIKYMLFTDHLHGNTYGHAI


 


NFLRVDKRNPNAPV


 


> Spy0269-1/Schmitz 1/123 (serotype 49); SEQ ID NO: 66


DDRASGETKASNTHDDSLPKPETIQEAKATIDAVEKTLSQQKAELTELATALTKTTAEINHLKEQQDNEQKAL


 


TSAQEIYTNTLASSEETLLAQGAEHQRELTATETELHNAQADQHSKETALSEQKASISAETTRAQDLVEQVKT


 


SEQNIAKLNAMISNPDAITKAAQTANDNTKALSSELEKAKADLENQKAKVKKQLTEELAAQKAALAEKEAELS


 


RLKSSAPSTQDSIVGNNTMKAPQGYPLEELKKLEASGYIGSASYNNYYKEHADQIIAKASPGNQLNQYQDIPA


 


DRNRFVDPDNLTPEVQNELAQFAAHMINSVRRQLGLPPVTVTAGSQEFARLLSTSYKKTHGNTRPSFVYGQPG


 


VSGHYGVGPHDKTIIEDSAGASGLIRNDDNMYENIGAFNDVHTVNGIKRGIYDSIKYMLFTDHLHGNTYGHAI


 


NFLRVDKRNPNAPV


 


> Spy0269-1/Schmitz 1/176 (serotype 83); SEQ ID NO: 67


DDRASGETKASNTHDDSLPKPETIQEAKATIEAVEKTLSQQKAELTELATALTKTTAEINHLKEQQDNEQKAL


 


TSAQEIYTNTLASSEETLLAQGAEHQRELTATETELHNAQADQHSKETALSEQKASISAETTRAQDLVEQVKT


 


SEQNIAKLNAMISNPDAITKAAQTANDNTKALSSELEKAKADLENQKAKVKKQLTEELAAQKAALAEKEAELS


 


RLKSSAPSTQDSIVGNNTMKAPQGYPLEELKKLEASGYIGSASYNNYYKEHADQIIAKASPGNQLNQYQDIPA


 


DRNRFVDPDNLTPEVQNELAQFAAHMINSVRRQLGLPPVTVTAGSQEFARLLSTSYKKTHGNTRPSFVYGQPG


 


VSGHYGVGPHDKTIIEDSAGASGLIRNDDNMYENIGAFNDVHTVNGIKRGIYDSIKYMLFTDHLHGNTYGHAI


 


NFLRVDKRNPNAPV


 


2. Spy0292


2.1 Full length Spy0292


> Spy0292/SF370 (serotype 1); SEQ ID NO: 68


MIKRLISLVVIALFFAASTVSGEEYSVTAKHAIAVDLESGKVLYEKDAKEVVPVASVSKLLTTYLVYKEVSKG


 


KLNWDSPVTISNYPYELTTNYTISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQL


 


RQWGISDAKVVNSTGLTNHFLGANTYPNTEPDDENCFCATDLAIIARHLLLEFPEVLKLSSKSSTIFAGQTIY


 


SYNYMLKGMPCYREGVDGLFVGYSKKAGASFVATSVENQMRVITVVLNADQSHEDDLAIFKTTNQLLQYLLIN


 


FQKVQLIENNKPVKTLYVLDSPEKTVKLVAQNSLFFIKPIHTKTKNTVHITKKSSTMIAPLSKGQVLGRATLQ


 


DKHLIGQGYLDTPPSINLILQKNISKSFFLKVWWNRFVRYVNTSL


 


2.2 Antigenic fragment Spy0292-1


> Spy0292-1/SF370 (serotype 1); SEQ ID NO: 2


EEYSVTAKHAIAVDLESGKVLYEKDAKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDAKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFC


 


2.3 Homologous sequences of other S. pyogenes isolates and/or serotypes


> Spy0292-1/Schmitz 1/39 (serotype 12); SEQ ID NO: 69


EEYSVTAKHAIAVDLESGKVLYEKDAKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDAKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFC


 


> Spy0292-1/Schmitz 1/55 (serotype 118); SEQ ID NO: 70


EEYSVTAKHAIAVDLESGKVLYEKDAKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDTKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFC


 


> Spy0292-1/Schmitz 1/56 (serotype 28); SEQ ID NO: 71


EEYSVTAKHAIAVDLESGKVLYEKDTKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDAKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFC


 


> Spy0292-1/Schmitz 1/74 (serotype 3); SEQ ID NO: 72


EEYSVTAKHAIAVDLESGKVLYEKDAKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDAKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFC


 


> Spy0292-1/Schmitz 1/76 (serotype 22); SEQ ID NO: 73


EEYSVTAKHAIAVDLESGKVLYEKDAKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDAKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFC


 


> Spy0292-1/Schmitz 1/92 (serotype 11); SEQ ID NO: 74


EEYSVTAKHAIAVDLESGKVLYEKDAKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDAKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFC


 


> Spy0292-1/Schmitz 1/94 (serotype 1); SEQ ID NO: 75


EEYSVTAKHAIAVDLESGKVLYEKDAKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDAKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFC


 


> Spy0292-1/Schmitz 1/142 (serotype 83); SEQ ID NO: 76


EEYSVTAKHAIAVDLESGKVLYEKDAKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDAKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFC


 


> Spy0292-1/Schmitz 1/144 (serotype 76); SEQ ID NO: 77


EEYSVTAKHAIAVDLESGKVLYEKDAKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDAKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFC


 


> Spy0292-1/Schmitz 1/194 (serotype 44); SEQ ID NO: 78


EEYSVTAKHAIAVDLESGKVLYEKDAKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDAKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFC


 


2.4 Antigenic fragment Spy0292-3


> Spy0292-3/SF370 (serotype 1); SEQ ID NO: 3


EEYSVTAKHAIAVDLESGKVLYEKDAKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDAKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFCATDLAIIARHLLLEFPEVLKLSSKSSTIFAGQTIYSYNYMLKGMPCYREGVDGLFVG


 


YSKKAGASFVATSVENQMRVITVVLNADQSHEDDLAIFKTTNQLLQYLLINFQKVQLIE


 


2.5 Homologous sequences of other S. pyogenes isolates and/or serotypes


> Spy0292-3/Schmitz 1/39 (serotype 12); SEQ ID NO: 79


EEYSVTAKHAIAVDLESGKVLYEKDAKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDAKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFCATDLAIIARHLLLEFPEVLKLSSKSSTIFDGQTIYSYNYMLKGMPCYREGVDGLFVG


 


YSKKAGASFVATSVENQMRVITVVLNADQSHEDDLAIFKTTNQLLQYLLINFQKVQLIE


 


> Spy0292-3/Schmitz 1/55 (serotype 118); SEQ ID NO: 80


EEYSVTAKHAIAVDLESGKVLYEKDAKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDTKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFCATDLAIIARHLLLEFPEVLKLSSKSSTIFDGQTIYSYNYMLKGMPCYREGVDGLFVG


 


YSKKAGASFVATSVENQMRVITVVLNADQSHEDDLAIFKTTNQLLQYLLINFQKVQLIE


 


> Spy0292-3/Schmitz 1/56 (serotype 28); SEQ ID NO: 81


EEYSVTAKHAIAVDLESGKVLYEKDTKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDAKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFCATDLAIIARHLLLEFPEVLKLSSKSSTIFDGQTIYSYNYMLKGMPCYREGVDGLFVG


 


YSKKAGASFVATSVENQMRVITVVLNADQSHEDDLAIFKTTNQLLQYLLINFQKVQLIE


 


> Spy0292-3/Schmitz 1/74 (serotype 3); SEQ ID NO: 82


EEYSVTAKHAIAVDLESGKVLYEKDAKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDAKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFCATDLAIIARHLLLEFPEVLKLSSKSSTIFAGQTIYSYNYMLKGMPCYREGVDGLFVG


 


YSKKAGASFVATSVENQMRVITVVLNADQSHEDDLAIFKTTNQLLQYLLINFQKVQLIE


 


> Spy0292-3/Schmitz 1/76 (serotype 22); SEQ ID NO: 83


EEYSVTAKHAIAVDLESGKVLYEKDAKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDAKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFCATDLAIIARHLLLEFPEVLKLSSKSSTIFDGQTIYSYNYMLKGMPCYREGVDGLFVG


 


YSKKAGASFVATSVENQMRVITVVLNADQSHEDDLAIFKTTNQLLQYLLINFQKVQLIE


 


> Spy0292-3/Schmitz 1/92 (serotype 11); SEQ ID NO: 84


EEYSVTAKHAIAVDLESGKVLYEKDAKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDAKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFCATDLAIIARHLLLEFPEVLKLSSKSSTIFDGQTIYSYNYMLKGMPCYREGVDGLFIG


 


YSKKAGASFVATSVENQMRVITVVLNADQSHEDDLAIFKTTNQLLQYLLINFQKVQLIE


 


> Spy0292-3/Schmitz 1/94 (serotype 1); SEQ ID NO: 85


EEYSVTAKHAIAVDLESGKVLYEKDAKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDAKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFCATDLAIIARHLLLEFPEVLKLSSKSSTIFAGQTIYSYNYMLKGMPCYREGVDGLFVG


 


YSKKAGASFVATSVENQMRVITVVLNADQSHEDDLAIFKTTNQLLQYLLINFQKVQLIE


 


> Spy0292-3/Schmitz 1/142 (serotype 83); SEQ ID NO: 86


EEYSVTAKHAIAVDLESGKVLYEKDAKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDAKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFCATDLAIIARHLLLEFPEVLKLSSKSSTIFDGQTIYSYNYMLKGMPCYREGVDGLFVG


 


YSKKAGASFVATSVENQMRVITVVLNADQSHEDDLAIFKTTNQLLQYLLINFQKVQLIE


 


> Spy0292-3/Schmitz 1/144 (serotype 76); SEQ ID NO: 87


EEYSVTAKHAIAVDLESGKVLYEKDAKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDAKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFCATDLAIIARHLLLEFPEVLKLSSKSSTIFDGQTIYSYNYMLKGMPCYREGVDGLFVG


 


YSKKAGASFVATSVENQMRVITVVINADQSHEDDLAIFKTTNQLLQYLLINFQKVQLIE


 


> Spy0292-3/Schmitz 1/194 (serotype 44); SEQ ID NO: 88


EEYSVTAKHAIAVDLESGKVLYEKDAKEVVPVASVSKLLTTYLVYKEVSKGKLNWDSPVTISNYPYELTTNYT


 


ISNVPLDKRKYTVKELLSALVVNNANSPAIALAEKIGGTEPKFVDKMKKQLRQWGISDAKVVNSTGLTNHFLG


 


ANTYPNTEPDDENCFCATDLAIIARHLLLEFPEVLKLSSKSSTIFAGQTIYSYNYMLKGMPCYREGVDGLFVG


 


YSKKAGASFVATSVENQMRVITVVLNADQSHEDDLAIFKTTNQLLQYLLINFQKVQLIE


 


3. Spy0416A


3.1 Full length Spy0416A


> Spy0416A/SF370 (serotype 1); SEQ ID NO: 89


ADELSTMSEPTITNHAQQQAQHLTNTELSSAESKSQDTSQITLKTNREKEQSQDLVSEPTTTELADTDAASMA


 


NTGSDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQGKVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLA


 


RQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDFDEDWENFEFDAEAEPKAIKKHKIYRPQSTQAPKET


 


VIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKEAAATGERFLGIAPEAQVMFMRVFANDIMGSAE


 


SLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIEKAKKAGVSVVVAAGNERVYGSDHDDPLATNPD


 


YGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRADLNHGKAIYSESVDFKDIKDSLGYDKSHQFAYVKE


 


STDAGYNAQDVKGKIALIERDPNKTYDEMIALAKKHGALGVLIFNNKPGQSNRSMRLTANGMGIPSAFISHEF


 


GKAMSQLNGNGTGSLEFDSVVSKAPSQKGNEMNHFSNWGLTSDGYLKPDITAPGGDIYSTYNDNHYGSQTGTS


 


MASPQIAGASLLVKQYLEKTQPNLPKEKIADIVKNLLMSNAQIHVNPETKTTTSPRQQGAGLLNIDGAVTSGL


 


YVTGKDNYGSISLGNITDTMTFDVTVHNLSNKDKTLRYDTELLTDHVDPQKGRFTLTSHSLKTYQGGEVTVPA


 


NGKVTVRVTMDVSQFTKELTKQMPNGYYLEGFVRFRDSQDDQLNRVNIPFVGFKGQFENLAVAEESIYRLKSQ


 


GKTGFYFDESGPKDDIYVGKHFTGLVTLGSE


 


3.2 Antigenic fragment Spy0416A-1


> Spy0416A-1/SF370 (serotype 1); SEQ ID NO: 4


ADELSTMSEPTITNHAQQQAQHLTNTELSSAESKSQDTSQITLKTNREKEQSQDLVSEPTTTELADTDAASMA


 


NTGSDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQGKVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLA


 


RQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDFDEDWENFEFDAEAEPKAIKKHKIYRPQSTQAPKET


 


VIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKEAAATGERFLGIAPEAQVMFMRVFANDIMGSAE


 


SLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIEKAKKAGVSVVVAAGNERVYGSDHDDPLATNPD


 


YGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRADLNHGKAIYSESVDFKDIKDSLGYDKSHQFAYVKE


 


STDAGYNAQDVKGKIALIERDPNKTYDEMIALAKKHGALGVLIFNNKPGQSNRSMRLTANGMGIPSAFISHEF


 


GKAMSQLNGNGTGSLEFDSVVSKAPSQKGNEMNHFSNWGLTSDGYLKPDITAPGGDIYSTYNDNHYGSQTGTS


 


MASPQIAGASLLVKQYLEKTQPNLPKEKIADIVKNLLMSNAQIHVNPETKTTTSPRQQGA


 


3.3 Homologous sequences of other S. pyogenes isolates and/or serotypes


> Spy0416A-1/Schmitz 1/7 (serotype 4); SEQ ID NO: 90


ADELTTTSEPTITNHAQQQAQHLTNTELSSAESQSPDTSQITPKTNREKEQPQGLVSEPTTTELADTDAASMA


 


NTGPDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQGKVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLA


 


RQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFGDFDEDWENFEFDAEPKAIKKNKIYRPQSTQAPKETVI


 


KTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKEAAATGERFLGIAPEAQVMFMRVFANDVMGSAESL


 


FIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIEKAKKAGVSVVVAAGNERVYGSDHDDPLATNPDYG


 


LVGSPSTGRTPTSVAAINSKWVIQRLMTAKELENRADLNHGKAIYSESVDFKDIKDSLGYDKSHQFAYVKEST


 


DAGYKAQDVKDKIALIERDPNKTYDEMIALAKKHGALGVLIFNNKPGQSNRSMRLTANGMGIPSAFISHEFGK


 


AMSQLNGNGTGSLEFDSVVSKAPSQKGNEMNHFSNWGLTSDGYLKPDITAPGGDIYSTYNDNHYGSQTGTSMA


 


SPQIAGASLLVKQYLEKTQPNLPKEKIADIVKNLLMSNAQIHVNPETKTTTSPRQQGA


 


> Spy0416A-1/Schmitz 1/39 (serotype 12); SEQ ID NO: 91


ADELTTTSEPTITNHTQQQAQHLTNTELSSAESKPQDTSQITLKTNREKEQPQGLVSEPTTTELADTDAAPMA


 


NTGPDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQGKVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLA


 


RQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDFDEDWENFEFDAEAEPKAIKKHKIYRPQSTQAPKET


 


VIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKEAAATGERFLGIAPEAQVMFMRVFANDVMGSAE


 


SLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIEKAKKAGVSVVVAAGNERVYGSDHDDPLATNPD


 


YGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRADLNHGKAIYSESVDFKDIKDSLGYDKSHQFAYVKE


 


STDAGYNAQDVKGKIALIERDPNKTYDEMIALAKKHGALGVLIFNNKPGQSNRSMRLTANGMGIPSAFISHEF


 


GKAMSQLNGNGTGSLEFDSVVSKAPSQKGNEMNHFSNWGLTSDGYLKPDITAPGGDIYSTYNDNHYGSQTGTS


 


MASPQIAGASLLVKQYLEKTQPNLPKEKIADIVKNLLMSNAQIHVNPETKTTTSPRQQGA


 


> Spy0416A-1/Schmitz 1/55 (serotype 118); SEQ ID NO: 92


ADELTTTSEPTITNHAQQQAPPLTNTELSSAESQPQDTSQVTPETNREKEQPQGLVSEPTTTELADTDAAPMA


 


NTGSDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQGKVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLA


 


RQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDFDEDWENFEFDAEAEPKAIKKHKIYRPQSTQAPKET


 


VIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKEAAATGERFLGIAPEAQVMFMRVFANDVMGSAE


 


SLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIEKAKKAGVSVVVAAGNERVYGSDHDDPLATNPD


 


YGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRADLNHGKAIYSESVDFKDIKDSLGYDKSHQFAYVKE


 


STDAGYNAQNVKGKIALIERDPNKTYDEMIALAKKHGALGVLIFNNKPGQSNRSMRLTANGMGIPSAFISHEF


 


GKAMSQLNGNGTGSLEFDSVVSKAPSQKGNEMNHFSNWGLTSDGYLKPDITAPGGDIYSTYNDNHYGSQTGTS


 


MASPQIAGASLLVKQYLEKTQPNLPKEKIADIVKNLLMSNAQIHVNPETKTTTSPRQQGA


 


> Spy0416A-1/Schmitz 1/56 (serotype 28); SEQ ID NO: 93


ADELTTTSEPTITNHAQQQAPPLTNTELSSAESQPQDTSQVTPETNREKEQPQGLVSEPTTTELADTDAAPMA


 


NTGSDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQGKVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLA


 


RQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDFDEDWENFEFDAEAEPKAIKKHKIYRPQSTQAPKET


 


VIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKEAAATGERFLGIAPEAQVMFMRVFANDVMGSAE


 


SLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIEKAKKAGVSVVVAAGNERVYGSDHDDPLATNPD


 


YGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRADLNHGKAIYSESVDFKDIKDSLGYDKSHQFAYVKE


 


STDAGYNAQNVKGKIALIERDPNKTYDEMIALAKKHGALGVLIFNNKPGQSNRSMRLTANGMGIPSAFISHEF


 


GKAMSQLNGNGTGSLEFDSVVSKAPSQKGNEMNHFSNWGLTSDGYLKPDITAPGGDIYSTYNDNHYGSQTGTS


 


MASPQIAGASLLVKQYLEKTQPNLPKEKIADIVKNLLMSNAQIHVNPETKTTTSPRQQGA


 


> Spy0416A-1/Schmitz 1/94 (serotype 1); SEQ ID NO: 94


ADELSTMSEPTITNHAQQQAQHLTNTELSSAESKSQDTSQITLKTNREKEQSQDLVSEPTTTELADTDAASMA


 


NTGSDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQGKVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLA


 


RQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDFDEDWENFEFDAEAEPKAIKKHKIYRPQSTQAPKET


 


VIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKEAAATGERFLGIAPEAQVMFMRVFANDIMGSAE


 


SLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIEKAKKAGVSVVVAAGNERVYGSDHDDPLATNPD


 


YGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRADLNHGKAIYSESVDFKDIKDSLGYDKSHQFAYVKE


 


STDAGYNAQDVKGKIALIERDPNKTYDEMIALAKKHGALGVLIFNNKPGQSNRSMRLTANGMGIPSAFISHEF


 


GKAMSQLNGNGTGSLEFDSVVSKAPSQKGNEMNHFSNWGLTSDGYLKPDITAPGGDIYSTYNDNHYGSQTGTS


 


MASPQIAGASLLVKQYLEKTQPNLPKEKIADIVKNLLMSNAQIHVNPETKTTTSPRQQGA


 


> Spy0416A-1/Schmitz 1/253 (serotype 49); SEQ ID NO: 95


ADELTTTSEPTITNHAQQQAQPLTNTELSSAESQSPDISQVTPETNREKEQPQGLVSEPTTTELADTDAAPMA


 


NTGPDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQGKVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLA


 


RQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDFDEDWENFEFDADAEPKAIKKHKIYRPQSTQAPKET


 


VIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKEAAATGERFLGIAPEAQVMFMRVFANDVMGSAE


 


SLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIEKAKKAGVSVVVAAGNERVYGSDHDDPLATNPD


 


YGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKGLENRADLNHGKAIYSESVDFKDIKDSLGYDKSHQFAYVKE


 


STDAGYNAQDVKGKIALIERDPNKTYDEMIALAKKHGALGLLIFNNKSGQSNRSMRLTANGMGIPSAFISHEF


 


GKAMSQLNGNGTGSLEFDSVVSKAPSQKGNEMNHFSNWGLTSDGYLKPDITAPGGDIYSTYNDNHYGSQTGTS


 


MASPQIAGASLLVKQYLEKTQPNLPKEKIADIVKNLLMSNAQIHVNPETKTTTSPRQQGA


 


> Spy0416A-1/Schmitz 1/174 (serotype 6); SEQ ID NO: 96


ADELTTTSEPTITNHAQQQAQHLTNTELSSAESKPQDTSQITPKTNREKEQSQDLVSEPTTTELADTDAASMA


 


NTGPDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQGKVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLA


 


RQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDFDEDWENFEFDAEAEPKAIKKHKIYRPQSTQAPKET


 


VIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKEAAATGERFLGIAPEAQVMFMRVFANDVMGSAE


 


SLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIEKAKKAGVSVVVAAGNERVYGSDHDDPLATNPD


 


YGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRADLNHGKAIYSESVDFKNIKDSLGYDKSHQFAYVKE


 


STDAGYNAQDVKGKIALIERDPNKTYDEMIALAKKHGALGVLIFNNKPGQSNRSMRLTSNGMGIPSAFISHEF


 


GKAMSQLNGNGTGSLEFDSVVSKAPSQKGNEMNHFSNWGLTSDGYLKPDITAPGGDIYSTYNDNHYGSQTGTS


 


MASPQIAGASLLVKQYLEKTQPNLPKEKIADIVKNLLMSNAQIHVNPETKTTTSPRQQGA


 


> Spy0416A-1/Schmitz 1/176 (serotype 83); SEQ ID NO: 97


ADELTTTSEPTITNHTQQQAQHLTNTELSSAESKPQDTSQITLKTNREKEQPQGLVSEPTTTELADTDAAPMA


 


NTGPDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQGKVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLA


 


RQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDFDEDWENFEFDAEAEPKAIKKHKIYRPQSTQAPKET


 


VIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKEAAATGERFLGIAPEAQVMFMRVFANDVMGSAE


 


SLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIEKAKKAGVSVVVAAGNERVYGSDHDDPLATNPD


 


YGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRADLNHGKAIYSESVDFKNIKDSLGYDKSHQFAYVKE


 


STDAGYKAQDVKGKIALIERDPNKTYDEMIALAKKHGALGVLIFNNKPGQSNRSMRLTANGMGIPSAFISHEF


 


GKAMSQLNGNGTGSLEFDSVVSKAPSQKGNEMNHFSNWGLTSDGYLKPDITAPGGDIYSTYNDNHYGSQTGTS


 


MASPQIAGASLLVKQYLEKTQPNLPKEKIADIVKNLLMSNAQIHVNPETKTTTSPRQQGA


 


> Spy0416A-1/Schmitz 1/234 (serotype 44); SEQ ID NO: 98


ADELSTMSEPTITNHAQQQAQHLTNTELSSAESKSQDTSQITPKTNREKEQSQDLVSEPTTTELADTDAASMA


 


NTGSDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQGKVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLA


 


RQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDFDEDWENFEFDADAEPKAIKKHKIYRPQSTQAPKET


 


VIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKEAAATGERFLGIAPEAQVMFMRVFANDVMGSAE


 


SLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIEKAKKAGVSVVVAAGNERVYGSDHDDPLATNPD


 


YGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRADLNHGKAIYSESVDFKDIKDSLGYDKSHQFAYVKE


 


STDAGYKAQDVKDKIALIERDPNKTYDEMIALAKKHGALGVLIFNNKPGQSNRSMRLTANGMGIPSAFISHEF


 


GKAMSQLNGNGTGSLEFDSVVSKAPSQKGNEMNHFSNWGLTSDGYLKPDITAPGGDIYSTYNDNHYGSQTGTS


 


MASPQIAGASLLVKQYLEKTQPNLPKEKIADIVKNLLMSNAQIHVNPETKTTTSPRQQGA


 


> Spy0416A-1/Schmitz 1/22 (serotype 4); SEQ ID NO: 99


ADELTTTSEPTITNHAQQQAQHLTNTELSSAESQSPDTSQITPKTNREKEQPQGLVSEPTTTELADTDAASMA


 


NTGPDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQGKVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLA


 


RQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFGDFDEDWENFEFDAEPKAIKKNKIYRPQSTQAPKETVI


 


KTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKEAAATGERFLGIAPEAQVMFMRVFANDVMGSAESL


 


FIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIEKAKKAGVSVVVAAGNERVYGSDHDDPLATNPDYG


 


LVGSPSTGRTPTSVAAINSKWVIQRLMTAKELENRADLNHGKAIYSESVDFKDIKDSLGYDKSHQFAYVKEST


 


DAGYKAQDVKDKIALIERDPNKTYDEMIALAKKHGALGVLIFNNKPGQSNRSMRLTANGMGIPSAFISHEFGK


 


AMSQLNGNGTGSLEFDSVVSKAPSQKGNEMNHFSNWGLTSDGYLKPDITAPGGDIYSTYNDNHYGSQTGTSMA


 


SPQIAGASLLVKQYLEKTQPNLPKEKIADIVKNLLMSNAQIHVNPETKTTTSPRQQGA


 


3.4 Antigenic fragment Spy0416A-6


> Spy0416A-6/SF370 (serotype 1); SEQ ID NO: 5


AVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDFDED


 


WENFEFDAEAEPKAIKKHKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKE


 


AAATGERFLGIAPEAQVMFMRVFANDIMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIE


 


KAKKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRADLN


 


HGKAIYSESVDFKDIKDSL


 


3.5 Homologous sequences of other S. pyogenes isolates and/or serotypes


> Spy0416A-6/Schmitz 1/7 (serotype 4); SEQ ID NO: 100


AVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFGDFDED


 


WENFEFDAEPKAIKKNKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKEAA


 


ATGERFLGIAPEAQVMFMRVFANDVMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIEKA


 


KKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTAKELENRADLNHG


 


KAIYSESVDFKDIKDSL


 


> Spy0416A-6/Schmitz 1/39 (serotype 12); SEQ ID NO: 101


AVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDFDED


 


WENFEFDAEAEPKAIKKHKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKE


 


AAATGERFLGIAPEAQVMFMRVFANDVMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIE


 


KAKKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRADLN


 


HGKAIYSESVDFKDIKDSL


 


> Spy0416A-6/Schmitz 1/55 (serotype 118); SEQ ID NO: 102


AVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDFDED


 


WENFEFDAEAEPKAIKKHKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKE


 


AAATGERFLGIAPEAQVMFMRVFANDVMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIE


 


KAKKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRADLN


 


HGKAIYSESVDFKDIKDSL


 


> Spy0416A-6/Schmitz 1/56 (serotype 28); SEQ ID NO: 103


AVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDFDED


 


WENFEFDAEPKAIKKHKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKEAA


 


ATGERFLGIAPETQVMFMRVFANDVMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIEKA


 


KKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRADLNHG


 


KAIYSESVDFKDIKDSL


 


> Spy0416A-6/Schmitz 1/94 (serotype 1); SEQ ID NO: 104


AVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDFDED


 


WENFEFDAEAEPKAIKKHKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKE


 


AAATGERFLGIAPEAQVMFMRVFANDIMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIE


 


KAKKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRADLN


 


HGKAIYSESVDFKDIKDSL


 


> Spy0416A-6/Schmitz 1/253 (serotype 49); SEQ ID NO: 105


AVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDFDED


 


WENFEFDADAEPKAIKKHKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKE


 


AAATGERFLGIAPEAQVMFMRVFANDVMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIE


 


KAKKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKGLENRADLN


 


HGKAIYSESVDFKDIKDSL


 


> Spy0416A-6/Schmitz 1/174 (serotype 6); SEQ ID NO: 106


AVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDFDED


 


WENFEFDAEAEPKAIKKHKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKE


 


AAATGERFLGIAPEAQVMFMRVFANDVMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIE


 


KAKKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRADLN


 


HGKAIYSESVDFKNIKDSL


 


> Spy0416A-6/Schmitz 1/176 (serotype 83); SEQ ID NO: 107


AVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDFDED


 


WENFEFDAEAEPKAIKKHKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKE


 


AAATGERFLGIAPEAQVMFMRVFANDVMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIE


 


KAKKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRADLN


 


HGKAIYSESVDFKNIKDSL


 


> Spy0416A-6/Schmitz 1/234 (serotype 44); SEQ ID NO: 108


AVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDFDED


 


WENFEFDADAEPKAIKKHKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKE


 


AAATGERFLGIAPEAQVMFMRVFANDVMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIE


 


KAKKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRADLN


 


HGKAIYSESVDFKDIKDSL


 


> Spy0416A-6/Schmitz 1/22 (serotype 4); SEQ ID NO: 109


AVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFGDFDED


 


WENFEFDAEPKAIKKNKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSKEAA


 


ATGERFLGIAPEAQVMFMRVFANDVMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAIEKA


 


KKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTAKELENRADLNHG


 


KAIYSESVDFKDIKDSL


 


3.6 Antigenic fragment Spy0416A-7


> Spy0416A-7/SF370 (serotype 1); SEQ ID NO: 6


SQITLKTNREKEQSQDLVSEPTTTELADTDAASMANTGSDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQG


 


KVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDF


 


DEDWENFEFDAEAEPKAIKKHKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGN


 


SKEAAATGERFLGIAPEAQVMFMRVFANDIMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLME


 


AIEKAKKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRA


 


DLNHGKAIYSESVDFKDIKDSLGYDKSHQFAYVKESTDAGYNAQDVKGKIALIERDPNKTYDEMIALAKKHGA


 


LGVLIFNNKPGQSNRSMRLTANGMGIPSAFISHEFGKAMSQLNGNGTGS


 


3.7 Homologous sequences of other S. pyogenes isolates and/or serotypes


> Spy0416A-7/Schmitz 1/7 (serotype 4); SEQ ID NO: 110


SQITPKTNREKEQPQGLVSEPTTTELADTDAASMANTGPDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQG


 


KVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFGDF


 


DEDWENFEFDAEPKAIKKNKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSK


 


EAAATGERFLGIAPEAQVMFMRVFANDVMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAI


 


EKAKKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTAKELENRADL


 


NHGKAIYSESVDFKDIKDSLGYDKSHQFAYVKESTDAGYKAQDVKDKIALIERDPNKTYDEMIALAKKHGALG


 


VLIFNNKPGQSNRSMRLTANGMGIPSAFISHEFGKAMSQLNGNGTGS


 


> Spy0416A-7/Schmitz 1/39 (serotype 12); SEQ ID NO: 111


SQITLKTNREKEQPQGLVSEPTTTELADTDAAPMANTGPDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQG


 


KVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDF


 


DEDWENFEFDAEAEPKAIKKHKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGN


 


SKEAAATGERFLGIAPEAQVMFMRVFANDVMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLME


 


AIEKAKKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRA


 


DLNHGKAIYSESVDFKDIKDSLGYDKSHQFAYVKESTDAGYNAQDVKGKIALIERDPNKTYDEMIALAKKHGA


 


LGVLIFNNKPGQSNRSMRLTANGMGIPSAFISHEFGKAMSQLNGNGTGS


 


> Spy0416A-7/Schmitz 1/55 (serotype 118); SEQ ID NO: 112


SQVTPETNREKEQPQGLVSEPTTTELADTDAAPMANTGSDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQG


 


KVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDF


 


DEDWENFEFDAEAEPKAIKKHKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGN


 


SKEAAATGERFLGIAPEAQVMFMRVFANDVMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLME


 


AIEKAKKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRA


 


DLNHGKAIYSESVDFKDIKDSLGYDKSHQFAYVKESTDAGYNAQNVKGKIALIERDPNKTYDEMIALAKKHGA


 


LGVLIFNNKPGQSNRSMRLTANGMGIPSAFISHEFGKAMSQLNGNGTGS


 


> Spy0416A-7/Schmitz 1/56 (serotype 28); SEQ ID NO: 113


SQITPKINREKEQPQGLVSEPTTTELADTDAAPMANTGPDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQG


 


KVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDF


 


DEDWENFEFDAEPKAIKKHKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSK


 


EAAATGERFLGIAPETQVMFMRVFANDVMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAI


 


EKAKKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRADL


 


NHGKAIYSESVDFKDIKDSLGYDKSHQFAYVKESTDAGYNAQDVKGKIALIERDPNKTYDEMIALAKKHGALG


 


VLIFNNKPGQSNRSMRLTANGMGIPSAFISHEFGKAMSQLNGNGTGS


 


> Spy0416A-7/Schmitz 1/94 (serotype 1); SEQ ID NO: 114


SQITLKTNREKEQSQDLVSEPTTTELADTDAASMANTGSDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQG


 


KVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDF


 


DEDWENFEFDAEAEPKAIKKHKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGN


 


SKEAAATGERFLGIAPEAQVMFMRVFANDIMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLME


 


AIEKAKKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRA


 


DLNHGKAIYSESVDFKDIKDSLGYDKSHQFAYVKESTDAGYNAQDVKGKIALIERDPNKTYDEMIALAKKHGA


 


LGVLIFNNKPGQSNRSMRLTANGMGIPSAFISHEFGKAMSQLNGNGTGS


 


> Spy0416A-7/Schmitz 1/253 (serotype 49); SEQ ID NO: 115


SQVTPETNREKEQPQGLVSEPTTTELADTDAAPMANTGPDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQG


 


KVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDF


 


DEDWENFEFDADAEPKAIKKHKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGN


 


SKEAAATGERFLGIAPEAQVMFMRVFANDVMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLME


 


AIEKAKKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKGLENRA


 


DLNHGKAIYSESVDFKDIKDSLGYDKSHQFAYVKESTDAGYNAQDVKGKIALIERDPNKTYDEMIALAKKHGA


 


LGLLIFNNKSGQSNRSMRLTANGMGIPSAFISHEFGKAMSQLNGNGTGS


 


> Spy0416A-7/Schmitz 1/174 (serotype 6); SEQ ID NO: 116


SQITPKTNREKEQSQDLVSEPTTTELADTDAASMANTGPDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQG


 


KVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDF


 


DEDWENFEFDAEAEPKAIKKHKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGN


 


SKEAAATGERFLGIAPEAQVMFMRVFANDVMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLME


 


AIEKAKKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRA


 


DLNHGKAIYSESVDFKNIKDSLGYDKSHQFAYVKESTDAGYNAQDVKGKIALIERDPNKTYDEMIALAKKHGA


 


LGVLIFNNKPGQSNRSMRLTSNGMGIPSAFISHEFGKAMSQLNGNGTGS


 


> Spy0416A-7/Schmitz 1/176 (serotype 83); SEQ ID NO: 117


SQITLKTNREKEQPQGLVSEPTTTELADTDAAPMANTGPDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQG


 


KVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDF


 


DEDWENFEFDAEAEPKAIKKHKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGN


 


SKEAAATGERFLGIAPEAQVMFMRVFANDVMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLME


 


AIEKAKKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRA


 


DLNHGKAIYSESVDFKNIKDSLGYDKSHQFAYVKESTDAGYKAQDVKGKIALIERDPNKTYDEMIALAKKHGA


 


LGVLIFNNKPGQSNRSMRLTANGMGIPSAFISHEFGKAMSQLNGNGTGS


 


> Spy0416A-7/Schmitz 1/234 (serotype 44); SEQ ID NO: 118


SQITPKTNREKEQSQDLVSEPTTTELADTDAASMANTGSDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQG


 


KVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFEDF


 


DEDWENFEFDADAEPKAIKKHKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGN


 


SKEAAATGERFLGIAPEAQVMFMRVFANDVMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLME


 


AIEKAKKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTVKELENRA


 


DLNHGKAIYSESVDFKDIKDSLGYDKSHQFAYVKESTDAGYKAQDVKDKIALIERDPNKTYDEMIALAKKHGA


 


LGVLIFNNKPGQSNRSMRLTANGMGIPSAFISHEFGKAMSQLNGNGTGS


 


> Spy0416A-7/Schmitz 1/22 (serotype 4); SEQ ID NO: 119


SQITPKTNREKEQPQGLVSEPTTTELADTDAASMANTGPDATQKSASLPPVNTDVHDWVKTKGAWDKGYKGQG


 


KVVAVIDTGIDPAHQSMRISDVSTAKVKSKEDMLARQKAAGINYGSWINDKVVFAHNYVENSDNIKENQFGDF


 


DEDWENFEFDAEPKAIKKNKIYRPQSTQAPKETVIKTEETDGSHDIDWTQTDDDTKYESHGMHVTGIVAGNSK


 


EAAATGERFLGIAPEAQVMFMRVFANDVMGSAESLFIKAIEDAVALGADVINLSLGTANGAQLSGSKPLMEAI


 


EKAKKAGVSVVVAAGNERVYGSDHDDPLATNPDYGLVGSPSTGRTPTSVAAINSKWVIQRLMTAKELENRADL


 


NHGKAIYSESVDFKDIKDSLGYDKSHQFAYVKESTDAGYKAQDVKDKIALIERDPNKTYDEMIALAKKHGALG


 


VLIFNNKPGQSNRSMRLTANGMGIPSAFISHEFGKAMSQLNGNGTGS


 


3.8 Full length Spy0416B


> Spy0416B/SF370 (serotype 1); SEQ ID NO: 56


HVDPQKGRFTLTSHSLKTYQGGEVTVPANGKVTVRVTMDVSQFTKELTKQMPNGYYLEGFVRFRDSQDDQLNR


 


VNIPFVGFKGQFENLAVAEESIYRLKSQGKTGFYEDESGPKDDIYVGKHFTGLVTLGSETNVSTKTISDNGLH


 


TLGTFKNADGKFILEKNAQGNPVLAISPNGDNNQDFAAFKGVFLRKYQGLKASVYHASDKEHKNPLWVSPESF


 


KGDKNFNSDIRFAKSTTLLGTAFSGKSLTGAELPDGHYHYVVSYYPDVVGAKRQEMTFDMILDRQKPVLSQAT


 


FDPETNRFKPEPLKDRGLAGVRKDSVFYLERKDNKPYTVTINDSYKYVSVEDNKTFVERQADGSFILPLDKAK


 


LGDFYYMVEDFAGNVAIAKLGDHLPQTLGKTPIKLKLTDGNYQTKETLKDNLEMTQSDTGLVTNQAQLAVVHR


 


NQPQSQLTKMNQDFFISPNEDGNKDFVAFKGLKNNVYNDLTVNVYAKDDHQKQTPIWSSQAGASVSAIESTAW


 


YGITARGSKVMPGDYQYVVTYRDEHGKEHQKQYTISVNDKKPMITQGRFDTINGVDHFTPDKTKALDSSGIVR


 


EEVFYLAKKNGRKFDVTEGKDGITVSDNKVYIPKNPDGSYTISKRDGVTLSDYYYLVEDRAGNVSFATLRDLK


 


AVGKDKAVVNFGLDLPVPEDKQIVNFTYLVRDADGKPIENLEYYNNSGNSLILPYGKYTVELLTYDTNAAKLE


 


SDKIVSFTLSADNNFQQVTFKITMLATSQITAHFDHLLPEGSRVSLKTAQDQLIPLEQSLYVPKAYGKTVQEG


 


TYEVVVSLPKGYRIEGNTKVNTLPNEVHELSLRLVKVGDASDSTGDHKVMSKNNSQALTASATPTKSTTSATA


 


KALPST


 


4. Spy0872


4.1 Full length Spy0872


> Spy0872/SF370 (serotype 1); SEQ ID NO: 120


DQVDVQFLGVNDFHGALDNTGTAYTPSGKIPNAGTAAQLGAYMDDAEIDFKQANQDGTSIRVQAGDMVGASPA


 


NSALLQDEPTVKVFNKMKFEYGTLGNHEFDEGLDEFNRIMTGQAPDPESTINDITKQYEHEASHQTIVIANVI


 


DKKTKDIPYGWKPYAIKDIAINDKIVKIGFIGVVTTEIPNLVLKQNYEHYQFLDVAETIAKYAKELQEQHVHA


 


IVVLAHVPATSKDGVVDHEMATVMEKVNQIYPEHSIDIIFAGHNHQYTNGTIGKTRIVQALSQGKAYADVRGT


 


LDTDTNDFIKTPSANVVAVAPGIKTENSDIKAIINHANDIVKTVTERKIGTATNSSTISKTENIDKESPVGNL


 


ATTAQLTIAKKTFPTVDFAMTNNGGIRSDLVVKNDRTITWGAAQAVQPFGNILQVIQMTGQHIYDVLNQQYDE


 


NQTYFLQMSGLTYTYTDNDPKNSDTPFKIVKVYKDNGEEINLTTTYTVVVNDFLYGGGDGFSAFKKAKLIGAI


 


NTDTEAFITYITNLEASGKTVNATIKGVKNYVTSNLESSTKVNSAGKHSIISKVFRNRDGNTVSSEVISDLLT


 


STENTNNSLGKKETTTNKNTISSSTLPIT


 


4.2 Antigenic fragment Spy0872-2


> Spy0872-2/SF370 (serotype 1); SEQ ID NO: 7


AIINHANDIVKTVTERKIGTATNSSTISKTENIDKESPVGNLATTAQLTIAKKTFPTVDFAMTNNGGIRSDLV


 


VKNDRTITWGAAQAVQPFGNILQVIQMTGQHIYDVLNQQYDENQTYFLQMSGLTYTYTDNDPKNSDTPFKIVK


 


VYKDNGEEINLTTTYTVVVNDFLYGGGDGFSAFKKAKLIGAINTDTEAFITYITNLEASGKTVNATIKGVKNY


 


VTSNLESSTKVNSAGKHSIISKVFRNRDGNTVSSEVISDLLTSTENTNNSLGKKETTTNKNTISSSTLPIT


 


4.3 Homologous sequences of other S. pyogenes isolates and/or serotypes


> Spy0872-2/Schmitz 1/7 (serotype 4); SEQ ID NO: 121


AIINHANDIVKTVTERKIGTATNSSTISKTENIDKESPVGNLVTTAQLTIAKKTFPTVDFAMTNNGGIRSDLV


 


VKNDRTITWEAAQAVQPFGNILQVIQMTGQHIYDVLNQQYDENQTYFLQMSGLTYTYTDNDPKNSDTPFKIVK


 


VYKDNGEEINLTTTYTVVVNDFLYGGGDGFSAFKKAKLIGAINTDTEAFITYITNLEASGKTVNATIKGVKNY


 


VTSNLESSTKVNSAGKHSIIIIISKVFRNRDGNIVSSEIISDLLTSTENTNNSFGKKEITTNKNTISNSTLPIT


 


> Spy0872-2/Schmitz 1/39 (serotype 12); SEQ ID NO: 122


AIINHANDIVKTVTERKIGTATNSSTISKTENIDKESPVGNLVTTAQLTIAKKTFPTVDFAMTNNGGIRSDLV


 


VKNDRTITWGAAQAVQPFGNILQVIQMTGQHIYDVLNQQYDENQTYFLQMSGLTYTYTDNDPKNSDTPFKIVK


 


VYKDNGEEINLTTTYTVVVNDFLYGGGDGFSAFKKAKLIGAINTDTEAFITYITNLEASGKTVNATIKGVKNY


 


VTSNLESSTKVNSAGKHSIISKVFRNRDGNIVSSEIISDLLTSTENTNNSLGKKETTTNKNTISSSTLPIT


 


> Spy0872-2/Schmitz 1/55 (serotype 118); SEQ ID NO: 123


AIINHANDIVKTVTERKIGTATNSSTISKTENIDKESPVGNLVTTAQLTIAKKTFPTVDFAMTNNGGIRSDLV


 


VKNDRTITWGAAQAVQPFGNILQVIQMTGQHIYDVLNQQYDENQTYFLQMSGLTYTYTDNDPKNSDIPFKIVK


 


VYKDNGEEINLTTTYTVVVNDFLYGGGDGFSAFKKAKLIGAINTDTEAFITYITNLEASGKTVNATIKGVKNY


 


VTSNLESSTKVNSAGKHSIISKVFRNRDGNIVSSEVISDLLTSTENTNNSLGKKETTTNKNTISSSTLPIT


 


> Spy0872-2/Schmitz 1/56 (serotype 28); SEQ ID NO: 124


AIINHANDIVKTVTERKIGTATNSSTISKTENIDKESPVGNLVTTAQLTIAKKTFPTVDFAMTNNGGIRSDLV


 


VKNDRTITWGAAQAVQPFGNILQVIQMTGQHIYDVLNQQYDENQTYFLQMSGLTYTYTDNDPKNSDTPFKIVK


 


VYKDNGEEINLTTTYTVVVNDFLYGGGDGFSAFKKAKLIGAINTDTEAFITYITNLEASGKTVNATIKGVKNY


 


VTSNLESSTKVNSAGKHSIISKVFRNRDGNIVSSEIISDLLTSTENTNNSLGKKETTTNKNTISSSTLPIT


 


> Spy0872-2/Schmitz 1/94 (serotype 1); SEQ ID NO: 125


AIINHANDIVKTVTERKIGTATNSSTISKTENIDKESPVGNLATTAQLTIAKKTFPTVDFAMTNNGGIRSDLV


 


VKNDRTITWGAAQAVQPFGNILQVIQMTGQHIYDVLNQQYDENQTYFLQMSGLTYTYTDNDPKNSDTPFKIVK


 


VYKDNGEEINLTTTYTVVVNDFLYGGGDGFSAFKKAKLIGAINTDTEAFITYITNLEASGKTVNATIKGVKNY


 


VTSNLESSTKVNSAGKHSIISKVFRNRDGNTVSSEVISDLLTSTENTNNSLGKKETTTNKNTISSSTLPIT


 


> Spy0872-2/Schmitz 1/253 (serotype 49); SEQ ID NO: 126


AIINHANDIVKTVTERKIGTATNSSTISKTENIDKESPVGNLVTTAQLTIAKKTFPTVDFAMTNNGGIRSDLV


 


VKNDRTITWGAAQAVQPFGNILQVIQMTGQHIYDVLNQQYDENQTYFLQMSGLTFTYTDNDPKNSDTPFKIVK


 


VYKDNGEEINLTTTYTVVVNDFLYGGGDGFSAFKKAKLIGAINTDTEAFITYITNLEASGKTVNATIKGVKNY


 


VTSNLESSTKVNSAGKHSIISKVFRNRDGNIVSSEIISDLLTSTENTNNSLGKKETTTNKNTISSSTLPIT


 


> Spy0872-2/Schmitz 1/176 (serotype 83); SEQ ID NO: 127


AIINHANDIVKTVTERKIGTATNSSTISKTENIDKESPVGNLVTTAQLTIAKKTFPTVDFAMTNNGGIRSDLV


 


VKNDRTITWGAAQAVQPFGNILQVIQMTGQHIYDVLNQQYDENQTYFLQMSGLTYTYTDNDPKNSDTPFKIVK


 


VYKDNGEEINLTTTYTVVVNDFLYGGGDGFSAFKKAKLVGAINTDTEAFITYITNLQASGKTVNATIKGVKNY


 


VTSNLERSTKINSAGKHSIISKVFRNRDGNIVSSEVISDLLTSTENTNNSFGKKETTTNKNTISNSTLPIT


 


> Spy0872-2/Schmitz 1/177 (serotype 22); SEQ ID NO: 128


AIINHANDIVKTVTERKIGTATNSSTISKTENIDKESPVGNLVTTAQLTIAKKTFPTVDFAMTNNGGIRSDLV


 


VKNDRTITWGAAQAVQPFGNILQVIQMTGQHIYDVLNQQYDENQTYFLQMSGLTYTYTDNDPKNSDTPFKIVK


 


VYKDNGEEINLTTTYTVVVNDFLYGGGDGFSAFKKAKLIGAINTDTEAFITYITNLEASGKTVNATIKGVKNY


 


VTSNLESSTKVNSAGKHSIISKVFRNRDGNIVSSEIISDLLTSTENTNNSLGKKETTTNKNTISSSTLPIT


 


> Spy0872-2/Schmitz 1/234 (serotype 44); SEQ ID NO: 129


AIINHANDIVKTVTERKIGTATNSSTISKTENIDKESPVGNLVTTAQLTIAKKTFPTVDFAMTNNGGIRSDLV


 


VKNDRTITWGAAQAVQPFGNILQVIQMTGQHIYDVLNQQYDENQTYFLQMSGLTYTYTDNDPKNSDTPFKIVK


 


VYKDNGEEINLTTTYTVVVNDFLYGGGDGFSAFKKAKLIGAINTDTEAFITYITNLEASGKTVNATIKGVKNY


 


VTSNLESSTKVNSAGKHSIISKVFRNRDGNIVSSEIISDLLTSTENTNNSLGKKETTTNKNTISSSTLPIT


 


> Spy0872-2/Schmitz 1/22 (serotype 4); SEQ ID NO: 130


AIINHANDIVKTVTERKIGTATNSSTISKTENIDKESPVGNLVTTAQLTIAKKTFPTVDFAMTNNGGIRSDLV


 


VKNDRTITWEAAQAVQPFGNILQVIQMTGQHIYDVLNQQYDENQTYFLQMSGLTYTYTDNDPKNSDTPFKIVK


 


VYKDNGEEINLTTTYTVVVNDFLYGGGDGFSAFKKAKLIGAINTDTEAFITYITNLEASGKTVNATIKGVKNY


 


VTSNLESSTKVNSAGKHSIIIISKVFRNRDGNIVSSEIISDLLTSTENTNNSFGKKEITTNKNTISNSTLPIT


 


5. Further Sequences


> Spy0488/SF370 (serotype 1); SEQ ID NO: 8


LRQIQSIRLIDVLELAFGVGYKEETTSQFSSDQPSQVVLYRGEANTVRFAYTNQMSLMKDIRIALDGSDKSLT


 


AQIVPGMGHVYEGFQTSARGIFTMSGVPESTVPVANPNVQTKYIRYFKVIDDMHNTMYKGTVFLVQPQAWKYT


 


MKSVDQLPVDDLNHIGVAGIERMTTLIKNAGALLTTGGSGAFPDNIKVSINPKGRQATITYGDGSTDIIPPAV


 


LWKKGSVKEPTEADQSVGTPTPGIPGKFKRDQSLNEHEAMVNVEPLSHVVKDNIKVIDEKSTGRFEPFRPNED


 


EKEKPASDVKVRPAEVGSWLEPATALPSVEMSAEDRLKS


 


> Spy0895/SF370 (serotype 1); SEQ ID NO: 9


TNNQTLDILLDVYAYNHAFRIAKALPNIPKTALYLLEMLKERRELNLAFLAEHAAENRTIEDQYHCSLWLNQS


 


LEDEQIANYILDLEVKVKNGAIIDFVRSVSPILYRLFLRLITSEIPNFKAYIFDTKNDQYDTWHFQAMLESDH


 


EVFKAYLSQKQSRNVTTKSLADMLTLTSLPQEIKDLVFLLRHFEKAVRNPLAHLIKPFDEEELHRTTHFSSQA


 


FLENIITLATFSGVIYRREPFYFDDMNAIIKKELSLWRQSIV


 


> Spy1536/SF370 (serotype 1); SEQ ID NO: 131


IEMPGGAYDIRTVLQVNGKEDKRKGAYQFVAVGISRASLAQLLYAWLTPFTEISTAEDTTGGYSDADFLRINQ


 


FYMETSQNAAIYQALSLAGKPVTLDYKGVYVLDVNNESTFKGTLHLADTVTGVNGKQFTSSAELIDYVSHLKL


 


GDEVTVQFTSDNKPKKGVGRIIKLKNGKNGIGIALTDHTSVNSEDTVIFSTKGVGGPSAGLMFTLDIYDQITK


 


EDLRKGRTIAGTGTIGKDGEVGDIGGAGLKVVAAAEAGADIFFVPNNPVDKEIKKVNPNAISNYEEAKRAAKR


 


LKTKMKIVPVTTVQEALVYLRK


 


> Spy1666/SF370 (serotype 1); SEQ ID NO: 132


TKEFHHVTVLLHETVDMLDIKPDGIYVDATLGGSGHSAYLLSKLGEEGHLYCFDQDQKAIDNAQVTLKSYIDK


 


GQVTFIKDNFRHLKARLTALGVDEIDGILYDLGVSSPQLDERERGFSYKQDAPLDMRMDRQSLLTAYEVVNTY


 


PFNDLVKIFFKYGEDKFSKQIARKIEQARAIKPIETTTELAELIKAAKPAKELKKKGHPAKQIFQAIRIEVND


 


ELGAADESIQDAMELLALDGRISVITFHSLEDRLTKQLFKEASTVDVPKGLPLIPEDMKPKFELVSRKPILPS


 


HSELTANKRAHSAKLRVAKKIRK


 


> Spy1727/SF370 (serotype 1); SEQ ID NO: 10


VTTTEQELTLTPLRGKSGKAYKGTYPNGECVFIKLNTTPILPALAKEQIAPQLLWAKRMGNGDMMSAQEWLNG


 


RTLTKEDMNSKQIIHILLRLHKSKKLVNQLLQLNYKIENPYDLLVDFEQNAPLQIQQNSYLQAIVKELKRSLP


 


EFKSEVATIVHGDIKHSNWVITTSGMIFLVDWDSVRLTDRMYDVAYLLSHYIPRSRWSEWLSYYGYKNNDKVM


 


QKIIWYGQFSHLTQILKCFDKRDMEHVNQEIYALRKFREIFRKK



















SEQUENCE DATA FOR DNA SEQUENCES
















1. Spy0269



1.1 Full length Spy0269


> Spy0269/SF370 (serotype 1); SEQ ID NO: 133


ATGGACTTAGAACAAACGAAGCCAAACCAAGTTAAGCAGAAAATTGCTTTAACCTCAACAATTGCTTTATTGA


 


GTGCCAGTGTAGGCGTATCTCACCAAGTCAAAGCAGATGATAGAGCCTCAGGAGAAACGAAGGCGAGTAATAC


 


TCACGACGATAGTTTACCAAAACCAGAAACAATTCAAGAGGCAAAGGCAACTATTGATGCAGTTGAAAAAACT


 


CTCAGTCAACAAAAAGCAGAACTGACAGAGCTTGCTACCGCTCTGACAAAAACTACTGCTGAAATCAACCACT


 


TAAAAGAGCAGCAAGATAATGAACAAAAAGCTTTAACCTCTGCACAAGAAATTTACACTAATACTCTTGCAAG


 


TAGTGAGGAGACGCTATTAGCCCAAGGAGCCGAACATCAAAGAGAGTTAACAGCTACTGAAACAGAGCTTCAT


 


AATGCTCAAGCAGATCAACATTCAAAAGAGACTGCATTGTCAGAACAAAAAGCTAGCATTTCAGCAGAAACTA


 


CTCGAGCTCAAGATTTAGTGGAACAAGTCAAAACGTCTGAACAAAATATTGCTAAGCTCAATGCTATGATTAG


 


CAATCCTGATGCTATCACTAAAGCAGCTCAAACGGCTAATGATAATACAAAAGCATTAAGCTCAGAATTGGAG


 


AAGGCTAAAGCTGACTTAGAAAATCAAAAAGCTAAAGTTAAAAAGCAATTGACTGAAGAGTTGGCAGCTCAGA


 


AAGCTGCTCTAGCAGAAAAAGAGGCAGAACTTAGTCGTCTTAAATCCTCAGCTCCGTCTACTCAAGATAGCAT


 


TGTGGGTAATAATACCATGAAAGCACCGCAAGGCTATCCTCTTGAAGAACTTAAAAAATTAGAAGCTAGTGGT


 


TATATTGGATCAGCTAGTTACAATAATTATTACAAAGAGCATGCAGATCAAATTATTGCCAAAGCTAGTCCAG


 


GTAATCAATTAAATCAATACCAAGATATTCCAGCAGATCGTAATCGCTTTGTTGATCCCGATAATTTGACACC


 


AGAAGTGCAAAATGAGCTAGCGCAGTTTGCAGCTCACATGATTAATAGTGTAAGAAGACAATTAGGTCTACCA


 


CCAGTTACTGTTACAGCAGGATCACAAGAATTTGCAAGATTACTTAGTACCAGCTATAAGAAAACTCATGGTA


 


ATACAAGACCATCATTTGTCTACGGACAGCCAGGGGTATCAGGGCATTATGGTGTTGGGCCTCATGATAAAAC


 


TATTATTGAAGACTCTGCCGGAGCGTCAGGGCTCATTCGAAATGATGATAACATGTACGAGAATATCGGTGCT


 


TTTAACGATGTGCATACTGTGAATGGTATTAAACGTGGTATTTATGACAGTATCAAGTATATGCTCTTTACAG


 


ATCATTTACACGGAAATACATACGGCCATGCTATTAACTTTTTACGTGTAGATAAACATAACCCTAATGCGCC


 


TGTTTACCTTGGATTTTCAACCAGCAATGTAGGATCTTTGAATGAACACTTTGTAATGTTTCCAGAGTCTAAC


 


ATTGCTAACCATCAACGCTTTAATAAGACCCCTATAAAAGCCGTTGGAAGTACAAAAGATTATGCCCAAAGAG


 


TAGGCACTGTATCTGATACTATTGCAGCGATCAAAGGAAAAGTAAGCTCATTAGAAAATCGTTTGTCGGCTAT


 


TCATCAAGAAGCTGATATTATGGCAGCCCAAGCTAAAGTAAGTCAACTTCAAGGTAAATTAGCAAGCACACTT


 


AAGCAGTCAGACAGCTTAAATCTCCAAGTGAGACAATTAAATGATACTAAAGGTTCTTTGAGAACAGAATTAC


 


TAGCAGCTAAAGCAAAACAAGCACAACTCGAAGCTACTCGTGATCAATCATTAGCTAAGCTAGCATCGTTGAA


 


AGCCGCACTGCACCAGACAGAAGCCTTAGCAGAGCAAGCCGCAGCCAGAGTGACAGCACTGGTGGCTAAAAAA


 


GCTCATTTGCAATATCTAAGGGACTTTAAATTGAATCCTAACCGCCTTCAAGTGATACGTGAGCGCATTGATA


 


ATACTAAGCAAGATTTGGCTAAAACTACCTCATCTTTGTTAAATGCACAAGAAGCTTTAGCAGCCTTACAAGC


 


TAAACAAAGCAGTCTAGAAGCTACTATTGCTACCACAGAACACCAGTTGACTTTGCTTAAAACCTTAGCTAAC


 


GAAAAGGAATATCGCCACTTAGACGAAGATATAGCTACTGTGCCTGATTTGCAAGTAGCTCCACCTCTTACGG


 


GCGTAAAACCGCTATCATATAGTAAGATAGATACTACTCCGCTTGTTCAAGAAATGGTTAAAGAAACGAAACA


 


ACTATTAGAAGCTTCAGCAAGATTAGCTGCTGAAAATACAAGTCTTGTAGCAGAAGCGCTTGTTGGCCAAACC


 


TCTGAAATGGTAGCAAGTAATGCCATTGTGTCTAAAATCACATCTTCGATTACTCAGCCCTCATCTAAGACAT


 


CTTATGGCTCAGGATCTTCTACAACGAGCAATCTCATTTCTGATGTTGATGAAAGTACTCAAAGAGCTCTTAA


 


AGCAGGAGTCGTCATGTTGGCAGCTGTCGGCCTCACAGGATTTAGGTTCCGTAAGGAATCTAAGTGA


 


1.2 Antigenic fragment Spy0269-1


> Spy0269-1/SF370 (serotype 1); SEQ ID NO: 11


GATGATAGAGCCTCAGGAGAAACGAAGGCGAGTAATACTCACGACGATAGTTTACCAAAACCAGAAACAATTC


 


AAGAGGCAAAGGCAACTATTGATGCAGTTGAAAAAACTCTCAGTCAACAAAAAGCAGAACTGACAGAGCTTGC


 


TACCGCTCTGACAAAAACTACTGCTGAAATCAACCACTTAAAAGAGCAGCAAGATAATGAACAAAAAGCTTTA


 


ACCTCTGCACAAGAAATTTACACTAATACTCTTGCAAGTAGTGAGGAGACGCTATTAGCCCAAGGAGCCGAAC


 


ATCAAAGAGAGTTAACAGCTACTGAAACAGAGCTTCATAATGCTCAAGCAGATCAACATTCAAAAGAGACTGC


 


ATTGTCAGAACAAAAAGCTAGCATTTCAGCAGAAACTAGTCGAGCTCAAGATTTAGTGGAACAAGTCAAAACG


 


TCTGAAGAAAATATTGCTAAGCTCAATGCTATGATTAGCAATCCTGATGCTATCACTAAAGCAGCTCAAACGG


 


CTAATGATAATACAAAAGCATTAAGCTCAGAATTGGAGAAGGCTAAAGCTGACTTAGAAAATCAAAAAGCTAA


 


AGTTAAAAAGCAATTGACTGAAGAGTTGGCAGCTCAGAAAGCTGCTCTAGCAGAAAAAGAGGCAGAACTTAGT


 


CGTCTTAAATCCTCAGCTCCGTCTACTCAAGATAGCATTGTGGGTAATAATACCATGAAAGCACCGCAAGGCT


 


ATCCTCTTGAAGAACTTAAAAAATTAGAAGCTAGTGGTTATATTGGATCAGCTAGTTACAATAATTATTACAA


 


AGAGCATGCAGATCAAATTATTGCCAAAGCTAGTCCAGGTAATCAATTAAATCAATACCAAGATATTCCAGCA


 


GATCGTAATCGCTTTGTTGATCCCGATAATTTGACACCAGAAGTGCAAAATGAGCTAGCGCAGTTTGCAGCTC


 


ACATGATTAATAGTGTAAGAAGACAATTAGGTCTACCACCAGTTACTGTTACAGCAGGATCACAAGAATTTGC


 


AAGATTACTTAGTACCAGCTATAAGAAAACTCATGGTAATACAAGACCATCATTTGTCTACGGACAGCCAGGG


 


GTATCAGGGCATTATGGTGTTGGGCCTCATGATAAAACTATTATTGAAGACTCTGCCGGAGCGTCAGGGCTCA


 


TTCGAAATGATGATAACATGTACGAGAATATCGGTGCTTTTAACGATGTGCATACTGTGAATGGTATTAAACG


 


TGGTATTTATGACAGTATCAAGTATATGCTCTTTACAGATCATTTACACGGAAATACATACGGCCATGCTATT


 


AACTTTTTACGTGTAGATAAACATAACCCTAATGCGCCTGTT


 


1.3 Homologous sequences of other S. pyogenes isolates and/or serotypes


> Spy0269-1/Schmitz 2/14 (serotype 1); SEQ ID NO: 134


GATGATAGAGCCTCAGGAGAAACGAAGGCGAGTAATACTCACGACGATAGTTTACCAAAACCAGAAACAATTC


 


AAGAGGCAAAGGCAACTATTGATGCAGTTGAAAAAACTCTCAGTCAACAAAAAGCAGAACTGACAGAGCTTGC


 


TACCGCTCTGACAAAAACTACTGCTGAAATCAACAACTTAAAAGAGCAGCAAGATAATGAACAAAAAGCTTTA


 


ACCTCTGCACAAGAAATTTACACTAATACTCTTGCAAGTAGTGAGGAGACGCTATTAGCCCAAGGAGCCGAAC


 


ATCAAAGAGAGTTAACAGCTACTGAAACAGAGCTTCATAATGCTCAAGCAGATCAACATTCAAAAGAGACTGC


 


ATTGTCAGAACAAAAAGCTAGCATTTCAGCAGAAACTACTCGAGCTCAAGATTTAGTGGAACAAGTCAAAACG


 


TCTGAACAAAATATTGCTAAGCTCAATGCTATGATTAGCAATCCTGATGCTATCACTAAAGCAGCTCAAACGG


 


CTAATGATAATACAAAAGCATTAAGCTCAGAATTGGAGAAGGCTAAAGCTGACTTAGAAAATCAAAAAGCTAA


 


AGTTAAAAAGCAATTGACTGAAGAGTTGGCAGCTCAGAAAGCTGCTCTAGCAGAAAAAGAGGCAGAACTTAGT


 


CGTCTTAAATCCTCAGCTCCGTCTACTCAAGATAGCATTGTGGGTAATAATACCATGAAAGCACCGCAAGGCT


 


ATCCTCTTGAAGAACTTAAAAAATTAGAAGCTAGTGGTTATATTGGATCAGCTAGTTACAATAATTATTACAA


 


AGAGCATGCAGATCAAATTATTGCCAAAGCTAGTCCAGGTAATCAATTAAATCAATACCAAGATATTCCAGCA


 


GATCGTAATCGCTTTGTTGATCCCGATAATTTGACACCAGAAGTGCAAAATGAGCTAGCGCAGTTTGCAGCTC


 


ACATGATTAATAGTGTAAGAAGACAATTAGGTCTACCACCAGTTACTGTTACAGCAGGATCACAAGAATTTGC


 


AAGATTACTTAGTACCAGCTATAAGAAAACTCATGGTAATACAAGACCATCATTTGTCTACGGACAGCCAGGG


 


GTATCAGGGCATTATGGTGTTGGGCCTCATGATAAAACTATTATTGAAGACTCTGCCGGAGCGTCAGGGCTCA


 


TTCGAAATGATGATAACATGTACGAGAATATCGGTGCTTTTAACGATGTGCATACTGTGAATGGTATTAAACG


 


TGGTATTTATGACAGTATCAAGTATATGCTCTTTACAGATCATTTACACGGAAATACATACGGCCATGCTATT


 


AACTTTTTACGTGTAGATAAACGTAACCCTAATGCCCCTGTT


 


> Spy0269-1/Schmitz 1/156 (serotype 4); SEQ ID NO: 135


GATGATAGAGCCTCAGGAGAAACGAAGGCGAGTAATACTCACGACGATAGTTTACCAAAACCAGAAACAATTC


 


AAGAGGCAAAGGCAACTATTGATGCAGTTGAAAAAACTCTCAGTCAACAAAAAGCAGAACTGACAGAGCTTGC


 


TACCGCTCTGACAAAAACTACTGCTGAAATCAACCACTTAAAAGAGCAGCAAGATAATGAACAAAAAGCTTTA


 


ACCTCTGCACAAGAAATTTACACTAATACTCTTGCAAGTAGTGAGGACACGCTATTAGCCCAAGGAGCCGAAC


 


ATCAAAGAGAGTTAACAGCTACTGAAACAGAGCTTCATAATGCTCAAGCAGATCAACATTCAAAAGAGACTGC


 


ATTGTCAGAACAAAAAGCTAGCATTTCAGCAGAAACTACTCGAGCTCAAGATTTAGTGGAACAAGTCAAAACG


 


TCTGAACAAAATATTGCTAAGCTCAATGCTATGATTAGCAATCCTGATGCTATCACTAAAGCAGCTCAAACGG


 


CTAATGATAATACAAAAGCATTAAGCTCAGAATTGGAGAAGGCTAAAGCTGACTTAGAAAATCAAAAAGCTAA


 


AGTTAAAAAGCAATTGACTGAAGAGTTGGCAGCTCAGAAAGCTGCTCTAGCAGAAAAAGAGGCAGAACTTAGT


 


CGTCTTAAATCCTCAGCTCCGTCTACTCAAGATAGCATTGTGGGTAATAATACCATGAAAGCACCGCAAGGCT


 


ATCCTCTTGAAGAACTTAAAAAATTAGAAGCTAGTGGTTATATTGGATCAGCTAGTTACAATAATTATTACAA


 


AGAGCATGCAGATCAAATTATTGCCAAAGCTAGTCCAGGTAATCAATTAAATCAATACCAAGATATTCCAGCA


 


GATCGTAATCGCTTTGTTGATCCCGATAATTTGACACCAGAAGTGCAAAATGAGCTAGCGCAGTTTGCAGCTC


 


ACATGATTAATAGTGTAAGGAGACAATTAGGTCTACCACCAGTTACTGTCACAGCAGGATCACAAGAATTTGC


 


AAGATTACTTAGTACCAGCTATAAGAAAACTCATGGTAATACAAGACCATCATTTGTCTACGGACAGCCAGGG


 


GTATCAGGGCATTATGGTGTTGGGCCTCATGATAAAACTATTATTGAAGACTCTGCCGGAGCGTCAGGGCTCA


 


TTCGAAATGATGATAACATGTACGAGAATATCGGTGCTTTTAACGATGTGCATACTGTGAATGGTATTAAACG


 


TGGTATTTATGACAGTATCAAGTATATGCTCTTTACAGATCATTTACACGGAAATACATATGGTCATGCTATT


 


AACTTTTTACGTGTAGATAAACATAACCCTAAGGCGCCTGTT


 


> Spy0269-1/Schmitz 1/59 (serotype 12); SEQ ID NO: 136


GATGATAGAGCCTCAGGAGAAACGAAGGCGAGTAATACTCACGACGATAGTTTACCAAAACCAGAAACAATTC


 


AAGAGGCAAAGGCAACTATTGATGGAGTTGAAAAAACTCTCAGTCAACAAAAAGCAGAACTGACAAAGCTTGC


 


TACCGCTCTGACAAAAACTACTGCTGAAATCAACCACTTAAAAGAGCAGCAAGATAATGAACAAAAAGCTTTA


 


ACCTCTGCACAAGAAATTTACACTAATACTCTTGCAAGTAGTGAGGAGACGCTATTAGCCCAAGGAGCCGAAC


 


ATCAAAGAGAGTTAACAGCTACTGAAACAGAGCTTCATAATGCTCAAGCAGATCAACATTCAAAAGAGACTGC


 


ATTGTCAGAACAAAAAGCTAGCATTTCAGCAGAAACTACTCGAGCTCAAGATTTAGTGGAACAAGTCAAAACG


 


TCTGAACAAAATATTGCTAAGCTCAATGCTATGATTAGCAATCCTGATGCTATCACTAAAGCAGCTCAAACGG


 


CTAATGATAATACAAAAGCATTAAGCTCAGAATTGGAGAAGGCTAAAGCTGACTTAGAAAATCAAAAAGCTAA


 


AGTTAAAAAGCAATTGACTGAAGAGTTGGCAGCTCAGAAAGCTGCTCTAGCAGAAAAAGAGGCAGAACTTAGT


 


CGTCTTAAATCCTCAGCTCCGTCTACTCAAGATAGCATTGTGGGTAATAATACCATGAAAGCACCGCAAGGCT


 


ATCCTCTTGAAGAACTTAAAAAATTAGAAGCTAGTGGTTATATTGGATCAGGTAGTTACAATAATTATTACAA


 


AGAGCATGCAGATCAAATTATTGCCAAAGCTAGTCCAGGTAATCAATTAAATCAATACCAAGATATTCGAGCA


 


GATCGTAATCGCTTTGTTGATCCCGATAATTTGACACCAGAAGTGCAAAATGAGCTAGCGCAGTTTGCAGCTC


 


ACATGATTAATAGTGTAAGAAGACAATTAGGTCTACCACCAGTTACTGTTACAGCAGGATCACAAGAATTTGC


 


AAGATTACTTAGTACCAGCTATAAGAAAACTCATGGTAATACAAGACCATCATTTGTCTACGGACAGCCAGGG


 


GTATCAGGGCATTATGGTGTTGGGCCTCATGATAAAACTATTATTGAAGACTCTGCCGGAGCGTCAGGGCTCA


 


TTCGAAATGATGATAACATGTACGAGAATATCGGTGCTTTTAACGATGTGCATACTGTGAATGGTATTAAACG


 


TGGTATTTATGACAGTATCAAGTATATGCTCTTTACAGATCATTTACACGGAAATACATACGGCCATGCTATT


 


AACTTTTTACGTGTAGATAAACGTAACCCTAATGCGCCTGTT


 


> Spy0269-1/Schmitz 1/177 (serotype 22); SEQ ID NO: 137


GATGATAGAGCCTCAGGAGAAACGAAGGCGAGTAATACTCACGACGATAGTTTACCAAAACCAGAAACAATTC


 


AAGAGGCAAAGGCAACTATTGAAGCAGTTGAAAAAGCTCTCAGTCAACAAAAAGCAGAACTGACAGAGCTTGC


 


TACCGCTCTGACAAAAACTACTGCTAAAATCAACCACTTAAAACAGCAGCAAGATAATGAACAAAAAGCTTTA


 


ACCTCTGCACAAGAAATTTACACTAATACTCTTGCAAGTAGTGAGGAGACGCTATTAGCCCAAGGAGCCGAAC


 


ATCAAAGAGAGTTAACAGCTACTGAAACAGAGCTTCATAATGCTCAAGCAGATCAACATTCAAAAGAGACTGC


 


ATTGTCAGAACAAAAAGCTAGCATTTCAGCAGAAACTACTCGAGCTCAAGATTTAGTGGAACAAGTCAAAACG


 


TCTGAACAAAATATTGCTAAGCTCAATGCTATGATTAGTAATCCTGATGCTATCACTAAAGCAGCTCAAACGG


 


CTAATGATAATACAAAAGCATTAAGCTCAGAATTGGAGAAGGCTAAAGCTGACTTAGAAAATCAAAAAGCTAA


 


AGTTAAAAAGCAATTGACTGAAGAGTTGGCAGCTCAGAAAGCTGCTCTAGCAGAAAAAGAGGCAGAACTTAGT


 


CGTCTTAAATCCTCAGCTCCGTCTACTCAAGATAGCATTGTGGGTAATAATACCATGAAAGCACCGCAAGGCT


 


ATCCTCTTGAAGAACTTAAAAAATTAGAAGCTAGTGGTTATATTGGATCAGCTAGTTACAATAATTATTACAA


 


AGAGCATGCAGATCAAATTATTGCCAAAGCTAGTCCAGGTAATCAATTAAATCAATACCAAGATATTCCAGCA


 


GATCGTAATCGCTTTGTTGATCCCGATAATTTGACACCAGAAGTGCAAAATGAGCTAGCGCAGTTTGCAGCTC


 


ACATGATTAATAGTGTAAGAAGACAATTAGGTCTACCACCAGTTACTGTCACAGCAGGATCACAAGAATTTGC


 


AAGATTACTTAGTACCAGCTATAAGAAAACTCATGGTAATACAAGACCATCATTTGTCTACGGACAGCCAGGG


 


GTATCAGGGCATTATGGTGTTGGGCCTCATGATAAAACTATTATTGAAGACTCTGCCGGAGCGTCAGGGCTCA


 


TTCGAAATGATGATAACATGTACGAGAATATCGGTGCTTTTAACGATGTGCATACTGTGAATGGTATTAAACG


 


TGGTATTTATGACAGTATCAAGTATATGCTCTTTACAGATCATTTACACGGAAATACATATGGCCATGCTATT


 


AACTTTTTACGTGTAGATAAACGTAACCCTAATGCGCCTGTT


 


> Spy0269-1/Schmitz 1/43 (serotype 22); SEQ ID NO: 138


GATGATAGAGCCTCAGGAGAAACGAAGGCGAGTAATACTCACGACGATAGTTTACCAAAACCAGAAACAATTC


 


AAGAGGCAAAGGCAACTATTGAAGCAGTTGAAAAAGCTCTCAGTCAACAAAAAGCAGAACTGACAGAGCTTGC


 


TACCGCTCTGACAAAAACTACTGCTAAAATCAACCACTTAAAAGAGCAGCAAGATAATGAACAAAAAGCTTTA


 


ACCTCTGCACAAGAAATTTACAGTAATACTCTTGCAAGTAGTGAGGAGACGCTATTAGCCCAAGGAGCCGAAC


 


ATCAAAGAGAGTTAACAGCTACTGAAACAGAGCTTCATAATGCTCAAGCAGATCAACATTCAAAAGAGACTGC


 


ATTGTCAGAACAAAAAGCTAGCATTTCAGCAGAAACTACTCGAGCTCAAGATTTAGTGGAACAAGTCAAAACG


 


TCTGAACAAAATATTGCTAAGCTCAATGCTATGATTAGTAATCCTGATGCTATCACTAAAGCAGCTCAAACGG


 


CTAATGATAATACAAAAGCATTAAGCTCAGAATTGGAGAAGGCTAAAGCTGACTTAGAAAATCAAAAAGCTAA


 


AGTTAAAAAGCAATTGACTGAAGAGTTGGCAGCTCAGAAAGCTGCTCTAGCAGAAAAAGAGGCAGAACTTAGT


 


CGTCTTAAATCCTCAGCTCCGTCTACTCAAGATAGCATTGTGGGTAATAATACCATGAAAGCACCGCAAGGCT


 


ATCCTCTTGAAGAACTTAAAAAATTAGAAGCTAGTGGTTATATTGGATCAGCTAGTTACAATAATTATTACAA


 


AGAGCATGCAGATCAAATTATTGCCAAAGCTAGTCCAGGTAATCAATTAAATCAATACCAAGATATTCCAGCA


 


GATCGTAATCGCTTTGTTGATCCGGATAATTTGACACCAGAAGTGCAAAATGAGCTAGCGCAGTTTGCAGCTC


 


ACATGATTAATAGTGTAAGAAGACAATTAGGTCTACCACCAGTTACTGTCACAGCAGGATCACAAGAATTTGC


 


AAGATTACTTAGTACCAGCTATAAGAAAACTCATGGTAATACAAGACCATCATTTGTCTACGGACAGCCAGGG


 


GTATCAGGGCATTATGGTGTTGGGCCTCATGATAAAACTATTATTGAAGACTCTGCCGGAGCGTCAGGGCTCA


 


TTCGAAATGATGATAACATGTACGAGAATATCGGTGCTTTTAACGATGTGCATACTGTGAATGGTATTAAACG


 


TGGTATTTATGACAGTATCAAGTATATGCTCTTTACAGATCATTTACACGGAAATACATATGGCCATGCTATT


 


AACTTTTTACGTGTAGATAAACGTAACCCTAATGCGCCTGTT


 


> Spy0269-1/Schmitz 1/136 (serotype 25); SEQ ID NO: 139


GATGATAGAGCCTCAGGAGAAACGAAGGCGAGTAATACTCACGACGATAGTTTACCAAAACCAGAAACAATTC


 


AAGAGGCAAAGGCAACTATTGATGCAGTTGAAAAAACTCTCAGTCAACAAAAAGCAGAACTGACAGAGCTTGC


 


TACCGCTCTGACAAAAACTACTGCTGAAATCAACCACTTAAAAGAGCAGCAAGATAATGAACAAAAAGCTTTA


 


ACCTCTGCACAAGAAATTTACACTAATACTCTTGCAAGTAGTGAGGAGACGCTATTAGCCCAAGGAGCCGAAC


 


ATCAAAGAGAGTTAACAGCTACTGAAACAGAGCTTCATAATGCTCAAGCAGATCAACATTCAAAAGAGACTGC


 


ATTGTCAGAACAAAAAGCTAGCATTTCAGCAGAAACTACTCGAGCTCAAGATTTAGTGGAACAAGTCAAAACG


 


TCTGAACAAAATATTGCTAAGCTCAATGCTATGATTAGCAATCCTGATGCTATCACTAAAGCAGCTCAAACGG


 


CTAATGATAATACAAAAGCATTAAGCTCAGAATTGGAGAAGGCTAAAGCTGACTTAGAAAATCAAAAAGCTAA


 


AGTTAAAAAGCAATTGACTGAAGAGTTGGCAGCTCAGAAAGCTGCTCTAGCAGAAAAAGAGGCAGAACTTAGT


 


CGTCTTAAATCCTCAGCTCCGTCTACTCAAGATAGCATTGTGGGTAATAATACCATGAAAGCACCGCAAGGCT


 


ATCCTCTTGAAGAACTTAAAAAATTAGAAGCTAGTGGTTATATTGGATCAGCTAGTTACAATAATTATTACAA


 


AGAGCATGCAGATCAAATTATTGCCAAAGCTAGTCCAGGTAATCAATTAAATCAATACCAAGATATTCCAGCA


 


GATCGTAATCGCTTTGTTGATCCCGATAATTTGACACCAGAAGTGCAAAATGAGCTAGCGCAGTTTGCAGCTC


 


ACATGATTAATAGTGTAAGAAGACAATTAGGTCTACCACCAGTTACTGTTACAGCAGGATCACAAGAATTTGC


 


AAGATTACTTAGTACCAGCTATAAGAAAACTCATGGTAATACAAGACCATCATTTGTCTACGGACAGCCAGGG


 


GTATCAGGGCATTATGGTGTTGGGCCTCATGATAAAACTATTATTGAAGACTCTGCCGGAGCGTCAGGGCTCA


 


TTCGAAATGATGATAACATGTACGAGAATATCGGTGCTTTTAACGATGTGCATACTGTGAATGGTATTAAACG


 


TGGTATTTATGACAGTATCAAGTATATGCTCTTTACAGATCATTTACACGGAAATACATACGGCCATGCTATT


 


AACTTTTTACGTGTAGATAAACGTAACCCTAATGCGCCTGTT


 


> Spy0269-1/Schmitz 1/85 (serotype 28); SEQ ID NO: 140


GATGATAGAGCCTCAGGAGAAACGAAGGCGAGTAATACTCACGACGATAGTTTACCAAAACCAGAAACAATTC


 


AAGAGGCAAAGGCAACTATTGATGCAGTTGAAAAAACTCTCAGTCAACAAAAAGCAGAACTGACAGAGCTTGC


 


TACCGCTCTGACAAAAACTACTGCTGAAATCAACCACTTAAAAGAGCAGCAAGATAATGAACAAAAAGCTTTA


 


ACCTCTGCACAAGAAATTTACACTAATACTCTTGCAAGTAGTGAGGAGACGCTATTAGCCCAAGGAGCCGAAC


 


ATCAAAGAGAGTTAACAGCTACTGAAACAGAGCTTCATAATGCTCAAGCAGATCAACATTCAAAAGAGACTGC


 


ATTGTCAGAACAAAAAGCTAGCATTTCAGCAGAAACTACTCGAGCTCAAGATTTAGTGGAACAAGTCAAAACG


 


TCTGAACAAAATATTGCTAAGCTCAATGCTATGATTAGCAATCCTGATGCTATCACTAAAGCAGCTCAAACGG


 


CTAATGATAATACAAAAGCATTAAGCTCAGAATTGGAGAAGGCTAAAGCTGACTTAGAAAATCAAAAAGCTAA


 


AGTTAAAAAGCAATTGACTGAAGAGTTGGCAGCTCAGAAAGCTGCTCTAGCAGAAAAAGAGGCAGAACTTAGT


 


CGTCTTAAATCCTCAGCTCCGTCTACTCAAGATAGCATTGTGGGTAATAATACCATGAAAGCACCGCAAGGCT


 


ATCCTCTTGAAGAACTTAAAAAATTAGAAGCTAGTGGTTATATTGGATCAGCTAGTTACAATAATTATTACAA


 


AGAGCATGCAGATCAAATTATTGCCAAAGCTAGTCCAGGTAATCAATtAAATCAATACCAAGatattccagca


 


gatcgtaatcgctttGTTGATCCCGATAATTTGACACCAGAAGTGCAAAATGAGCTAGCGCAGTTTGCAGCTC


 


ACATGATTAATAGTGTAAGAAGACAATTAGGTCTACCACCAGTTACTGTTACAGCAGGATCACaagaatttgc


 


aagattacttagtaccagctataagaaaactcatggtaatacaagaccatcatttgtctACGGACAGCCAGGG


 


GTATCAGGGCATTATGGTGTTGGGCCTCATGATAAAACTATTATTGAAGACTCTGCCGGAGCGTCAGGGCTCA


 


TTCGAAATGATGATAACATGTACGAGAATATCGGTGCTTTTAACGATGTGCATACTGTGAATGGTATTAAACG


 


TGCTATTTATGACAGTATCAAGTATATGCTCTTTACAGATCATTTACACGGAAATACATACGGCCATGCTATT


 


AACTTTTTACGTGTAGATAAACATAACCCTAATGCGCCTGTT


 


> Spy0269-1/Schmitz 2/50 (serotype 28); SEQ ID NO: 141


GATGATAGAGCCTCAGGAGAAACGAAGGCGAGTAATACTCACGACGATAGTTTACCAAAACCAGAAACAATTC


 


AAGAGGCAAAGGCAACTATTGATGCAGTTGAAAAAACTCTCAGTCAACAAAAAGCAGAACTGACAGAGCTTGC


 


TACCGCTCTGACAAAAACTACTGCTGAAATCAACCACTTAAAAGAGCAGCAAGATAATGAACAAAAAGCTTTA


 


ACCTCTGCACAAGAAATTTACACTAATACTCTTGCAAGTAGTGAGGAGACGCTATTAGCCCAAGGAGCCGAAC


 


ATCAAAGAGAGTTAACAGCTACTGAAACAGAGCTTCATAATGCTCAAGTAGATCAACATTCAAAAGAGACTGC


 


ATTGTCAGAACAAAAAGCTAGCATTTCAGCAGAAACTACTCGAGCTCAAGATTTAGTGGAACAAGTCAAAACG


 


TCTGAACAAAATATTGCTAAGCTCAATGCTATGATTAGCAATCCTGATGCTATCACTAAAGCAGCTCAAACGG


 


CTAATGATAATACAAAAGCATTAAGCTCAGAATTGGAGAAGGCTAAAGCTGACTTAGAAAATCAAAAAGCTAA


 


AGTTAAAAAGCAATTGACTGAAGAGTTGGCAGCTCAGAAAGCTGCTCTAGCAGAAAAAGAGGCAGAACTTAGT


 


CGTCTTAAATCCTCAGCTCCGTCTACTCAAGATAGCATTGTGGGTAATAATACCATGAAAGCACCGCAAGGCT


 


ATCCTCTTGAAGAACTTAAAAAATTAGAAGCTAGTGGTTATATTGGATCAGCTAGTTACAATAATTATTACAA


 


AGAGCATGCAGATCAAATTATTGCCAAAGCTAGTCCAGGTAATCAATTAAATCAATACCAAGATATtCCAGCA


 


GATCGTAATCGCTTTGTTGATCCCGATAATTTGACACCAGAAGTGCAAaATGAGCTAGCGCAGTTTGCAGCTC


 


ACATGATTAATAGTGTAAGAAGACAATTAGGTCTACCACCAGTTACTGTTACAGCAGGATCACAAGAATTTGC


 


AAGATTACTTAGTACCAGCTATAAGAAGACTCATGGTAATACAAGACCATCATTTGTCTACGGACAGCCAGGG


 


GTATCAGGGCATTATGGTGTTGGGCCTCATGATAAAACTATTATTGAAGACTCTGGCGGAGCGTCAGGGCTCA


 


TTCGAAATGATGATAACATGTACGAGAATATCGGTGCTTTTAACGATGTGCATACTGTGAATGGTATTAAACG


 


TGGTATTTATGACAGTATCAAGTATATGCTCTTTACAGATCATTTACACGGAAATACATACGGCCATGCTATT


 


AACTTTTTACGTGTAGATAAACGTAACCCTAATGCGCCTGTT


 


> Spy0269-1/Schmitz 1/123 (serotype 49); SEQ ID NO: 142


GATGATAGAGCCTCAGGAGAAACGAAGGCGAGTAATACTCACGACGATAGTTTACCAAAACCAGAAACAATTC


 


AAGAGGCAAAGGCAACTATTGATGCAGTTGAAAAAACTCTCAGTCAACAAAAAGCAGAACTGACAGAGCTTGC


 


TACCGCTCTGACAAAAACTACTGCTGAAATCAACCACTTAAAAGAGCAGCAAGATAATGAACAAAAAGCTTTA


 


ACCTCTGCACAAGAAATTTACACTAATACTCTTGCAAGTAGTGAGGAGACGCTATTAGCCCAAGGAGCCGAAC


 


ATCAAAGAGAGTTAACAGCTACTGAAACAGAGCTTCATAATGCTCAAGCAGATCAACATTCAAAAGAGACTGC


 


ATTGTCAGAACAAAAAGCTAGCATTTCAGCAGAAACTACTCGAGCTCAAGATTTAGTGGAACAAGTCAAAACG


 


TCTGAACAAAATATTGCTAAGCTCAATGCTATGATTAGCAATCCTGATGCTATCACTAAAGCAGCTCAAACGG


 


CTAATGATAATACAAAAGCATTAAGCTCAGAATTGGAGAAGGCTAAAGCTGACTTAGAAAATCAAAAAGCTAA


 


AGTTAAAAAGCAATTGACTGAAGAGTTGGCAGCTCAGAAAGCTGCTCTAGCAGAAAAAGAGGCAGAACTTAGT


 


CGTCTTAAATCCTCAGCTCCGTCTACTCAAGATAGCATTGTGGGTAATAATACCATGAAAGCACCGCAAGGCT


 


ATCCTCTTGAAGAACTTAAAAAATTAGAAGCTAGTGGTTATATTGGATCAGCTAGTTACAATAATTATTACAA


 


AGAGCATGCAGATCAAATTATTGCCAAAGCTAGTCCAGGTAATCAATTAAATCAATACCAAGATATtCCAGCA


 


GAtcgtaatcgctttGTTGATCCCGATAATTTGACACCAGAAGTGCAAAATGAGCTAGCGCAGTTTGCAGCTC


 


ACATGATTAATAGTGTAAGGAGACAATTAGGTCTACCACCAGTTACTGTTACAGCAGGATCACAAGAATTTGC


 


AAGATTACTTAGTACCAGCTATAAGAAAACTCATGGTAATACAAGACCATCATTTGTCTACGGACAACCAGGG


 


GTATCAGGGCATTATGGTGTTGGGCCTCATGATAAAACTATTATTGAAGACTCTGCCGGAGCGTCAGGGCTCA


 


TTCGAAATGATGATAACATGTACGAGAATATCGGTGCTTTTAACGATGTGCATACTGTGAATGGTATTAAACG


 


TGGTATTTATGACAGTATCAAGTATATGCTCTTTACAGATCATTTACACGGAAATACATATGGCCATGCTATT


 


AACTTTTTACGTGTAGATAAACGTAACCCTAATGCGCCTGTT


 


> Spy0269-1/Schmitz 1/176 (serotype 83); SEQ ID NO: 143


GATGATAGAGCCTCAGGAGAAACGAAGGCGAGTAATACTCACGACGATAGTTTACCAAAACCAGAAACAATTC


 


AAGAGGCAAAGGCAACTATTGAAGCAGTTGAAAAAACTCTCAGTCAACAAAAAGCAGAACTGACAGAGCTTGC


 


TACCGCTCTGACAAAAACTACTGCTGAAATCAACCACTTAAAAGAGCAGCAAGATAACGAACAAAAAGCTTTA


 


ACCTCTGCACAAGAAATTTACACTAATACTCTTGCAAGTAGTGAGGAGACGCTATTAGCCCAAGGAGCCGAAC


 


ATCAAAGAGAGTTAACAGCTACTGAAACAGAGCTTCATAATGCTCAAGCAGATCAACATTCAAAAGAGACTGC


 


ATTGTCAGAACAAAAAGCTAGCATTTCAGCAGAAACTACTCGAGCTCAAGATTTAGTGGAACAAGTCAAAACG


 


TCTGAACAAAATATTGCTAAGCTCAATGCTATGATTAGCAATCCTGATGCTATCACTAAAGCAGCTCAAACGG


 


CTAATGATAATACAAAAGCATTAAGCTCAGAATTGGAGAAGGCTAAAGCTGACTTAGAAAATCAAAAAGCTAA


 


AGTTAAAAAGCAATTGACTGAAGAGTTGGCAGCTCAGAAAGCTGCTCTAGCAGAAAAAGAGGCAGAACTTAGT


 


CGTCTTAAATCCTCAGCTCCGTCTACTCAAGATAGCATTGTGGGTAATAATACCATGAAAGCACCGCAAGGCT


 


ATCCTCTTGAAGAACTTAAAAAATTAGAAGCTAGTGGTTATATTGGATCAGCTAGTTACAATAATTATTACAA


 


AGAGCATGCAGATCAAATTATTGCCAAAGCTAGTCCAGGTAATCAATtAAATCAATACCAAGatATTCCAGCA


 


GatcgtaatcgctttGTTGATCCCGATAATTTGACACCAGAAGTGCAAAATGAGCTAGCGCAGTTTGCAGCTC


 


ACATGATTAATAGTGTAAGAAGACAATTAGGTCTACCACCAGTTACTGTCACAGCAGGATCACAAGAATTTGC


 


AAGATTACTTAGTACCAGCTATAAGAAAACTCATGGTAATACAAGACCATCATTTGTCTACGGACAGCCAGGG


 


GTATCAGGGCATTATGGTGTTGGGCCTCATGATAAAACTATTATTGAAGACTCTGCCGGAGCGTCAGGGCTCA


 


TTCGAAATGATGATAACATGTACGAGAATATCGGTGCTTTTAACGATGTGCATACTGTGAATGGTATTAAACG


 


TGGTATTTATGACAGTATCAAGTATATGCTCTTTACAGATCATTTACACGGAAATACATATGGCCATGCTATT


 


AACTTTTTACGTGTAGATAAACGTAACCCTAATGCGCCTGTT


 


2. Spy0292


2.1 Full length Spy0292


> Spy0292/SF370 (serotype 1); SEQ ID NO: 144


ATGATCAAACGATTAATTTCCCTAGTGGTCATCGCCTTATTTTTTGCAGCAAGCACTGTTAGCGGTGAAGAGT


 


ATTCGGTAACTGCTAAGCATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAGATGCTAA


 


AGAAGTTGTCCCAGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTCTAAGGGC


 


AAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTCACTACAAACTATACTATTAGTA


 


ACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACGCCAATAG


 


CCCCGCTATTGCTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAAACAATTA


 


AGACAATGGGGCATTTCCGATGCAAAGGTCGTCAATTCAACTGGCTTAACTAACCATTTTTTAGGAGCTAATA


 


CTTATCCTAATACAGAACCAGATGATGAAAATTGTTTTTGCGCCACTGATTTAGCTATTATTGCCAGGCATCT


 


CTTATTAGAATTTCCAGAAGTACTGAAATTATCTAGCAAATCCTCCACTATTTTTGCTGGACAAACCATTTAC


 


AGTTATAATTACATGCTTAAAGGCATGCCTTGTTATCGAGAAGGCGTGGATGGTCTTTTTGTTGGTTATTCTA


 


AAAAAGCCGGTGCTTCTTTTGTAGCTACTAGTGTCGAAAATCAAATGAGGGTTATTACAGTAGTTTTAAATGC


 


TGATCAAAGCCACGAGGATGATTTAGCTATATTTAAAACAACCAATCAATTGTTGCAGTACCTTTTAATTAAT


 


TTTCAAAAAGTCCAGTTAATTGAAAATAATAAACCAGTAAAAACGTTATATGTCTTAGACAGTCCTGAAAAAA


 


CTGTCAAACTTGTAGCCCAAAATAGTTTATTTTTTATCAAACCAATACATACAAAGACCAAAAATACCGTCCA


 


TATTACTAAGAAATCATCCACAATGATCGCACCTCTATCAAAGGGACAAGTCTTAGGTAGAGCAACCCTTCAA


 


GATAAACATCTTATTGGACAAGGTTATCTGGATACTCCTCCTTCTATCAATCTTATCCTTCAAAAAAACATTT


 


CTAAAAGTTTCTTTTTAAAGGTCTGGTGGAACCGTTTTGTGAGGTATGTCAATACCTCTTTATAG


 


2.2 Antigenic fragment Spy0292-1


> Spy0292-1/SF370 (serotype 1); SEQ ID NO: 12


GAAGAGTATTCGGTAACTGCTAAGCATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATGCTAAAGAAGTTGTCCCAGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTCACTACAAACTATACT


 


ATTAGTAACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGCTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGACAATGGGGCATTTCCGATGCAAAGGTCGTCAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAACCAGATGATGAAAATTGTTTTTGC


 


2.3 Homologous sequences of other S. pyogenes isolates and/or serotypes


> Spy0292-1/Schmitz 1/39 (serotype 12); SEQ ID NO: 145


GAAGAGTATTCGGTAACTGCTAAGCATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATGCTAAAGAAGTTGTCCCAGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTCACTACAAACTATACT


 


ATTAGTAACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGCTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGACAATGGGGCATTTCCGATGCAAAGGTCGTCAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAACcagaTGATGAAAATTGTTTTTGC


 


> Spy0292-1/Schmitz 1/55 (serotype 118); SEQ ID NO: 146


GAAGAGTATTCGGTAACTGCTAAGCATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATGCTAAAGAAGTTGTCCCAGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTTACTACAAACTATACT


 


ATTAGTAACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGCTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGACAATGGGGCATTTCCGATACAAAGGTCGTCAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAACCAGATGATGAAAATTGTTTTTGC


 


> Spy0292-1/Schmitz 1/56 (serotype 28); SEQ ID NO: 147


GAAGAGTATTCGGTAACTGCTAAGCATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATACTAAAGAAGTTGTCCCAGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTCACTACAAACTATACT


 


ATTAGTAACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGCTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGGCAATGGGGCATTTCCGATGCAAAGGTCGTTAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAACCAGATGATGAAAATTGTTTTTGC


 


> Spy0292-1/Schmitz 1/74 (serotype 3); SEQ ID NO: 148


GAAGAGTATTCGGTAACTGCTAAACATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATGCTAAAGAGGTTGTCCCAGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTCACTACAAACTATACT


 


ATTAGTAACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGcTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGACAATGGGGCATTTCCGATGCAAAGGTCGTCAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAACCAGATGATGAAAATTGTTTTTGC


 


> Spy0292-1/Schmitz 1/76 (serotype 22); SEQ ID NO: 149


GAAGAGTATTCGGTAACTGCTAAGCATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATGCTAAAGAAGTTGTCCCTGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTCACTACAAACTATACT


 


ATTAGTACGGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGCTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGACAATGGGGCATTTCCGATGCAAAGGTCGTCAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAAccagATGATGAAAATTGTTTTTGC


 


> Spy0292-1/Schmitz 1/92 (serotype 11); SEQ ID NO: 150


GAAGAGTATTCGGTAACTGCTAAGCATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATGCTAAAGAAGTTGTCCCAGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTCACTACAAACTATACT


 


ATTAGTAACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGCTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGGCAATGGGGCATTTCCGATGCAAAGGTCGTTAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAACCAGATGATGaaaATTGTTTTTGC


 


> Spy0292-1/Schmitz 1/94 (serotype 1); SEQ ID NO: 151


GAAGAGTATTCGGTAACTGCTAAGCATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATGCTAAAGAAGTTGTCCCAGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTCACTACAAACTATACT


 


ATTAGTAACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGCTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGACAATGGGGCATTTCCGATGCAAAGGTCGTCAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAACCAGATGATGAAAATTGTTTTTGC


 


> Spy0292-1/Schmitz 1/142 (serotype 83); SEQ ID NO: 152


GAAGAGTATTCGGTAACTGCTAAGCATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATGCTAAAGAGGTTGTCCCAGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTCACTACAAACTATACT


 


ATTAGTAACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGCTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGACAATGGGGCATTTCCGATGCAAAGGTCGTCAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAAccagaTGATGAAAATTGTTTTTGC


 


> Spy0292-1/Schmitz 1/144 (serotype 76); SEQ ID NO: 153


GAAGAGTATTCGGTAACTGCTAAGCATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATGCTAAAGAAGTTGTCCCTGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTCACTACAAACTATACT


 


ATTAGTAACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGCTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGACAATGGGGCATTTCCGATGCAAAGGTCGTCAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAaccagaTGATGAAAATTGTTTTTGC


 


> Spy0292-1/Schmitz 1/194 (serotype 44); SEQ ID NO: 154


GAAGAGTATTCGGTAACTGCTAAGCATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATGCTAAAGAAGTTGTCCCTGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTCACTACAAACTATACT


 


ATTAGTAACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGCTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGACAATGGGGCATTTCCGATGCAAAGGTCGTCAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAACCAGATGATGAAAATTGTTTTTGC


 


2.4 Antigenic fragment Spy0292-3


> Spy0292-3/SF370 (serotype 1); SEQ ID NO: 13


GAAGAGTATTCGGTAACTGCTAAGCATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATGCTAAAGAAGTTGTCCCAGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTCACTACAAACTATACT


 


ATTAGTAACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGCTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGACAATGGGGCATTTCCGATGCAAAGGTCGTCAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAACCAGATGATGAAAATTGTTTTTGCGCCACTGATTTAGCTATTATTGCCA


 


GGCATCTCTTATTAGAATTTCCAGAAGTACTGAAATTATCTAGCAAATCCTCCACTATTTTTGCTGGACAAAC


 


CATTTACAGTTATAATTACATGCTTAAAGGCATGCCTTGTTATCGAGAAGGCGTGGATGGTCTTTTTGTTGGT


 


TATTCTAAAAAAGCCGGTGCTTCTTTTGTAGCTACTAGTGTCGAAAATCAAATGAGGGTTATTACAGTAGTTT


 


TAAATGCTGATCAAAGCCACGAGGATGATTTAGCTATATTTAAAACAACCAATCAATTGTTGCAGTACCTTTT


 


AATTAATTTTCAAAAAGTCCAGTTAATTGAA


 


2.5 Homologous sequences of other S. pyogenes isolates and/or serotypes


> Spy0292-3/Schmitz 1/39 (serotype 12); SEQ ID NO: 155


GAAGAGTATTCGGTAACTGCTAAGCATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATGCTAAAGAAGTTGTCCCAGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTCACTACAAACTATACT


 


ATTAGTAACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGCTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGACAATGGGGCATTTCCGATGCAAAGGTCGTCAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAACcagaTGATGAAAATTGTTTTTGCGCCACTGATTTAGCTATTATTGCCA


 


GGCATCTCTTATTAGAATTTCCAGAAGTACTGAAATTATCTAGCAAATCCTCCACTATTTTTGATGGACAAAC


 


CATTTACAGTTATAATTACATGCTTAAAGGCATGCCTTGTTATCGAGAAGGCGTGGATGGTCTTTTTGTTGGT


 


TATTCTAAAAAAGCCGGTGCTTCTTTTGTAGCTACTAGTGTCGAAAATCAAATGAGGGTTATTACAGTAGTTT


 


TAAATGCTGATCAAAGCCACGAGGATGATTTAGCTATATTTAAAACAACCAATCAATTGTTGCAGTACCTTTT


 


AATTAATTTTCAAAAAGTCCAGTTAATTGAA


 


> Spy0292-3/Schmitz 1/55 (serotype 118); SEQ ID NO: 156


GAAGAGTATTCGGTAACTGCTAAGCATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATGCTAAAGAAGTTGTCCCAGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTTACTACAAACTATACT


 


ATTAGTAACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGCTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGACAATGGGGCATTTCCGATACAAAGGTCGTCAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAACCAGATGATGAAAATTGTTTTTGCGCCACTGATTTAGCTATTATTGCCA


 


GGCATCTCTTATTAGAATTTCCAGAAGTACTGAAATTATCTAGCAAATCCTCCACTATTTTTGATGGACAAAC


 


CATTTACAGTTATAATTACATGCTTAAAGGCATGCCTTGTTATCGAGAAGGCGTGGATGGTCTCTTTGTCGGT


 


TATTCTAAAAAAGCCGGTGCTTCTTTTGTAGCTACTAGTGTCGAAAATCAAATGAGGGTTATTACAGTAGTTT


 


TAAATGCTGATCAAAGCCACGAGGATGATTTAGCTATATTTAAAACAACCAATCAATTGTTGCAGTACCTTTT


 


AATTAATTTTCAAAAAGTCCAGTTAATTGAA


 


> Spy0292-3/Schmitz 1/56 (serotype 28); SEQ ID NO: 157


GAAGAGTATTCGGTAACTGCTAAGCATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATACTAAAGAAGTTGTCCCAGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTCACTACAAACTATACT


 


ATTAGTAACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGCTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGGCAATGGGGCATTTCCGATGCAAAGGTCGTTAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAACCAGATGATGAAAATTGTTTTTGCGCCACTGATTTAGCTATTATTGCCA


 


GGCATCTCTTATTAGAATTTCCAGAAGTACTGAAATTATCTAGCAAATCCTCCACTATTTTTGATGGACAAAC


 


CATTTACAGTTATAATTACATGCTTAAAGGCATGCCTTGTTATCGAGAAGGCGTGGATGGTCTTTTTGTTGGT


 


TATTCTAAAAAAGCCGGTGCTTCTTTTGTAGCTACTAGTGTCGAAAATCAAATGAGGGTTATTACAGTAGTTT


 


TAAATGCTGATCAAAGCCACGAGGATGATTTAGCTATATTTAAAACAACCAATCAATTGTTGCAGTACCTTTT


 


AATTAATTTTCAAAAAGTCCAGTTAATTGAA


 


> Spy0292-3/Schmitz 1/74 (serotype 3); SEQ ID NO: 158


GAAGAGTATTCGGTAACTGCTAAACATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATGCTAAAGAGGTTGTCCCAGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTCACTACAAACTATACT


 


ATTAGTAACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGcTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGACAATGGGGCATTTCCGATGCAAAGGTCGTCAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAACCAGATGATGAAAATTGTTTTTGCGCCACTGATTTAGCTATTATTGCCA


 


GGCATCTCTTATTAGAATTTCCAGAAGTACTGAAATTATCTAGCAAATCCTCCACTATTTTTGCTGGACAAAC


 


CATTTACAGTTATAATTACATGCTTAAAGGCATGCCTTGTTATCGAGAAGGCGTGGATGGTCTTTTTGTTGGT


 


TATTCTAAAAAAGCCGGTGCTTCTTTTGTAGCTACTAGTGTCGAAAATCAAATGAGGGTTATTACAGTAGTTT


 


TAAATGCTGATCAAAGCCACGAGGATGATTTAGCTATATTTAAAACAACCAATCAATTGTTGCAGTACCTTTT


 


AATTAATTTTCAAAAAGTCCAGTTAATTGAA


 


> Spy0292-3/Schmitz 1/76 (serotype 22); SEQ ID NO: 159


GAAGAGTATTCGGTAACTGCTAAGCATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATGCTAAAGAAGTTGTCCCTGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTCACTACAAACTATACT


 


ATTAGTAACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGCTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGACAATGGGGCATTTCCGATGCAAAGGTCGTCAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAAccagATGATGAAAATTGTTTTTGCGCCACTGATTTAGCTATTATTGCCA


 


GGCATCTCTTATTAGAATTTCCAGAAGTACTGAAATTATCTAGCAAATCCTCCACTATTTTTGATGGACAAAC


 


CATTTACAGTTATAATTACATGCTTAAAGGCATGCCTTGTTATCGAGAAGGCGTGGATGGTCTTTTTGTTGGT


 


TATTCTAAAAAAGCCGGTGCTTCTTTTGTAGCTACTAGTGTCGAAAATCAAATGAGGGTTATTACAGTAGTTT


 


TAAATGCTGATCAAAGCCACGAGGATGATTTAGCTATATTTAAAACAACCAATCAATTGTTGCAGTACCTTTT


 


AATTAATTTTCAAAAAGTCCAGTTAATTGAA


 


> Spy0292-3/Schmitz 1/92 (serotype 11); SEQ ID NO: 160


GAAGAGTATTCGGTAACTGCTAAGCATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATGCTAAAGAAGTTGTCCCAGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTCACTACAAACTATACT


 


ATTAGTAACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGCTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGGCAATGGGGCATTTCCGATGCAAAGGTCGTTAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAACCAGATGATGaaaATTGTTTTTGCGCCACTGATTTAGCTATTATTGCCA


 


GGCATCTCTTATTAGAATTTCCAGAAGTACTGAAATTATCTAGCAAATCCTCCACTATTTTTGATGGACAAAC


 


CATTTACAGTTATAATTACATGCTTAAAGGCATGCCTTGTTATCGAGAAGGCGTGGATGGTCTTTTTATTGGT


 


TATTCTAAAAAAGCCGGTGCTTCTTTTGTAGCTACTAGTGTCGAAAATCAAATGAGGGTTATTACAGTAGTTT


 


TAAATGCTGATCAAAGCCACGAGGATGATTTAGCTATATTTAAAACAACCAATCAATTGTTGCAGTACCTTTT


 


AATTAATTTTCAAAAAGTCCAGTTAATTGAA


 


> Spy0292-3/Schmitz 1/94 (serotype 1); SEQ ID NO: 161


GAAGAGTATTCGGTAACTGCTAAGCATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATGCTAAAGAAGTTGTCCCAGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTCACTACAAACTATACT


 


ATTAGTAACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGCTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGACAATGGGGCATTTCCGATGCAAAGGTCGTTAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAACCAGATGATGAAAATTGTTTTTGCGCCACTGATTTAGCTATTATTGCCA


 


GGCATCTCTTATTAGAATTTCCAGAAGTACTGAAATTATCTAGCAAATCCTCCACTATTTTTGCTGGACAAAC


 


CATTTACAGTTATAATTACATGCTTAAAGGCATGCCTTGTTATCGAGAAGGCGTGGATGGTCTTTTTGTTGGT


 


TATTCTAAAAAAGCCGGTGCTTCTTTTGTAGCTACTAGTGTCGAAAATCAAATGAGGGTTATTACAGTAGTTT


 


TAAATGCTGATCAAAGCCACGAGGATGATTTAGCTATATTTAAAACAACCAATCAATTGTTGCAGTACCTTTT


 


AATTAATTTTCAAAAAGTCCAGTTAATTGAA


 


> Spy0292-3/Schmitz 1/142 (serotype 83); SEQ ID NO: 162


GAAGAGTATTCGGTAACTGCTAAGCATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATGCTAAAGAGGTTGTCCCAGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTCACTACAAACTATACT


 


ATTAGTAACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGCTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGACAATGGGGCATTTCCGATGCAAAGGTCGTTAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAAccagaTGATGAAAATTGTTTTTGCGCCACTGATTTAGCTATTATTGCCA


 


GGCATCTCTTATTAGAATTTCCAGAAGTACTGAAATTATCTAGCAAATCCTCCACTATTTTTGATGGACAAAC


 


CATTTACAGTTATAATTACATGCTTAAAGGCATGCCTTGTTATCGAGAAGGCGTGGATGGTCTTTTTGTTGGT


 


TATTCTAAAAAAGCCGGTGCTTCTTTTGTAGCTACTAGTGTCGAAAATCAAATGAGGGTTATTACAGTAGTTT


 


TAAATGCTGATCAAAGCCACGAGGATGATTTAGCTATATTTAAAACAACCAATCAATTGTTGCAGTACCTTTT


 


AATTAATTTTCAAAAAGTCCAGTTAATTGAA


 


> Spy0292-3/Schmitz 1/144 (serotype 76); SEQ ID NO: 163


GAAGAGTATTCGGTAACTGCTAAGCATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATGCTAAAGAAGTTGTCCCTGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTCACTACAAACTATACT


 


ATTAGTAACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGCTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGACAATGGGGCATTTCCGATGCAAAGGTCGTCAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAaccagaTGATGAAAATTGTTTTTGCGCCACTGATTTAGCTATTATTGCCA


 


GGCATCTCTTATTAGAATTTCCAGAAGTACTGAAATTATCTAGCAAATCCTCCACTATTTTTGATGGACAAAC


 


CATTTACAGTTATAATTACATGCTTAAAGGCATGCCTTGTTATCGAGAAGGCGTGGATGGTCTTTTTGTTGGT


 


TATTCTAAAAAAGCCGGTGCTTCTTTTGTAGCTACTAGTGTCGAAAATCAAATGAGGGTTATTACAGTAGTTA


 


TAAATGCTGATCAAAGCCACGAGGATGATTTAGCTATATTTAAAACAACCAATCAATTGTTGCAGTACCTTTT


 


AATTAATTTTCAAAAAGTCCAGTTAATTGAA


 


> Spy0292-3/Schmitz 1/194 (serotype 44); SEQ ID NO: 164


GAAGAGTATTCGGTAACTGCTAAGCATGCGATTGCCGTTGACCTTGAAAGTGGCAAAGTTTTATACGAAAAAG


 


ATGCTAAAGAAGTTGTCCCTGTCGCCTCAGTCAGTAAGCTCTTGACAACCTATCTGGTTTACAAAGAAGTTTC


 


TAAGGGCAAGCTAAATTGGGATAGTCCTGTAACTATTTCTAACTACCCTTATGAACTCACTACAAACTATACT


 


ATTAGTAACGTTCCTCTTGATAAGAGAAAATATACCGTTAAAGAACTTTTAAGTGCGTTAGTTGTTAATAACG


 


CCAATAGCCCCGCTATTGCTTTAGCTGAAAAAATAGGCGGAACCGAACCCAAATTTGTTGACAAAATGAAAAA


 


ACAATTAAGACAATGGGGCATTTCCGATGCAAAGGTCGTCAATTCAACTGGCTTAACTAACCATTTTTTAGGA


 


GCTAATACTTATCCTAATACAGAACCAGATGATGAAAATTGTTTTTGCGCCACTGATTTAGCTATTATTGCCA


 


GGCATCTCTTATTAGAATTTCCAGAAGTACTGAAATTATCTAGCAAATCCTCCACTATTTTTGCTGGACAAAC


 


CATTTACAGTTATAATTACATGCTTAAAGGCATGCCTTGTTATCGAGAAGGCGTGGATGGTCTTTTTGTTGGT


 


TATTCTAAAAAAGCCGGTGCTTCTTTTGTAGCTACTAGTGTCGAAAATCAAATGAGGGTTATTACAGTAGTTT


 


TAAATGCTGATCAAAGCCACGAGGATGATTTAGCTATATTTAAAACAACCAATCAATTGTTGCAGTACCTTTT


 


AATTAATTTTCAAAAAGTCCAGTTAATTGAA


 


3. Spy0416A


3.1 Full length Spy0416A


> Spy0416A/SF370 (serotype 1); SEQ ID NO: 165


GCAGATGAGCTAAGCACAATGAGCGAACCAACAATCACGAATCACGCTCAACAACAAGCGCAACATCTCACCA


 


ATACAGAGTTGAGCTCAGCTGAATCAAAATCTCAAGACACATCACAAATCACTCTCAAGACAAATCGTGAAAA


 


AGAGCAATCACAAGATCTAGTCTCTGAGCCAACCACAACTGAGCTAGCTGACACAGATGCAGCATCAATGGCT


 


AATACAGGTTCTGATGCGACTCAAAAAAGCGCTTCTTTACCGCCAGTCAATACAGATGTTCACGATTGGGTAA


 


AAACCAAAGGAGCTTGGGACAAGGGATACAAAGGACAAGGCAAGGTTGTCGCAGTTATTGACACAGGGATCGA


 


TCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAAAATCAAAAGAAGACATGCTAGCA


 


CGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGTTGTTTTTGCACATAATTATGTGG


 


AAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTTGATGAGGACTGGGAAAACTTTGAGTTTGATGC


 


AGAGGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATCGTCCCCAATCAACCCAGGCACCGAAAGAAACT


 


GTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACAAACAGACGATGACACCAAATACG


 


AGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAAGAAGCCGCTGCTACTGGAGAACGCTT


 


TTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTGCCAACGACATCATGGGATCAGCTGAA


 


TCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGGAGCAGATGTGATCAACCTGAGTCTTGGAACCG


 


CTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAAAAAGCTAAAAAAGCCGGTGTATC


 


AGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATGATCCATTGGCGACAAATCCAGAC


 


TATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTGGCAGCTATAAACAGTAAGTGGGTGA


 


TTCAACGTCTAATGACGGTCAAAGAATTAGAAAACCGTGCCGATTTAAACCATGGTAAAGCCATCTATTCAGA


 


GTCTGTCGACTTTAAAGACATAAAAGATAGCCTAGGTTATGATAAATCGCATCAATTTGCTTATGTCAAAGAG


 


TCAACTGATGCGGGTTATAACGCACAAGACGTTAAAGGTAAAATTGCTTTAATTGAACGTGATCCCAATAAAA


 


CCTATGACGAAATGATTGCTTTGGCTAAGAAACATGGAGCTCTGGGAGTACTTATTTTTAATAACAAGCCTGG


 


TCAATCAAACCGCTCAATGCGTCTAACAGCTAATGGGATGGGGATACCATCTGCTTTCATATCGCACGAATTT


 


GGTAAGGCCATGTCCCAATTAAATGGCAATGGTACAGGAAGTTTAGAGTTTGACAGTGTGGTCTCAAAAGCAC


 


CGAGTCAAAAAGGCAATGAAATGAATCATTTTTCAAATTGGGGCCTAACTTCTGATGGCTATTTAAAACCTGA


 


CATTACTGCACCAGGTGGCGATATCTATTCTACCTATAACGATAACCACTATGGTAGCCAAACAGGAACAAGT


 


ATGGCCTCTCCTCAGATTGCTGGCGCCAGCCTTTTGGTCAAACAATACCTAGAAAAGACTCAGCCAAACTTGC


 


CAAAAGAAAAAATTGCTGATATCGTTAAGAACCTATTGATGAGCAATGCTCAAATTCATGTTAATCCAGAGAC


 


AAAAACGACGACCTCACCGCGTGAGCAAGGGGCAGGATTACTTAATATTGACGGAGCTGTCACTAGCGGCCTT


 


TATGTGACAGGAAAAGACAACTATGGCAGTATATCATTAGGCAACATCACAGATACGATGACGTTTGATGTGA


 


CTGTTCACAACCTAAGCAATAAAGACAAAACATTACGTTATGACACAGAATTGCTAACAGATCATGTAGACCC


 


ACAAAAGGGCCGCTTCACTTTGACTTCTCACTCCTTAAAAACGTACCAAGGAGGAGAAGTTACAGTCCCAGCC


 


AATGGAAAAGTGACTGTAAGGGTTACCATGGATGTCTCACAGTTCACAAAAGAGCTAACAAAACAGATGCCAA


 


ATGGTTACTATCTAGAAGGTTTTGTCCGCTTTAGAGATAGTCAAGATGACCAACTAAATAGAGTAAACATTCC


 


TTTTGTTGGTTTTAAAGGGCAATTTGAAAACTTAGCAGTTGCAGAAGAGTCCATTTACAGATTAAAATCTCAA


 


GGCAAAACTGGTTTTTACTTTGATGAATCAGGTCCAAAAGACGATATCTATGTCGGTAAACACTTTACAGGAC


 


TTGTCACTCTTGGTTCAGAG


 


3.2 Antigenic fragment Spy0416A-1


> Spy0416A-1/SF370 (serotype 1); SEQ ID NO: 14


GCAGATGAGCTAAGCACAATGAGCGAACCAACAATCACGAATCACGCTCAACAACAAGCGCAACATCTCACCA


 


ATACAGAGTTGAGCTCAGCTGAATCAAAATCTCAAGACACATCACAAATCACTCTCAAGACAAATCGTGAAAA


 


AGAGCAATCACAAGATCTAGTCTCTGAGCCAACCACAACTGAGCTAGCTGACACAGATGCAGCATCAATGGCT


 


AATACAGGTTCTGATGCGACTCAAAAAAGCGCTTCTTTACCGCCAGTCAATACAGATGTTCACGATTGGGTAA


 


AAACCAAAGGAGCTTGGGACAAGGGATACAAAGGACAAGGCAAGGTTGTCGCAGTTATTGACACAGGGATCGA


 


TCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAAAATCAAAAGAAGACATGCTAGCA


 


CGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGTTGTTTTTGCACATAATTATGTGG


 


AAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTTGATGAGGACTGGGAAAACTTTGAGTTTGATGC


 


AGAGGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATCGTCCCCAATCAACCCAGGCACCGAAAGAAACT


 


GTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACAAACAGACGATGACACCAAATACG


 


AGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAAGAAGCCGCTGCTACTGGAGAACGCTT


 


TTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTGCCAACGACATCATGGGATCAGCTGAA


 


TCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGGAGCAGATGTGATCAACCTGAGTCTTGGAACCG


 


CTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAAAAAGCTAAAAAAGCCGGTGTATC


 


AGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATGATCCATTGGCGACAAATCCAGAC


 


TATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTGGCAGCTATAAACAGTAAGTGGGTGA


 


TTCAACGTCTAATGACGGTCAAAGAATTAGAAAACCGTGCCGATTTAAACCATGGTAAAGCCATCTATTCAGA


 


GTCTGTCGACTTTAAAGACATAAAAGATAGCCTAGGTTATGATAAATCGCATCAATTTGCTTATGTCAAAGAG


 


TCAACTGATGCGGGTTATAACGCACAAGACGTTAAAGGTAAAATTGCTTTAATTGAACGTGATCCCAATAAAA


 


CCTATGACGAAATGATTGCTTTGGCTAAGAAACATGGAGCTCTGGGAGTACTTATTTTTAATAACAAGCCTGG


 


TCAATCAAACCGCTCAATGCGTCTAACAGCTAATGGGATGGGGATACCATCTGCTTTCATATCGCACGAATTT


 


GGTAAGGCCATGTCCCAATTAAATGGCAATGGTACAGGAAGTTTAGAGTTTGACAGTGTGGTCTCAAAAGCAC


 


CGAGTCAAAAAGGCAATGAAATGAATCATTTTTCAAATTGGGGCCTAACTTCTGATGGCTATTTAAAACCTGA


 


CATTACTGCACCAGGTGGCGATATCTATTCTACCTATAACGATAACCACTATGGTAGCCAAACAGGAACAAGT


 


ATGGCCTCTCCTCAGATTGCTGGCGCCAGCCTTTTGGTCAAACAATACCTAGAAAAGACTCAGCCAAACTTGC


 


CAAAAGAAAAAATTGCTGATATCGTTAAGAACCTATTGATGAGCAATGCTCAAATTCATGTTAATCCAGAGAC


 


AAAAACGACCACCTCACCGCGTCAGCAAGGGGCA


 


3.3 Homologous sequences of other S. pyogenes isolates and/or serotypes


> Spy0416A-1/Schmitz 1/7 (serotype 4); SEQ ID NO: 166


GCAGATGAGCTAACCACAACGAGTGAACCAACAATCACGAATCACGCTCAACAACAAGCGCAACATCTCACCA


 


ATACAGAGTTGAGCTCAGCTGAATCACAATCCCCAGACACATCACAAATCACTCCCAAGACAAATCGTGAAAA


 


AGAGCAACCACAAGGTCTAGTCTCTGAGCCAACCACAACTGAGCTAGCTGACACAGATGCAGCATCAATGGCT


 


AATACAGGTCCTGATGCGACTCAAAAAAGCGCTTCTTTACCGCCAGTCAATACAGATGTTCACGATTGGGTAA


 


AAACCAAAGGAGCTTGGGACAAGGGATACAAAGGACAAGGCAAGGTTGTCGCAGTTATTGACACAGGGATCGA


 


TCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAAAATCAAAAGAAGACATGCTAGCA


 


CGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGTTGTTTTTGCACATAATTATGTGG


 


AAAATAGCGATAATATCAAAGAAAATCAATTCGGGGATTTTGATGAGGACTGGGAAAACTTTGAGTTTGATGC


 


AGAGCCAAAAGCCATCAAAAAAAACAAGATCTATCGTCCCCAATCAACCCAGGCACCGAAAGAAACTGTTATC


 


AAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACAAACAGACGATGACACCAAATACGAGTCAC


 


ACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAAGAAGCCGCTGCTACTGGAGAACGCTTTTTAGG


 


AATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTGCCAACGACGTCATGGGATCAGCTGAATCACTC


 


TTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGGAGCAGATGTGATCAACCTGAGTCTTGGAACCGCTAATG


 


GGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAAAAAGCTAAAAAAGCCGGTGTATCAGTTGT


 


TGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATGATCCATTGGCAACAAATCCAGACTATGGT


 


TTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTGGCAGCTATAAACAGTAAGTGGGTGATTCAAC


 


GTCTAATGAGGGCCAAAGAATTAGAAAACCGTGCCGATTTAAACCATGGTAAAGCCATCTATTCAGAGTCTGT


 


CGActttaaagacataaaagatagcctaggttatgataaATCGCATCAATTTGCTTATGTCAAaGAGTCAACT


 


GATGCGGGTTATAAAGCACAAGACGTTAAAGATAAAATTGCTTTAATTGAACGTGATCCCAATAAAACCTATG


 


ACGAAATGATTGCTTTGGCTAAGAAACATGGAGCCCTGGGAGTACTTATTTTTAATAACAAGCCTGGTCAATC


 


AAACCGCTCAATGCGTCTAACAGCTAATGGGATGGGGATACCATCTGCTTTCATATCGCACGAATTTGGTAAG


 


GCCATGTCCGAATTAAATGGCAATGGTACAGGAAGTTTAGAGTTTGACAGTGTGGTCTCAAAAGCACCGAGTC


 


AAAAAGGCAATGAAATGAATCATTTTTCAAATTGGGGCCTAACTTCTGATGGCTATTTAAAACCTGACATTAC


 


TGCACCAGGTGGCGATATCTACTCTACCTATAACGATAACCACTATGGTAGCCAAACAGGAACAAGTATGGCC


 


TCTCCTCAGATTGCTGGCGCCAGCCTTTTGGTCAAACAATACCTAGAAAAGACTCAGCCAAACTTGCCAAAAG


 


AAAAAATTGCTGATATCGTTAAGAACCTATTGATGAGCAATGCTCAAATTCATGTTAATCCAGAGACAAAAAC


 


GACCACCTCACCGCGTCAGCAAGGGGCA


 


> Spy0416A-1/Schmitz 1/39 (serotype 12); SEQ ID NO: 167


GCAGATGAGCTAACCACAACGAGTGAACCAACAATCACGAATCACACTCAACAACAAGCGCAACATCTCACCA


 


ATACAGAGTTGAGCTCAGCTGAATCAAAACCTCAAGACACATCACAAATCACTCTCAAGACAAATCGTGAAAA


 


AGAGCAACCACAAGGTCTAGTCTCTGAGCCAACCACAACTGAGCTAGCTGACACAGATGCAGCACCAATGGCT


 


AATACAGGTCCTGATGCGACTCAAAAAAGCGCTTCTTTACCGCCAGTCAATACAGATGTTCACGATTGGGTAA


 


AAACCAAAGGAGCTTGGGACAAGGGATACAAAGGACAAGGCAAGGTTGTCGCAGTTATTGACACAGGGATCGA


 


TCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAAAATCAAAAGAAGACATGCTAGCA


 


CGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGTTGTTTTTGCACATAATTATGTGG


 


AAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTTGATGAGGACTGGGAAAACTTTGAGTTTGATGC


 


AGAGGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATCGTCCCCAATCAACCCAGGCACCGAAAGAAACT


 


GTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACAAACAGACGATGACACCAAATACG


 


AGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAAGAAGCCGCTGCTACTGGAGAACGCTT


 


TTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTGCCAACGACGTCATGGGATCAGCTGAA


 


TCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGGAGCAGATGTGATCAACCTGAGTCTTGGAACCG


 


CTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAAAAAGCTAAAAAAGCCGGTGTATC


 


AGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATGATCCATTGGCAACAAATCCAGAC


 


TATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTGGCAGCTATAAACAGTAAGTGGGTGA


 


TTCAACGTCTAATGACGGTCAAAGAATTAGAAAACCGTGCCGATTTAAACCATGGTAAAGCCATCTaTTCAGA


 


GTCTGTCGActttaaaGACATAAAAGATAGCCTAGGTTATGATAAATCGCATCAATTTGCTTATGTCaAAGAG


 


TCAACTGATGCGGGTTATAACGCACAAGACGTTAAAGGTAAAATTGCTTTAATTGAACGTGATCCCAATAAAA


 


CCTATGACGAAATGATTGCTTTGGCTAAGAAACATGGAGCCCTGGGAGTACTTATTTTTAATAACAAGCCTGG


 


TCAATCAAACCGCTCAATGCGTCTAACAGCTAATGGGATGGGGATACCATCTGCTTTCATATCGCACGAATTT


 


GGTAAGGCCATGTCCCAATTAAATGGCAATGGTACAGGAAGTTTAGAGTTTGACAGTGTGGTCTCAAAAGCAC


 


CGAGTCAAAAAGGCAATGAAATGAATCATTTTTCAAATTGGGGCCTAACTTCTGATGGCTATTTAAAACCTGA


 


CATTACTGCACCAGGTGGCGATATCTACTCTACCTATAACGATAACCACTATGGTAGCCAAACAGGAACAAGT


 


ATGGCCTCTCCTCAGATTGCTGGCGCCAGCCTTTTGGTCAAACAATACCTAGAAAAGACTCAGCCAAACTTGC


 


CAAAAGAAAAAATTGCTGATATCGTTAAGAACCTATTGATGAGCAATGCTCAAATTCATGTTAATCCAGAGAC


 


AAAAACGACCACCTCACCGCGTCAGCAAGGGGCA


 


> Spy0416A-1/Schmitz 1/55 (serotype 118); SEQ ID NO: 168


GCAGATGAGCTAACCACAACGAGTGAACCAACAATCACGAATCACGCTCAACAACAAGCGCCACCTCTCACCA


 


ATACAGAGTTGAGCTCAGCTGAATCACAACCTCAAGACACATCACAAGTAACTCCAGAGACAAATCGTGAAAA


 


AGAGCAACCACAAGGTCTAGTCTCTGAGCCAACAACAACTGAGCTAGCTGACACAGATGCAGCACCAATGGCT


 


AATACAGGTTCTGATGCGACTCAAAAAAGCGCTTCTTTACCGCCAGTCAATACAGATGTTCACGATTGGGTAA


 


AAACCAAAGGAGCTTGGGACAAGGGATACAAAGGACAAGGCAAGGTTGTCGCAGTTATTGACACAGGGATCGA


 


TCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAAAATCAAAAGAAGACATGCTAGCA


 


CGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGTTGTTTTTGCACATAATTATGTGG


 


AAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTTGATGAGGACTGGGAAAACTTTGAGTTTGATGC


 


AGAGGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATCGTCCCCAATCAACCCAGGCACCGAAAGAAACT


 


GTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACAAACAGACGATGACACCAAATACG


 


AGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAAGAAGCCGCTGCTACTGGAGAACGCTT


 


TTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTGCCAACGACGTCATGGGATCAGCTGAA


 


TCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCCTTAGGAGCAGATGTGATCAACCTGAGTCTTGGAACCG


 


CTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAAAAAGCTAAAAAAGCCGGTGTATC


 


AGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATGATCCATTGGCGACAAATCCAGAC


 


TATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTAGCAGCTATAAACAGTAAGTGGGTGA


 


TTCAACGTCTAATGACGGTCAAAGAATTGGAAAACCGTGCCGATTTAAACCATGGTAAAGCCATCTaTTCAGA


 


GTCTGTCGACTTTAAAGACATAAAAGATAGCCTAGGTTATGATAAATCGCATCAATTTGCTTATGTCAaAGAG


 


TCAACTGATGCGGGTTATAACGCACAAAACGTTAAAGGTAAAATTGCTTTAATTGAACGTGATCCCAATAAAA


 


CCTATGACGAAATGATTGCTTTGGCTAAGAAACATGGAGCCCTGGGAGTACTTATTTTTAATAACAAGCCTGG


 


TGAATCAAACCGCTCAATGCGTCTAACAGCTAATGGGATGGGGATACCATCTGCTTTCATATGGCACGAATTT


 


GGTAAGGCCATGTCCCAATTAAATGGCAATGGTACAGGAAGTTTAGAGTTTGACAGTGTGGTCTCAAAAGCAC


 


CGAGTCAAAAAGGCAATGAAATGAATCATTTTTCAAATTGGGGCCTAACCTCTGATGGCTATTTAAAACCTGA


 


CATTACTGCACCAGGTGGCGATATCTACTCTACCTATAACGATAACCACTATGGTAGCCAAACAGGAACAAGT


 


ATGGCCTCTCCTCAGATTGCTGGCGCCAGCCTTTTGGTCAAACAATACCTAGAAAAGACTCAGCCAAATTTGC


 


CAAAAGAAAAAATTGCTGATATCGTTAAGAACCTATTGATGAGCAATGCTCAAATTCATGTTAATCCAGAGAC


 


AAAAACGACCACCTCACCGCGTCAGCAAGGGGCA


 


> Spy0416A-1/Schmitz 1/56 (serotype 28); SEQ ID NO: 169


GCAGATGAGCTAACCACAACGAGTGAACCAACAATCACGAATCACGCTCAACAACAAGCGCAACATCTCACCA


 


ATACAGAGTTGAGCTCAGCTGAATCACAATCCCCAGACACATCACAAATCACTCCCAAGATAAATCGTGAAAA


 


AGAGCAACCACAAGGTCTAGTCTCTGAGCCAACCACAACTGAGCTAGCTGACACAGATGCAGCACCAATGGCT


 


AATACAGGTCCTGATGCGACTCAAAAAAGCGCTTCTTTACCGCCAGTCAATACAGATGTTCACGATTGGGTAA


 


AAACCAAAGGAGCTTGGGACAAGGGGTACAAAGGACAAGGTAAGGTTGTCGCAGTTATTGACACAGGGATCGA


 


TCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAAAATCAAAAGAAGACATGCTAGCA


 


CGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGTTGTTTTTGCACATAATTATGTGG


 


AAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTTGATGAGGACTGGGAAAACTTTGAGTTTGATGC


 


AGAGCCAAAAGCCATCAAAAAACACAAGATCTATCGTCCCCAATCAACCCAGGCACCGAAAGAAACTGTTATC


 


AAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACAAACAGACGATGACACCAAATACGAGTCAC


 


ACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGTAAAGAAGCCGCTGCTACTGGAGAACGCTTTTTAGG


 


AATTGCACCAGAGACCCAAGTCATGTTCATGCGTGTTTTTGCCAACGACGTCATGGGATCAGCTGAATCACTC


 


TTTATCAAAGCTATCGAAGATGCCGTGGCCTTAGGAGCAGATGTGATCAACCTGAGTCTTGGGACCGCTAATG


 


GTGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAAAAAGCTAAAAAAGCCGGTGTATCAGTTGT


 


TGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATGATCCATTGGCAACAAATCCAGACTATGGT


 


TTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTGGCAGCTATAAACAGTAAGTGGGTGATTCAAC


 


GTCTAATGACGGTCAAAGAATTAGAAAACCGTGCCGATTTAAACCATGGTAAAGCCATCTaTTCAGAGTCTGT


 


CGACTTtAAAGACATAAAAGATAGCCTAGGTTATGATAAATCGCATCAATTTGCTTATGTCAAAGAGTCAACT


 


GATGCGGGTTATAACGCACAAGACGTTAAAGGTAAAATTGCTTTAATTGAACGTGATCCCAATAAAACCTATG


 


ACGAAATGATTGCTTTGGCTAAGAAACATGGAGCCCTGGGAGTACTTATTTTTAATAACAAGCCTGGTCAATC


 


AAACCGCTCAATGCGCCTAACAGCTAATGGGATGGGGATACCATCTGCTTTCATATCGCACGAATTTGGTAAG


 


GCCATGTCCCAATTAAATGGCAATGGTACAGGAAGTTTAGAGTTTGACAGTGTGGTCTCAAAAGCACCGAGTC


 


AAAAAGGCAATGAAATGAATCATTTTTCAAATTGGGGCCTAACTTCTGATGGCTATTTAAAACCTGACATTAC


 


TGCACCAGGGGGTGATATCTACTCTACCTATAACGATAACCACTATGGTAGCCAAACAGGAACAAGTATGGCC


 


TCTCCTCAGATTGCTGGCGCCAGCCTTTTGGTCAAACAATACCTAGAAAAGACTCAGCCAAAACTTGCCAAAAG


 


AAAAAATTGCTGATATCGTTAAGAACCTATTGATGAGCAATGCTCAAATTCATGTTAATCCAGAGACAAAAAC


 


GACCACCTCACCGCGTCAGCAAGGGGCA


 


> Spy0416A-1/Schmitz 1/94 (serotype 1); SEQ ID NO: 170


GCAGATGAGCTAAGCACAATGAGCGAACCAACAATCACGAATCACGCTCAACAACAAGCGCAACATCTCACCA


 


ATACAGAGTTGAGCTCAGCTGAATCAAAATCTCAAGACACATCACAAATCACTCTCAAGACAAATCGTGAAAA


 


AGAGCAATCACAAGATCTAGTCTCTGAGCCAACCACAACTGAGCTAGCTGACACAGATGCAGCATCAATGGCT


 


AATACAGGTTCTGATGCGACTCAAAAAAGCGCTTCTTTACCGCCAGTCAATACAGATGTTCACGATTGGGTAA


 


AAACCAAAGGAGCTTGGGACAAGGGATACAAAGGACAAGGCAAGGTTGTCGCAGTTATTGACACAGGGATCGA


 


TCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAAAATCAAAAGAAGACATGCTAGCA


 


CGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGTTGTTTTTGCACATAATTATGTGG


 


AAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTTGATGAGGACTGGGAAAACTTTGAGTTTGATGC


 


AGAGGCAGAGCCAAAAGCCATGAAAAAACACAAGATCTATCGTCCCCAATCAACCCAGGCACCGAAAGAAACT


 


GTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACAAACAGACGATGACACCAAATACG


 


AGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAAGAAGCCGCTGCTACTGGAGAACGCTT


 


TTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTGCCAACGACATCATGGGATCAGCTGAA


 


TCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGGAGCAGATGTGATCAACCTGAGTCTTGGAACCG


 


CTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAAAAAGCTAAAAAAGCCGGTGTATC


 


AGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATGATCCATTGGCGACAAATCCAGAC


 


TATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTGGCAGCTATAAACAGTAACTGGGTGA


 


TTCAACGTCTAATGACGGTCAAAGAATTAGAAAACCGTGCCGATTTAAACCATGGTAAAGCCATCTATTCAGA


 


GTCTGTCGACTTTAAAGACATAAAAGATAGCCTAGGTTATGATAAATCGCATCAATTTGCTTATGTCaAAGAG


 


TCAACTGATGCGGGTTATAACGCACAAGACGTTAAAGGTAAAATTGCTTTAATTGAACGTGATCCCAATAAAA


 


CCTATGACGAAATGATTGCTTTGGCTAAGAAACATGGAGCTCTGGGAGTACTTATTTTTAATAACAAGCCTGG


 


TCAATCAAACCGCTCAATGCGTCTAACAGCTAATGGGATGGGGATACCATCTGCTTTCATATCGCACGAATTT


 


GGTAAGGCCATGTCCCAATTAAATGGCAATGGTACAGGAAGTTTAGAGTTTGACAGTGTGGTCTCAAAAGCAC


 


CGAGTCAAAAAGGCAATGAAATGAATCATTTTTCAAATTGGGGCCTAACTTCTGATGGCTATTTAAAACCTGA


 


CATTACTGCACCAGGTGGCGATATCTATTCTACCTATAACGATAACCACTATGGTAGCCAAACAGGAACAAGT


 


ATGGCCTCTCCTCAGATTGCTGGCGCCAGCCTTTTGGTCAAACAATACCTAGAAAAGACTCAGCCAAACTTGC


 


CAAAAGAAAAAATTGCTGATATCGTTAAGAACCTATTGATGAGCAATGCTCAAATTCATGTTAATCCAGAGAC


 


AAAAACGACCACCTCACCGCGTCAGCAAGGGGCA


 


> Spy0416A-1/Schmitz 1/253 (serotype 49); SEQ ID NO: 171


GCAGATGAGCTAACCACAACGAGTGAACCAACAATCACGAATCACGCTCAACAACAAGCGCAACCTCTCACCA


 


ATACAGAGTTGAGCTCAGCTGAATCACAATCCCCAGACATATCACAAGTAACTCCAGAGACAAATCGTGAAAA


 


AGAGCAACCACAAGGTCTAGTCTCTGAGCCAACAACAACTGAGCTAGCTGACACAGATGCAGCACCAATGGCT


 


AATACAGGTCCTGATGCGACTCAAAAAAGCGCTTCTTTACCGCCAGTCAATACAGATGTTCACGATTGGGTAA


 


AAACCAAAGGAGCTTGGGACAAGGGATACAAAGGACAAGGCAAGCTTGTCGCAGTTATTGACACAGGGATCGA


 


TCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAAAATCAAAAGAAGACATGCTAGCA


 


CGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGTTGTTTTTGCACATAATTATGTGG


 


AAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTTGATGAGGACTGGGAAAACTTTGAGTTTGATGC


 


AGATGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATCGTCCCCAATCAACCCAGGCACCGAAAGAAACT


 


GTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACAAACAGACGATGACACCAAATACG


 


AGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAAGAAGCCGCTGCTACTGGAGAACGCTT


 


TTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTGCCAACGACGTCATGCGATCAGCTGAA


 


TCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGGAGCAGATGTGATCAACCTGAGTCTTGGAACCG


 


CTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAAAAAGCTAAAAAAGCCGGTGTATC


 


AGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTCACCATGATGATCCATTGGCAACAAATCCAGAC


 


TATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTGGCAGCTATAAACAGTAAGTGGGTGA


 


TTCAACGTCTAATGACGGTCAAAGGATTAGAAAACCGTGCCGATTTAaACCATGGTAAAGCCATCTATTCAGA


 


GTCTGTCGACTTTAAAGACATAAAAGATAGCCTAGGTTATGATAAATCGCATCAATTTGCTTATGTCAAaGAG


 


TCAACTGATGCGGGTTATAACGCACAAGACGTTAAACGTAAAATTGCTTTAATTGAACGTGATCCCAATAAAA


 


CCTATGACGAAATGATTGCTTTGGCTAAGAAACATGCAGCCCTGGGACTACTTATTTTTAATAACAAGTCTGG


 


TCAATCAAACCGCTCAATGCGTCTAACAGCTAATGGGATGGGGATACCATCTGCTTTCATATCGCACGAATTT


 


GGTAAGGCCATGTCCCAATTAAATGGCAATGGTACAGGAAGTTTAGAGTTTGACAGTGTGGTCTCAAAAGCAC


 


CGAGTCAAAAAGGCAATGAAATGAATCATTTTTCAAATTGGGGCCTAACTTCTGATGGCTATTTAAAACCTGA


 


CATTACTGCACCAGGTGGCGATATCTACTCTACCTATAACGATAACCACTATGGTAGCCAAACAGGAACAAGT


 


ATGGCCTCTCCTCAGATTGCTGGCGCCAGCCTTTTGGTCAAACAATACCTAGAAAAGACCCAGCCAAACTTGC


 


CAAAAGAAAAAATTGCTGATATCGTTAAGAACCTATTGATGAGCAATGCTCAAATTCATGTTAATCCAGAGAC


 


AAAAACAACCACCTCACCGCGTCAGCAAGGGGCA


 


> Spy0416A-1/Schmitz 1/174 (serotype 6); SEQ ID NO: 172


GCAGATGAGCTAACCACAACGAGTGAACCAACAATCACGAATCACGCTCAACAACAAGCGCAACATCTCACCA


 


ATACAGAGTTGAGCTCAGCTGAATCAAAACCTCAAGACACATCACAAATCACTCCCAAGACAAATCGTGAAAA


 


AGAGCAATCACAAGATCTAGTCTCTGAGCCAACCACAACTGAGCTAGCTGACACAGATGCAGCATCAATGGCT


 


AATACAGGTCCTGATGCGACTCAAAAAAGCGCTTCTTTACCGCCAGTCAATACAGATGTTCACGATTGGGTAA


 


AAACCAAAGGAGCTTGGGACAAGGGATACAAAGGACAAGGCAAGGTTGTCGCAGTTATTGACACAGGGATCGA


 


TCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAAAATCAAAAGAAGACATGCTAGCA


 


CGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGTTGTTTTTGCACATAATTATGTGG


 


AAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTTGATGAGGACTGGGAAAACTTTGAGTTTGATGC


 


AGAGGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATCGTCCCCAATCAACCCAGGCACCGAAAGAAACT


 


GTTATCAAAACAGAAGAAACAGATGCTTCACATGATATTGACTGGACACAAACAGACGATGACACCAAATACG


 


AGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAAGAAGCCGCTGCTACTGGAGAACGCTT


 


TTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTGCCAACGACGTCATGGGATCAGCTGAA


 


TCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGGAGCAGATGTGATCAACCTGAGTCTTGGAACCG


 


CTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAAAAAGCTAAAAAAGCCGGTGTATC


 


AGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATGATCCATTGGCAACAAATCCAGAC


 


TATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTGGCAGCTATAAACAGTAAGTGGGTGA


 


TTCAACGTCTAATGACGGTCAAAGAATTAGAAAACCGTGCCGATTTAAACCATGGTAAAGCCATCTaTTCAGA


 


GTCTGTCGACTTTAAAaACATAAAAGATAGCCTAGGTTATGATAAATCGCATCAATTTGCTTATGTCAAaGAG


 


TCAACTGATGCGGGTTATAACGCAGAAGACGTTAAAGGTAAAATTGCTTTAATTGAACGTGATCCCAATAAAA


 


CCTATGACGAAATGATTGCTTTGGCTAAGAAACATGGAGCCCTGGGAGTACTTATTTTTAATAACAAACCTGG


 


TCAATCAAACCGCTCAATGCGCCTAACATCTAATGGGATGGGAATACCATCTGCTTTCATATCGCACGAATTT


 


GGTAAGGCCATGTCCCAATTAAATGGCAATGGTACAGGAAGTTTAGAGTTTGACAGTGTGGTCTCAAAAGCAC


 


CGAGTCAAAAAGGCAATGAAATGAATCATTTTTCAAATTGGGGCCTAACTTCTGATGGCTATTTAAAACCTGA


 


CATTACTGCACCAGGTGGCGATATCTACTCTACCTATAACGATAACCACTATGGTAGCCAAACAGGAACAAGT


 


ATGGCCTCTCCTCAGATTGCTGGCGCCAGCCTTTTGGTCAAACAATACCTAGAAAAGACTCAGCCAAACTTGC


 


CAAAAGAAAAAATTGCTGATATCGTTAAGAACCTATTGATGAGCAATGCTCAAATTCATGTTAATCCAGAGAC


 


AAAAACGACCACCTCACCGCGTCAGCAAGGGGCA


 


> Spy0416A-1/Schmitz 1/176 (serotype 83); SEQ ID NO: 173


GCAGATGAGCTAACCACAACGAGTGAACCAACAATCACGAATCACACTCAACAACAAGCGCAACATCTCACCA


 


ATACAGAGTTGAGCTCAGCTGAATCAAAACCTCAAGACACATCACAAATCACTCTCAAGACAAATCGTGAAAA


 


AGAGCAACCACAAGGTCTAGTCTCTGAGCCAACCACAACTGAGCTAGCTGACACAGATGCAGCACCAATGGCT


 


AATACAGGTCCTGATGCGACTCAAAAAAGCGCTTCTTTACCGCCAGTCAATACAGATGTTCACGATTGGGTAA


 


AAACCAAAGGAGCTTGGGACAAGGGATACAAAGGACAAGGCAAGGTTGTCGCAGTTATTGACACAGGGATCGA


 


TCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAAAATCAAAAGAAGACATGCTAGCA


 


CGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGTTGTTTTTGCACATAATTATGTGG


 


AAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTTGATGAGGACTGGGAAAACTTTGAGTTTGATGC


 


AGAGGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATCGTCCCCAATCAACCCAGGCACCGAAAGAAACT


 


GTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACAAACAGACGATGACACCAAATACG


 


AGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAAGAAGCCGCTGCTACTGGAGAACGCTT


 


TTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTGCCAACGACGTCATGGGATCAGCTGAA


 


TCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGGAGCAGATGTGATCAACCTGAGTCTTGGAACCG


 


CTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAAAAAGCTAAAAAAGCCGGTGTATC


 


AGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATGATCCATTGGCAACAAATCCAGAC


 


TATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTGGCAGCTATAAACAGTAAGTGGGTGA


 


TTCAACGTCTAATGACGGTCAAAGAATTAGAAAACCGTGCCGATTTAAACCATGGTAAAGCCATCTATTCAGA


 


GTCTGTCGACTTTAAAAACATAAAAGATAGCCTAGGTTATGATAAATCGCATCAATTTGCTTATGTCAAAGAG


 


TCAACTGATGCGGGTTATAAAGCACAAGACGTTAAAGGTAAAATTGCTTTAATTGAACGTGATCCCAATAAAA


 


CCTATGACGAAATGATTGCTTTGGCTAAGAAACATGGAGCCCTGGGAGTACTTATTTTTAATAACAAGCCTGG


 


TCAATCAAACCGCTCAATGCGTCTAACAGCTAATGGGATGGGGATACCATCTGCTTTCATATCGCACGAATTT


 


GGTAAGGCCATGTCCCAATTAAATGGCAATGGTACAGGAAGTTTAGAGTTTGACAGTGTGGTCTCAAAAGCAC


 


CGAGTCAAAAAGGCAATGAAATGAATCATTTTTCAAATTGGGGCCTAACTTCTGATGGCTATTTAAAACCTGA


 


CATTACTGCACCAGGTGGCGATATCTACTCTACCTATAACGATAACCACTATGGTAGCCAAACAGGAACAAGT


 


ATGGCCTCTCCTCAGATTGCTGGCGCCAGCCTTTTGGTCAAACAATACCTAGAAAAGACTCAGCCAAACTTGC


 


CAAAAGAAAAAATTGCTGATATCGTTAAGAACCTATTGATGAGCAATGCTCAAATTCATGTTAATCCAGAGAC


 


AAAAACGACCACCTCACCGCGTCAGCAAGGGGCA


 


> Spy0416A-1/Schmitz 1/234 (serotype 44); SEQ ID NO: 174


GCAGATGAGCTAAGCACAATGAGTGAACCAACAATCACGAATCACGCTCAACAACAAGCGCAACATCTCACCA


 


ATACAGAGTTGAGCTCAGCTGAATCAAAATCTCAAGACACATCACAAATCACTCCCAAGACAAATCGTGAAAA


 


AGAGCAATCACAAGATCTAGTCTCTGAGCCAACAACAACTGAGCTAGCTGACACAGATGCAGCATCAATGGCT


 


AATACAGGTTCTGATGCGACTCAAAAAAGCGCTTCTTTACCGCCAGTCAATACAGATGTTCACGATTGGGTAA


 


AAACCAAAGGAGCTTGGGACAAGGGATACAAAGGACAAGGCAAGGTTGTCGCAGTTATTGACACAGGGATCGA


 


TCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAAAATCAAAAGAAGACATGCTAGCA


 


CGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGTTGTTTTTGCACATAATTATGTGG


 


AAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTTGATGAGGACTGGGAAAACTTTGAGTTTGATGC


 


AGATGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATCGTCCCCAATCAACCCAGGCACCGAAAGAAACT


 


GTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACAAACAGACGATGACACCAAATACG


 


AGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAAGAAGCCGCTGCTACTGGAGAACGCTT


 


TTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTGCCAACGACGTCATGGGATCAGCTGAA


 


TCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGGAGCAGATGTGATCAACCTGAGTCTTGGAACCG


 


CTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAAAAAGCTAAAAAAGCCGGTGTATC


 


AGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATGACCCATTGGCAACAAATCCAGAC


 


TATGGTTTGGTTGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTGGCAGCTATAAACAGTAAGTGGGTGA


 


TTCAACGTCTAATGACGGTCAAAGAATTGGAAAACCGTGCCGATTTAAACCATGGTAAAGCCATCTaTTCAGA


 


GTCTGTCGACTTtAAAGACATAAAAGATAGCCTAGGTTATGATAAATCGCATCAATTTGCTTATGTCAAAGAG


 


TCAACTGATGCGGGTTATAAAGCACAAGACGTTAAAGATAAAATTGCTTTAATTGAACGTGATCCCAATAAAA


 


CCTATGACGAAATGATTGCTTTGGCTAAGAAACATGGAGCCCTGGGGGTACTTATTTTTAATAACAAGCCTGG


 


TCAATCAAACCGCTCAATGCGTCTAACAGCTAATGGGATGGGGATACCATCTGCTTTCATATCGCACGAATTT


 


GGTAAGGCCATGTCCCAATTAAATGGCAATGGTACAGGAAGTTTAGAGTTTGACAGTGTGGTCTCAAAAGCAC


 


CGAGTCAAAAAGGCAATGAAATGAATCATTTTTCAAATTGGGGCCTAACTTCTGATGGCTATTTAAAACCTGA


 


CATTACTGCACGAGGCGGCGATATCTACTCTACCTATAACGATAACCACTATGGTAGCCAAACAGGAACAAGT


 


ATGGCCTCTCCTCAGATTGCTGGCGCCAGCCTTTTGGTCAAACAATATCTAGAAAAGACTCAGCCAAACTTGC


 


CAAAAGAAAAAATTGCTGATATCGTTAAGAACCTATTGATGAGCAATGCTCAAATTCATGTTAATCCAGAGAC


 


AAAAACGACCACCTCACCGCGTCAGCAAGGGGCA


 


> Spy0416A-1/Schmitz 1/22 (serotype 4); SEQ ID NO: 175


GCAGATGAGCTAACCACAACGAGTGAACCAACAATCACGAATCACGCTCAACAACAAGCGCAACATCTCACCA


 


ATACAGAGTTGAGCTCAGCTGAATCACAATCCCCAGACACATCACAAATCACTCCCAAGACAAATCGTGAAAA


 


AGAGCAACCACAAGGTCTAGTCTCTGAGCCAACCACAACTGAGCTAGCTGACACAGATGCAGCATCAATGGCT


 


AATACAGGTCCTGATGCGACTCAAAAAAGCGCTTCTTTACCGCCAGTCAATACAGATGTTCACGATTGGGTAA


 


AAACCAAAGGAGCTTGGGACAAGGGATACAAAGGACAAGGCAAGGTTGTCGCAGTTATTGACACAGGGATCGA


 


TCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAAAATCAAAAGAAGACATGCTAGCA


 


CGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGTTGTTTTTGCACATAATTATGTGG


 


AAAATAGCGATAATATCAAAGAAAATCAATTCGGGGATTTTGATGAGGACTGGGAAAACTTTGAGTTTGATGC


 


AGAGCCAAAAGCCATCAAAAAAAACAAGATCTATCGTCCCCAATCAACCCAGGCACCGAAAGAAACTGTTATC


 


AAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACAAACAGACGATGACACCAAATACGAGTCAC


 


ACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAAGAAGCCGCTGCTACTGGAGAACGCTTTTTAGG


 


AATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTGCCAACGACGTCATGGGATCAGCTGAATCACTC


 


TTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGGAGCAGATGTGATCAACCTGAGTCTTGGAACCGCTAATG


 


GGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAAAAAGCTAAAAAAGCCGGTGTATCAGTTGT


 


TGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATGATCCATTGGCAACAAATCCAGACTATGGT


 


TTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTGGCAGCTATAAACAGTAAGTGGGTGATTCAAC


 


GTCTAATGACGGCCAAAGAATTAGAAAACCGTGCCGATTTAAACCATGGTAAAGCCATCTATTCAGAGTCTGT


 


CGACTTTAAAGACATAAAAGATAGCCTAGGTTATGATAAATCGCATCAATTTGCTTATGTCAAAGAGTCAACT


 


GATGCGGGTTATAAAGCACAAGACGTTAAAGATAAAATTGCTTTAATTGAACGTGATCCCAATAAAACCTATG


 


ACGAAATGATTGCTTTGGCTAAGAAACATGGAGCCCTGGGAGTACTTATTTTTAATAACAAGCCTGGTCAATC


 


AAACCGCTCAATGCGTCTAACAGCTAATGGGATGGGGATACCATCTGCTTTCATATCGCACGAATTTGGTAAG


 


GCCATGTCCCAATTAAATGGCAATGGTACAGGAAGTTTAGAGTTTGACAGTGTGGTCTCAAAAGCACCGAGTC


 


AAAAAGGCAATGAAATGAATCATTTTTCAAATTGGGGCCTAACTTCTGATGGCTATTTAAAACCTGACATTAC


 


TGCACCAGGTGGCGATATCTACTCTACCTATAACGATAACCACTATGGTAGCCAAACAGGAACAAGTATGGCC


 


TCTCCTCAGATTGCTGGCGCCAGCCTTTTGGTCAAACAATACCTAGAAAAGACTCAGCCAAACTTGCCAAAAG


 


AAAAAATTGCTGATATCGTTAAGAACCTATTGATGAGCAATGCTCAAATTCATGTTAATCCAGAGACAAAAAC


 


GACCACCTCACCGCGTCAGCAAGGGGCA


 


3.4 Antigenic fragment Spy0416A-6


> Spy0416A-6/SF370 (serotype 1); SEQ ID NO: 15


GCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAA


 


AATCAAAAGAAGACATGCTAGCACGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGT


 


TGTTTTTGCACATAATTATGTGGAAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTTGATGAGGAC


 


TGGGAAAACTTTGAGTTTGATGCAGAGGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATCGTCCCCAAT


 


CAACCCAGGCACCGAAAGAAACTGTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACA


 


AACAGACGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAAGAA


 


GCCGCTGCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTGCCA


 


ACGACATCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGGAGCAGATGT


 


GATCAACCTGAGTCTTGGAACCGCTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAA


 


AAAGCTAAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATG


 


ATCCATTGGCGACAAATCCAGACTATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTGGC


 


AGCTATAAACAGTAAGTGGGTGATTCAACGTCTAATGACGGTCAAAGAATTAGAAAACCGTGCCGATTTAAAC


 


CATGGTAAAGCCATCTATTCAGAGTCTGTCGACTTTAAAGACATAAAAGATAGCCTA


 


3.5 Homologous sequences of other S. pyogenes isolates and/or serotypes


> Spy0416A-6/Schmitz 1/7 (serotype 4); SEQ ID NO: 176


GCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAA


 


AATCAAAAGAAGACATGCTAGCACGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGT


 


TGTTTTTGCACATAATTATGTGGAAAATAGCGATAATATCAAAGAAAATCAATTCGGGGATTTTGATGAGGAC


 


TGGGAAAACTTTGAGTTTGATGCAGAGCCAAAAGCCATCAAAAAAAACAAGATCTATCGTCCCCAATCAACCC


 


AGGCACCGAAAGAAACTGTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACAAACAGA


 


CGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAAGAAGCCGCT


 


GCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTGCCAACGACG


 


TCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGGAGCAGATGTGATCAA


 


CCTGAGTCTTGGAACCGCTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAAAAAGCT


 


AAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATGATCCAT


 


TGGCAACAAATCCAGACTATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTGGCAGCTAT


 


AAACAGTAAGTGGGTGATTCAACGTCTAATGACGGCCAAAGAATTAGAAAACCGTGCCGATTTAAACCATGGT


 


AAAGCCATCTATTCAGAGTCTGTCGActttaaagacataaaagatagccta


 


> Spy0416A-6/Schmitz 1/39 (serotype 12); SEQ ID NO: 177


GCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAA


 


AATCAAAAGAAGACATGCTAGCACGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGT


 


TGTTTTTGCACATAATTATGTGGAAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTTGATGAGGAC


 


TGGGAAAACTTTGAGTTTGATGCAGAGGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATCGTCCCCAAT


 


CAACCCAGGCACCGAAAGAAACTGTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACA


 


AACAGACGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAAGAA


 


GCCGCTGCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTGCCA


 


ACGACGTCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGGAGCAGATGT


 


GATCAACCTGAGTCTTGGAACCGCTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAA


 


AAAGCTAAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATG


 


ATCCATTGGCAACAAATCCAGACTATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTGGC


 


AGCTATAAACAGTAAGTGGGTGATTCAACGTCTAATGACGGTCAAAGAATTAGAAAACCGTGCCGATTTAAAC


 


CATGGTAAAGCCATCTaTTCAGAGTCTGTCGActttaaaGACATAAAAGATAGCCTA


 


> Spy0416A-6/Schmitz 1/55 (serotype 118); SEQ ID NO: 178


GCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAA


 


AATCAAAAGAAGACATGCTAGCACGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGT


 


TGTTTTTGCACATAATTATGTGGAAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTTGATGAGGAC


 


TGGGAAAACTTTGAGTTTGATGCAGAGGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATCGTCCCCAAT


 


CAACCCAGGCACCGAAAGAAACTGTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACA


 


AACAGACGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAAGAA


 


GCCGCTGCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTGCCA


 


ACGACGTCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCCTTAGGAGCAGATGT


 


GATCAACCTGAGTCTTGGAACCGCTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAA


 


AAAGCTAAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATG


 


ATCCATTGGCGACAAATCCAGACTATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTAGC


 


AGCTATAAACAGTAAGTGGGTGATTCAACGTCTAATGACGGTCAAAGAATTGGAAAACCGTGCCGATTTAAAC


 


CATGGTAAAGCCATCTaTTCAGAGTCTGTCGACTTTAAAGACATAAAAGATAGCCTA


 


> Spy0416A-6/Schmitz 1/56 (serotype 28); SEQ ID NO: 179


GCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAA


 


AATCAAAAGAAGACATGCTAGCACGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGT


 


TGTTTTTGCACATAATTATGTGGAAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTTGATGAGGAC


 


TGGGAAAACTTTGAGTTTGATGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATCGTCCCCAATCAACCC


 


AGGCACCGAAAGAAACTGTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACAAACAGA


 


CGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGTAAAGAAGCCGCT


 


GCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGACCCAAGTCATGTTCATGCGTGTTTTTGCCAACGACG


 


TCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCCTTAGGAGCAGATGTGATCAA


 


CCTGAGTCTTGGGACCGCTAATGGTGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAAAAAGCT


 


AAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATGATCCAT


 


TGGCAACAAATCCAGACTATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTGGCAGCTAT


 


AAACAGTAAGTGGGTGATTCAACGTCTAATGACGGTCAAAGAATTAGAAAACCGTGCCGATTTAAACCATGGT


 


AAAGCCATCTaTTCAGAGTCTGTCGACTTtAAAGACATAAAAGATAGCCTA


 


> Spy0416A-6/Schmitz 1/94 (serotype 1); SEQ ID NO: 180


GCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAA


 


AATCAAAAGAAGACATGCTAGCACGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGT


 


TGTTTTTGCACATAATTATGTGGAAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTTGATGAGGAC


 


TGGGAAAACTTTGAGTTTGATGCAGAGGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATCGTCCCCAAT


 


CAACCCAGGCACCGAAAGAAACTGTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACA


 


AACAGACGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAAGAA


 


GCCGCTGCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTGCCA


 


ACGACATCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGGAGCAGATGT


 


GATCAACCTGAGTCTTGGAACCGCTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAA


 


AAAGCTAAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATG


 


ATCCATTGGCGACAAATCCAGACTATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTGGC


 


AGCTATAAACAGTAAGTGGGTGATTCAACGTCTAATGACGGTCAAAGAATTAGAAAACCGTGCCGATTTAAAC


 


CATGGTAAAGCCATCTATTCAGAGTCTGTCGACTttAAAGACATAAAAGATAGCCTA


 


> Spy0416A-6/Schmitz 1/253 (serotype 49); SEQ ID NO: 181


GCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAA


 


AATCAAAAGAAGACATGCTAGCACGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGT


 


TGTTTTTGCACATAATTATGTGGAAAATAGCGATAATATCAAAGAAAATGAATTCGAGGATTTTGATGAGGAC


 


TGGGAAAACTTTGAGTTTGATGCAGATGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATCGTCCCCAAT


 


CAACCCAGGCACCGAAAGAAACTGTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACA


 


AACAGACGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAAGAA


 


GCCGCTGCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTGCCA


 


ACGACGTCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGGAGCAGATGT


 


GATCAACCTGAGTCTTGGAACCGCTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAA


 


AAAGCTAAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATG


 


ATCCATTGGCAACAAATCCAGACTATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTGGC


 


AGCTATAAACAGTAAGTGGGTGATTCAACGTCTAATGACGGTCAAAGGATTAGAAAACCGTGCCGATTTAaAC


 


CATGGTAAAGCCATCTATTCAGAGTCTGTCGACTTTAAAGACATAAAAGATAGCCTA


 


> Spy0416A-6/Schmitz 1/174 (serotype 6); SEQ ID NO: 182


GCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAA


 


AATCAAAAGAAGACATGCTAGCACGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGT


 


TGTTTTTGCACATAATTATGTGGAAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTTGATGAGGAC


 


TGGGAAAACTTTGAGTTTGATGCAGAGGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATCGTCCCCAAT


 


CAACCCAGGCACCGAAAGAAACTGTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACA


 


AACAGACGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAAGAA


 


GCCGCTGCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTGCCA


 


ACGACGTCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGGAGCAGATGT


 


GATCAACCTGAGTCTTGGAACCGCTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAA


 


AAAGCTAAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATG


 


ATCCATTGGCAACAAATCCAGACTATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTGGC


 


AGCTATAAACAGTAAGTGGGTGATTCAACGTCTAATGACGGTCAAAGAATTAGAAAACCGTGCCGATTTAAAC


 


CATGGTAAAGCCATCTaTTCAGAGTCTGTCGACTTTAAAaACATAAAAGATAGCCTA


 


> Spy0416A-6/Schmitz 1/176 (serotype 83); SEQ ID NO: 183


GCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAA


 


AATCAAAAGAAGACATGCTAGCACGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGT


 


TGTTTTTGCACATAATTATGTGGAAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTTGATGAGGAC


 


TGGGAAAACTTTGAGTTTGATGCAGAGGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATCGTCCCCAAT


 


CAACCCAGGCACCGAAAGAAACTGTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACA


 


AACAGACGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAAGAA


 


GCCGCTGCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTGCCA


 


ACGACGTCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGGAGCAGATGT


 


GATCAACCTGAGTCTTGGAACCGCTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAA


 


AAAGCTAAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATG


 


ATCCATTGGCAACAAATCCAGACTATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTGGC


 


AGCTATAAACAGTAAGTGGGTGATTCAACGTCTAATGACGGTCAAAGAATTAGAAAACCGTGCCGATTTAAAC


 


CATGGTAAAGCCATCTATTCAGAGTCTGTCGACTTTAAAAACATAAAAGATAGCCTA


 


> Spy0416A-6/Schmitz 1/234 (serotype 44); SEQ ID NO: 184


GCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAA


 


AATCAAAAGAAGACATGCTAGCACGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGT


 


TGTTTTTGCACATAATTATGTGGAAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTTGATGAGGAC


 


TGGGAAAACTTTGAGTTTGATGCAGATGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATCGTCCCCAAT


 


CAACCCAGGCACCGAAAGAAACTGTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACA


 


AACAGACGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAAGAA


 


GCCGCTGCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTGCCA


 


ACGACGTCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGGAGCAGATGT


 


GATCAACCTGAGTCTTGGAACCGCTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAA


 


AAAGCTAAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATG


 


ACCCATTGGCAACAAATCCAGACTATGGTTTGGTTGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTGGC


 


AGCTATAAACAGTAAGTGGGTGATTCAACGTCTAATGACGGTCAAAGAATTGGAAAACCGTGCCGATTTAAAC


 


CATGGTAAAGCCATCTaTTCAGAGTCTGTCGACTTtAAAGACATAAAAGATAGCCTA


 


> Spy0416A-6/Schmitz 1/22 (serotype 4); SEQ ID NO: 185


GCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTGCTAAAGTAA


 


AATCAAAAGAAGACATGCTAGCACGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAATGATAAAGT


 


TGTTTTTGCACATAATTATGTGGAAAATAGCGATAATATCAAAGAAAATCAATTCGGGGATTTTGATGAGGAC


 


TGGGAAAACTTTGAGTTTGATGCAGAGCCAAAAGCCATCAAAAAAAACAAGATCTATCGTCCCCAATCAACCC


 


AGGCACCGAAAGAAACTGTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGACACAAACAGA


 


CGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAAGAAGCCGCT


 


GCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTGCCAACGACG


 


TCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGGAGCAGATGTGATCAA


 


CCTGAGTCTTGGAACCGCTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATTGAAAAAGCT


 


AAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATGATGATCCAT


 


TGGCAACAAATCCAGACTATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGTGGCAGCTAT


 


AAACAGTAAGTGGGTGATTCAACGTCTAATGACGGCCAAAGAATTAGAAAACCGTGCCGATTTAAACCATGGT


 


AAAGCCATCTATTCAGAGTCTGTCGACTTTAAAGACATAAAAGATAGCCTA


 


3.6 Antigenic fragment Spy0416A-7


> Spy0416A-7/SF370 (serotype 1); SEQ ID NO: 16


TCACAAATCACTCTCAAGACAAATCGTGAAAAAGAGCAATCACAAGATCTAGTCTCTGAGCCAACCACAACTG


 


AGCTAGCTGACACAGATGCAGCATCAATGGCTAATACAGGTTCTGATGCGACTCAAAAAAGCGCTTCTTTACC


 


GCCAGTCAATACAGATGTTCACGATTGGGTAAAAACCAAAGGAGCTTGGGACAAGGGATACAAAGGACAAGGC


 


AAGGTTGTCGCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTG


 


CTAAAGTAAAATCAAAAGAAGACATCCTAGCACGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAA


 


TGATAAAGTTGTTTTTGCACATAATTATGTGGAAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTT


 


GATGAGGACTGGGAAAACTTTGAGTTTGATGCAGAGGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATC


 


GTCCCCAATCAACCCAGGCACCGAAAGAAACTGTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGA


 


CTGGACACAAACAGACGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAAT


 


AGCAAAGAAGCCGCTGCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTG


 


TTTTTGCCAACGACATCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGG


 


AGCAGATGTGATCAACCTGAGTCTTGGAACCGCTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAA


 


GCAATTGAAAAAGCTAAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTG


 


ACCATGATGATCCATTGGCGACAAATCCAGACTATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAAC


 


ATCAGTGGCAGCTATAAACAGTAAGTGGGTGATTCAACGTCTAATGACGGTCAAAGAATTAGAAAACCGTGCC


 


GATTTAAACCATGGTAAAGCCATCTATTCAGAGTCTGTCGACTTTAAAGACATAAAAGATAGCCTAGGTTATG


 


ATAAATCGCATCAATTTGCTTATGTCAAAGAGTCAACTGATGCGGGTTATAACGCACAAGACGTTAAAGGTAA


 


AATTGCTTTAATTGAACGTGATCCCAATAAAACCTATGACGAAATGATTGCTTTGGCTAAGAAACATGGAGCT


 


CTGGGAGTACTTATTTTTAATAACAAGCCTGGTCAATCAAACCGCTCAATGCGTCTAACAGCTAATGGGATGG


 


GGATACCATCTGCTTTCATATCGCACGAATTTGGTAAGGCCATGTCCCAATTAAATGGCAATGGTACAGGAAG


 


T


 


3.7 Homologous sequences of other S. pyogenes isolates and/or serotypes


> Spy0416A-7/Schmitz 1/7 (serotype 4); SEQ ID NO: 186


TCACAAATCACTCCCAAGACAAATCGTGAAAAAGAGCAACCACAAGGTCTAGTCTCTGAGCCAACCACAACTG


 


AGCTAGCTGACACAGATGCAGCATCAATGGCTAATACAGGTCCTGATGCGACTCAAAAAAGCGCTTCTTTACC


 


GCCAGTCAATACAGATGTTCACGATTGGGTAAAAACCAAAGGAGCTTGGGACAAGGGATACAAAGGACAAGGC


 


AAGGTTGTCGCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTG


 


CTAAAGTAAAATCAAAAGAAGACATGCTAGCACGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAA


 


TGATAAAGTTGTTTTTGCACATAATTATGTGGAAAATAGCGATAATATCAAAGAAAATCAATTCGGGGATTTT


 


GATGAGGACTGGGAAAACTTTGAGTTTGATGCAGAGCCAAAAGCCATCAAAAAAAACAAGATCTATCGTCCCC


 


AATCAACCCAGGCACCGAAAGAAACTGTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGAC


 


ACAAACAGACGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAA


 


GAAGCCGCTGCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTG


 


CCAACGACGTCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGGAGCAGA


 


TGTGATCAACCTGAGTCTTGGAACCGCTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATT


 


GAAAAAGCTAAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATG


 


ATGATCCATTGGCAACAAATCCAGACTATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGT


 


GGCAGCTATAAACAGTAAGTGGGTGATTCAACGTCTAATGACGGCCAAAGAATTAGAAAACCGTGCCGATTTA


 


AACCATGGTAAAGCCATCTATTCACAGTCTGTCGActttaaagacataaaagatagcctaggttatgataaAT


 


CGCATCAATTTGCTTATGTCAAaGAGTCAACTGATGCGGGTTATAAAGCACAAGACGTTAAAGATAAAATTGC


 


TTTAATTGAACGTGATCCCAATAAACCTATGACGAAAATGATTGCTTTGGCTAAGAAACATGGAGCCCTGGGA


 


GTACTTATTTTTAATAACAAGCCTGGTCAATCAAACCGCTCAATGCGTCTAACAGCTAATGGGATGGGGATAC


 


CATCTGCTTTCATATCGCACGAATTTGGTAAGGCCATGTCCCAATTAAATGGCAATGGTACAGGAAGT


 


> Spy0416A-7/Schmitz 1/39 (serotype 12); SEQ ID NO: 187


TCACAAATCACTCTCAAGACAAATCGTGAAAAAGAGCAACCACAAGGTCTAGTCTCTGAGCCAACCACAACTG


 


AGCTAGCTGACACAGATGCAGCACCAATGGCTAATACAGGTCCTGATGCGACTCAAAAAAGCGCTTCTTTACC


 


GCCAGTCAATACAGATGTTCACGATTGGGTAAAAACCAAAGGAGCTTGGGACAAGGGATACAAAGGACAAGGC


 


AAGGTTGTCGCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTG


 


CTAAAGTAAAATCAAAAGAAGACATGCTAGCACGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAA


 


TGATAAAGTTGTTTTTGCACATAATTATGTGGAAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTT


 


GATGAGGACTGGGAAAACTTTGAGTTTGATGCAGAGGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATC


 


GTCCCCAATCAACCCAGGCACCGAAAGAAACTGTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGA


 


CTGGACACAAACAGACGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAAT


 


AGCAAAGAAGCCGCTGCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTG


 


TTTTTGCCAACGACGTCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGG


 


AGCAGATGTGATCAACCTGAGTCTTGGAACCGCTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAA


 


GCAATTGAAAAAGCTAAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTG


 


ACCATGATGATCCATTGGCAACAAATCCAGACTATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAAC


 


ATCAGTGGCAGCTATAAACAGTAAGTGGGTGATTCAACGTCTAATGACGGTCAAAGAATTAGAAAACCGTGCC


 


GATTTAAACCATGGTAAAGCCATCTaTTCAGAGTCTGTCGActttaaaGACATAAAAGATAGCCTAGGTTATG


 


ATAAATCGCATCAATTTGCTTATGTCaAGAGTCAACTGATGCGGGTTATAACGCACAAGACGTTAAAGGTAA


 


AATTGCTTTAATTGAACGTGATCCCAATAAAACCTATGACGAAATGATTGCTTTGGCTAAGAAACATGGAGCC


 


CTGGGAGTACTTATTTTTAATAACAAGCCTGGTCAATCAAACCGCTCAATGCGTCTAACAGCTAATGGGATGG


 


GGATACCATCTGCTTTCATATCGCACGAATTTGGTAAGGCCATGTCCCAATTAAATGGCAATGGTACAGGAAG


 


T


 


> Spy0416A-7/Schmitz 1/55 (serotype 118); SEQ ID NO: 188


TCACAAGTAACTCCAGAGACAAATCGTGAAAAAGAGCAACCACAAGGTCTAGTCTCTGAGCCAACAACAACTG


 


AGCTAGCTGACACAGATGCAGCACCAATGGCTAATACAGGTTCTGATGCGACTCAAAAAAGCGCTTCTTTACC


 


GCCAGTCAATACAGATGTTCACGATTGGGTAAAAACCAAAGGAGCTTGGGACAAGGGATACAAAGGACAAGGC


 


AAGGTTGTCGCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTG


 


CTAAAGTAAAATCAAAAGAAGACATGCTAGCACGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAA


 


TGATAAAGTTGTTTTTGCACATAATTATGTGGAAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTT


 


GATGAGGACTGGGAAAACTTTGAGTTTGATGCAGAGGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATC


 


GTCCCCAATCAACCCAGGCACCGAAAGAAACTGTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGA


 


CTGGACACAAACAGACGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAAT


 


AGCAAAGAAGCCGCTGCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTG


 


TTTTTGCCAACGACGTCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCCTTAGG


 


AGCAGATGTGATCAACCTGAGTCTTGGAACCGCTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAA


 


GCAATTGAAAAAGCTAAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTG


 


ACCATGATGATCCATTGGCGACAAATCCAGACTATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAC


 


ATCAGTAGCAGCTATAAACAGTAAGTGGGTGATTCAACGTCTAATGACGGTCAAAGAATTGGAAACCGTGCC


 


GATTTAAACCATGGTAAAGCCATCTaTTCAGAGTCTGTCGACTTTAAAGACATAAAAGATAGCCTAGGTTATG


 


ATAAATCGCATCAATTTGCTTATGTCAaAGAGTCAACTGATGCGGGTTATAACGCACAAAACGTTAAGGTAA


 


AATTGCTTTAATTGAACGTGATCCCAATAAAACCTATGACGAAATGATTGCTTTGGCTAAGAAACATGGAGCC


 


CTGGGAGTACTTATTTTTAATAACAAGCCTGGTCAATCAAACCGCTCAATGCGTCTAACAGCTAATGGGATGG


 


GGATACCATCTGCTTTCATATCGCACGAATTTGGTAAGGCCATGTCCCAATTAAATGGCAATGGTACAGGAG


 


T


 


> Spy0416A-7/Schmitz 1/56 (serotype 28); SEQ ID NO: 189


TCACAAATCACTCCCAAGATAAATCGTGAAAAAGAGCAACCACAAGGTCTAGTCTCTGAGCCAACCACAACTG


 


AGCTAGCTGACACAGATGCAGCACCAATGGCTAATACAGGTCCTGATGCGACTCAAAAAAGCGCTTCTTTACC


 


GCCAGTCAATACAGATGTTCACGATTGGGTAAAAACCAAAGGAGCTTGGGACAGGGGTACAAAGGACAAGGT


 


AAGGTTGTCGCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTG


 


CTAAAGTAAAATCAAAAGAAGACATGCTAGCACGCCAAAAAGCCGCCGGTATTATTATGGGAGTTGGATAAA


 


TGATAAAGTTGTTTTTGCACATAATTATGTGGAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTT


 


GATGAGGACTGGGAAAACTTTGAGTTTGATGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATCGTCCCC


 


AATCAACCCAGGCACCGAAAGAAACTGTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGAC


 


ACAAACAGACGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGTAAA


 


GAAGCCGCTGCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGACCCAAGTCATGTTCATGCGTGTTTTTG


 


CCAACGACGTCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCCTTAGGAGCAGA


 


TGTGATCAACCTGAGTCTTGGGACCGCTAATGGTGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATT


 


GAAAAAGCTAAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATG


 


ATGATCCATTGGCAACAAATCCAGACTATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGT


 


GGCAGCTATAAACAGTAAGTGGTGATTCAACGTCTAATGACGGTCAAAGAATTAGAAAACCGTGCCGATTTA


 


AACCATGGTAAAGCCATCTaTTCAGAGTCTGTCGACTTtAAAGACATAAAAGATAGCCTAGGTTATGATAAAT


 


CGCATCAATTTGCTTATGTCAAAGAGTCAACTGATGCGGGTTATAACGCACAAGACGTTAAAGGTAAAATTGC


 


TTTAATTGAACGTGATCCCAATAAAACCTATGACGAAATGATTGCTTTGGCTAAGAAACATGGAGCCCTGGGA


 


GTACTTATTTTTAATAACAAGCCTGGTCAATCAAACCGCTCAATGCGCCTAACAGCTAATGGGATGGGGATAC


 


CATCTGCTTTCATATCGCACGAATTTGGTAAGGCCATGTCCCAATTAAATGGCAATGGTACAGGAAGT


 


> Spy0416A-7/Schmitz 1/94 (serotype 1); SEQ ID NO: 190


TCACAAATCACTCTCAAGACAAATCGTGAAAAAGAGCAATCACAAGATCTAGTCTCTGAGCCAACCACAACTG


 


AGCTAGCTGACACAGATGCAGCATCAATGGCTAATACAGGTTCTGATGCGACTCAAAAAAGCGCTTCTTTACC


 


GCCAGTCAATACAGATGTTCACGATTGGGTAAAAACCAAAGGAGCTTGGGACAAGGGATACAAAGGACAAGGC


 


AAGGTTGTCGCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTG


 


CTAAAGTAAAATCAAAAGAAGACATGCTAGCACGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAA


 


TGATAAAGTTGTTTTTGCACATAATTATGTGGAAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTT


 


GATGAGGACTGGGAAAACTTTGAGTTTGATGCAGAGGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATC


 


GTCCCCAATCAACCCAGGCACCGAAAGAAACTGTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGA


 


CTGGACACAAACAGACGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAAT


 


AGCAAAGAAGCCGCTGCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTG


 


TTTTTGCCAACGACATCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGG


 


AGCAGATGTGATCAACCTGAGTCTTGGAACCGCTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAA


 


GCAATTGAAAAAGCTAAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTG


 


ACCATGATGATCCATTGGCGACAAATCCAGACTATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAAC


 


ATCAGTGGCAGCTATAAACAGTAAGTGGGTGATTCAACGTCTAATGACGGTCAAAGAATTAGAAAACCGTGCC


 


GATTTAAACCATGGTAAAGCCATCTATTCAGAGTCTGTCGACTttAAAGACATAAAAGATAGCCTAGGTTATG


 


ATAAATCGCATCAATTTGCTTATGTCaAAGAGTCAACTGATGCGGGTTATAACGCACAAGACGTTAAAGGTAA


 


AATTGCTTTAATTGAACGTGATCCCAATAAAACCTATGACGAAATGATTGCTTTGGCTAAGAAACATGGAGCT


 


CTGGGAGTACTTATTTTTAATAACAAGCCTGGTCAATCAAACCGCTCAATGCGTCTAACAGCTAATGGGATGG


 


GGATACCATCTGCTTTCATATCGCACGAATTTGGTAAGGCCATGTCCCAATTAAATGGCAATGGTACAGGAAG


 


T


 


> Spy0416A-7/Schmitz 1/253 (serotype 49); SEQ ID NO: 191


TCACAAGTAACTCCAGAGACAAATCGTGAAAAGAGCAACCACAAGGTCTAGTCTCTGAGCCAACAACAACTG


 


AGCTAGCTGACACAGATGCAGCACCAATGGCTAATACAGGTCCTGATGCGACTCAAAAAAGCGCTTCTTTACC


 


GCCAGTCAATACAGATGTTCACGATTGGGTAAAAACCAAAGGAGCTTGGGACAAGGGATACAAAGGACAAGGC


 


AAGGTTGTCGCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTG


 


CTAAAGTAAAATCAAAAGAAGACATGCTAGCACGCCAAAAAGCCGCCGGTATTATTATGGGAGTTGGATAAA


 


TGATAAAGTTGTTTTTGCACATAATTATGTGGAAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTT


 


GATGAGGACTGGGAAAACTTTGAGTTTGATGCAGATGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATC


 


GTCCCCAATCAACCCAGGCACCGAAAGAAACTGTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGA


 


CTGGACACAAACAGACGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAAT


 


AGCAAAGAAGCCGCTGCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTG


 


TTTTTGCCAACGACGTCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGG


 


AGCAGATGTGATCAACCTGAGTCTTGGAACCGCTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAA


 


GCAATTGAAAAAGCTAAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTG


 


ACCATGATGATCCATTGGCAACAAATCCAGACTATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAAC


 


ATCAGTGGCAGCTATAAACAGTAAGTGGGTGATTCAACGTCTAATGACGGTCAAAGGATTAGAAAACCGTGCC


 


GATTTAaACCATGGTAAAGCCATCTATTCAGAGTCTGTCGACTTTAAAGACATAAAAGATAGCCTAGGTTATG


 


ATAAATCGCATCAATTTGCTTATGTCAAaGAGTCAACTGATGCGGGTTATAACGCACAAGACGTTAAAGGTAA


 


AATTGCTTTAATTGAACGTGATCCCAATAAAACCTATGACGAAATGATTGCTTTGGCTAAGAAACATGGAGCC


 


CTGGGACTACTTATTTTTAATAACAAGTCTGGTCAATCAAACCGCTCAATGCGTCTAACAGCTAATGGGATGG


 


GGATACCATCTGCTTTCATATCGCACGATTTGGTAAGGCCATGTCCCAATTAAATGGCAATGGTACAGGAAG


 


T


 


> Spy0416A-7/Schmitz 1/174 (serotype 6); SEQ ID NO: 192


TCACAATCACTCCGAAGACAAATCGTGAAAAAGAGCAATCACAAGATCTAGTCTCTGAGCCAACCACAACTG


 


AGCTAGCTGACACAGATGCAGCATCAATGGCTAATACAGGTCCTGATGCGACTCAAAAAAGCGCTTCTTTACC


 


GCCAGTCAATACAGATGTTCACGATTGGGTAAAAACCAAAGGAGCTTGGGACAAGGGATACAAAGGACAAGGC


 


AAGGTTGTCGCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCACTG


 


CTAAAGTAAAATCAAAAGAAGACATGCTAGCACGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAA


 


TGATAAAGTTGTTTTTGCACATAATTATGTGGAAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTT


 


GATGAGGACTGGGAAAACTTTGAGTTTGATGCAGAGGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATC


 


GTCCCCAATCAACCCAGGCACCGAAAGAAACTGTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGA


 


CTGGACACAAACAGACGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAAT


 


AGCAAAGAAGCCGCTGCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTG


 


TTTTTGCCAACGACGTCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGG


 


AGCAGATGTGATCAACCTGAGTCTTGGAACCGCTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAA


 


GCAATTGAAAAAGCTAAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTG


 


ACCATGATGATCCATTGGCAACAAATCCAGACTATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAAC


 


ATCAGTGGCAGCTATAAACAGTAAGTGGGTGATTCAACGTCTAATGACGGTCAAAGAATTAGAAAACCGTGCC


 


GATTTAAACCATGGTAAAGCCATCTaTTCAGAGTCTGTCGACTTTAAAaACATAAAAGATAGCCTAGGTTATG


 


ATAAATCGCATCAATTTGCTTATGTCAAaGAGTCAACTGATGCGGGTTATAACGCACAAGACGTTAAAGGTAA


 


AATTGCTTTAATTGAACGTGATCCCAATAAAACCTATGACGAAATGATTGCTTTGGCTAAGAAAACATGGAGCC


 


CTGGGAGTACTTATTTTTAATAACAAACCTGGTCAATCAAACCGCTCAATGCGCCTAACATCTAATGGGATGG


 


GAATACCATCTGCTTTCATATCGCACGAATTTGGTAAGGCCATGTCCCAATTAAATGGCAATGGTACAGGAG


 


T


 


> Spy0416A-7/Schmitz 1/176 (serotype 83); SEQ ID NO: 193


TCACAAATCACTCTCAAGACAAATCGTGAAAAAGAGCAACCACAAGGTCTAGTCTCTGAGCCAACCACAACTG


 


AGCTAGCTGACACAGATGCAGCACCAATGGCTAATACAGGTCCTGATGCGACTCAAAAAAGCGCTTCTTTACC


 


GCCAGTCAATACAGATGTTCACGATTGGGTAAAAACCAAAGGAGCTTGGGACAAGGGATACAAAGGACAAGGC


 


AAGGTTGTCGCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTG


 


CTAAAGTAAAATCAAAAGAAGACATGCTAGCACGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAA


 


TGATAAAGTTGTTTTTGCACATAATTATGTGGAAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTT


 


GATGAGGACTGGGAAAACTTTGAGTTTGATGCAGAGGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATC


 


GTCCCCAATCAACCCAGGCACCGAAAGAAACTGTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGA


 


CTGGACACAAACAGACGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAAT


 


AGCAAAGAAGCCGCTGCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTG


 


TTTTTGCCAACGACGTCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGG


 


AGCAGATGTGATCAACCTGAGTCTTGGAACCGCTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAA


 


GCAATTGAAAAAGCTAAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTG


 


ACCATGATGATCCATTGGCAACAATCCAGACTATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAAC


 


ATCAGTGGCAGCTATAAACAGTAAGTGGGTGATTCAACGTCTAATGACGGTCAAAGAATTAGAAAACCGTGCC


 


GATTTAAACCATGGTAAAGCCATCTATTCAGAGTCTGTCGACTTTAAAAACATAAAAGATAGCCTAGGTTATG


 


ATAAATCGCATCAATTTGCTTATGTCAAAGAGTCAACTGATGCGGGTTATAAAGCACAAGACGTTAAAGGTAA


 


AATTGCTTTAATTGAACGTGATCCCAATAAAACCTATGACGAAATGATTGCTTTGGCTAAGAAACATGGAGCC


 


CTGGGAGTACTTATTTTTAATAACAAGCCTGGTCAATCAAACCGCTCAATGCGTCTAACAGCTAATGGGATGG


 


GGATACCATCTGCTTTCATATCGCACGAATTTGGTAAGGCCATGTCCCAATTAAATGGCAATGGTACAGGAAG


 


T


 


> Spy0416A-7/Schmitz 1/234 (serotype 44); SEQ ID NO: 194


TCACAAATCACTCCCAAGACAAATCGTGAAAAAGAGCAATCACAAGATCTAGTCTCTGAGCCAACAACAACTG


 


AGCTAGCTGACACAGATGCAGCATCAATGGCTAATACAGGTTCTGATGCGACTCAAAAAGCGCTTCTTTACC


 


GCCAGTCAATACAGATGTTCACGATTGGGTAAAAACCAAAGGAGCTTGGGACAAGGGATACAAAGGACAAGGC


 


AAGGTTGTCGCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTG


 


CTAAAGTAAAATCAAAAGAAGACATGCTAGCACGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAA


 


TGATAAAGTTCTTTTTGCACATAATTATGTGGAAAATAGCGATAATATCAAAGAAAATCAATTCGAGGATTTT


 


GATGAGGACTGGGAAAACTTTGAGTTTGATGCAGATGCAGAGCCAAAAGCCATCAAAAAACACAAGATCTATC


 


GTCCCCAATCAACCCAGGCACCGAAAGAAACTGTTATCAAACAGAGAAACAGATGGTTCACATGATATTGA


 


CTGGACACAAACAGACGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAAT


 


AGCAAAGAAGCCGCTGCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTG


 


TTTTTGCCAACGACGTCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGG


 


AGCAGATGTGATCAACCTGAGTCTTGGAACCGCTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAA


 


GCAATTGAAAAAGCTAAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTG


 


ACCATGATGACCCATTGGCAACAATCCAGACTATGGTTTGGTTGGTTCTCCCTCAACAGGTCGAACACCAAC


 


ATCAGTGGCAGCTATAAACAGTAAGTGGGTGATTCAACGTCTAATGACGGTCAAAGAATTGGAAAACCGTGCC


 


GATTTAAACCATGGTAAAGCCATCTaTTCAGAGTCTGTCGACTTtAAAGACATAAAAGATAGCCTAGGTTATG


 


ATAAATCGCATCAATTTGCTTATGTCAAAGAGTCAACTGATGCGGGTTATAAAGCACAAGACGTTAAAGATAA


 


AATTGCTTTAATTGAACGTGATCCCAATAAAACCTATGACGAAATGATTGCTTTGGCTAAGAAACATGGAGCC


 


CTGGGGGTACTTATTTTTAATAACAAGCCTGGTCAATCAAACCGCTCAATGCGTCTAACAGCTAATGGGATGG


 


GGATACCATCTGCTTTCATATCGCACGAATTTGGTAAGGCCATGTCCCAATTAAATGGCAATGGTACAGGAAG


 


T


 


> Spy0416A-7/Schmitz 1/22 (serotype 4); SEQ ID NO: 195


TCACAAATCACTCCCAAGACAAATCGTGAAAAAGAGCAACCACAAGGTCTAGTCTCTGAGCCAACCACAACTG


 


AGCTAGCTGACACAGATGCAGCATCAATGGCTAATACAGGTCCTGATGCGACTCAAAAAAGCGCTTCTTTACC


 


GCCAGTCAATACAGATGTTCACGATTGGGTAAAAACCAAAGGAGCTTGGGACAAGGGATACAAAGGACAAGGC


 


AAGGTTGTCGCAGTTATTGACACAGGGATCGATCCGGCCCATCAAAGCATGCGCATCAGTGATGTATCAACTG


 


CTAAAGTAAAATCAAAAGAAGACATGCTAGCACGCCAAAAAGCCGCCGGTATTAATTATGGGAGTTGGATAAA


 


TGATAAAGTTGTTTTTGCACATAATTATGTGGAAAATAGCGATAATATCAAAAGAAAATCAATTCGGGGATTTT


 


GATGAGGACTGGGAAAACTTTGAGTTTGATGCAGAGCCAAAAGCCATCAAAAAAAACAAGATCTATCGTCCCC


 


AATCAACCCAGGCACCGAAAGAAACTGTTATCAAAACAGAAGAAACAGATGGTTCACATGATATTGACTGGAC


 


ACAAACAGACGATGACACCAAATACGAGTCACACGGTATGCATGTGACAGGTATTGTAGCCGGTAATAGCAAA


 


GAAGCCGCTGCTACTGGAGAACGCTTTTTAGGAATTGCACCAGAGGCCCAAGTCATGTTCATGCGTGTTTTTG


 


CCAACGACGTCATGGGATCAGCTGAATCACTCTTTATCAAAGCTATCGAAGATGCCGTGGCTTTAGGAGCAGA


 


TGTGATCAACCTGAGTCTTGGAACCGCTAATGGGGCACAGCTTAGTGGCAGCAAGCCTCTAATGGAAGCAATT


 


GAAAAAGCTAAAAAAGCCGGTGTATCAGTTGTTGTAGCAGCAGGAAATGAGCGCGTCTATGGATCTGACCATG


 


ATGATCCATTGGCAACAAATCCAGACTATGGTTTGGTCGGTTCTCCCTCAACAGGTCGAACACCAACATCAGT


 


GGCAGCTATAAACAGTAAGTGGGTGATTCAACGTCTAATGACGGCCAAAGAATTAGAAAACCGTGCCGATTTA


 


AACCATGGTAAAGCCATCTATTCAGAGTCTGTCGACTTTAAAGACATAAAAGATAGCCTAGGTTATGATAAAT


 


CGCATCAATTTGCTTATGTCAAAGAGTCAACTGATGCGGGTTATAAAGCACAAGACGTTAAAGATAAAATTGC


 


TTTAATTGAACGTGATCCCAATAAAACCTATGACGAAATGATTGCTTTGGCTAAGAAACATGGAGCCCTGGGA


 


GTACTTATTTTTAATAACAAGCCTGGTCAATCAAACCGCTCAATGCGTCTAACAGCTAATGGGATGGGGATAC


 


CATCTGCTTTCATATCGCACGAATTTGGTAAGGCCATGTCCCAATTAAATGGCAATGGTACAGGAAGT


 


4. Spy0872


4.1 Full length Spy0872


> Spy0872/SF370 (serotype 1); SEQ ID NO: 196


GATCAAGTTGATGTGCAATTCCTTGGCGTCAATGATTTTCACGGCGCTCTTGATAATACCGGAACAGCTTACA


 


CACCAAGTGGTAAAATACCAAATGCTGGGACGGCTGCTCAATTAGGTGCTTATATGGATGACGCTGAGATAGA


 


CTTCAAGCAAGCAAATCAAGACGGAACAAGTATACGTGTTCAAGCTGGAGATATGGTCGGAGCCAGTCCTGCT


 


AACTCTGCACTTTTACAAGATGAGCCTACTGTCAAAGTCTTTAACAAAATGAAATTTGAATATGGCACTCTTG


 


GTAATCATGAATTTGACGAAGGACTAGATGAATTTAACCGTATCATGACAGGTCAAGCGCCTGATCCTGAATC


 


AACAATTAATGATATCACCAAACAATATGAGCACGAAGCTTCGCATCAAACCATCGTCATTGCTAATGTTATT


 


GATAAAAAAACCAAGGATATCCCCTATGGTTGGAAACCTTATGCTATAAAAGACATAGCCATTAATGACAAAA


 


TCGTTAAGATTGGCTTCATTGGTGTTGTGACTACAGAGATTCCAAATCTCGTTTTAAAGCAAAACTATGAACA


 


CTATCAATTTTTAGATGTAGCTGAAACCATTGCCAAATATGCTAAAGAACTACAAGAACAACATGTTCATGCT


 


ATTGTGGTTTTAGCTCATGTTCCTGCAACAAGTAAAGATGGTGTTGTTGATCATGAAATGGCTACGGTTATGG


 


AAAAAGTGAACCAAATCTATCCCGAACATAGCATTGATATTATTTTTGCAGGACATAATCATCAATACACTAA


 


TGGAACTATCGGTAAAACACGTATCGTTCAAGCCCTCTCTCAAGGAAAAGCTTATGCAGATGTCCGTGGTACG


 


CTAGATACTGATACCAATGATTTTATTAAAACTCCATCAGCAAATGTTGTTGCTGTAGCACCAGGTATCAAAA


 


CAGAAAATTCAGATATCAAAGCTATAATAAATCATGCTAATGATATTGTTAAAACAGTTACTGAACGAAAAAT


 


CGGAACTGCAACTAATTCTTCAACTATTTCTAAAACAGAAAATATTGATAAAGAATCTCCTGTCGGTAACTTA


 


GCAACAACGGCTCAGCTTACTATTGCTAAGAAAACTTTTCCAACTGTTGACTTTGCTATGACCAATAATGGTG


 


GTATTCGAAGTGACCTAGTTGTCAAAAATGACCGGACCATCACCTGGGGAGCTGCACAGGCTGTACAACCATT


 


TGGTAATATCCTTCAAGTCATTCAAATGACTGGTCAACACATTTACGATGTCCTAAATCAGCAATACGATGAA


 


AACCAGACCTATTTTCTTCAATGTCAGGTTTAACATACACTTATACAGATAATGATCCTAAGAACTCTGATA


 


CCCCCTTCAAGATAGTTAAGGTTTATAAAGACAATGGTGAAGAAATTAACTTAACAACTACTTACACCGTTGT


 


TGTCAAGGACTTTCTTTATGGTGGTGGTGATGGCTTTTCAGCATTTAAAAAAGCTAAATTATCGGAGCTATT


 


AACACAGATACTGAAGCTTTCATCACATATATCACAAATTTAGAAGCATCAGGTAAAACTGTTAATGCTACTA


 


TAAAAGGGGTTAAAAATTATGTAACTTCAAACCTTGAAAGTTCGACAAAAGTTAATAGTGCTGGTAAACACAG


 


TATCATTAGTAAGGTTTTTAGAAATCGTGATGGCAATACAGTGTCTAGTGAAGTCATTTCAGACCTTTTGACT


 


TCTACTGAAAACACTAATAACAGCCTTGGCAAAAAAGAAACAACAACAAACAAAAATACTATCTCTAGTTCCA


 


CTCTTCCAATAACA


 


4.2 Antigenic fragment Spy0872-2


> Spy0872-2/SF370 (serotype 1); SEQ ID NO: 17


GCTATAATAAATCATGCTAATGATATTGTTAAAACAGTTACTGAACGAAAAATCGGAACTGCACTAATTCTT


 


CAACTATTTCTAAAACAGAAAATATTGATAAAGAATCTCCTGTCGGTAACTTAGCAACAACGGCTCAGCTTAC


 


TATTGCTAAGAAAACTTTTCCAACTGTTGACTTTGCTATGACCAATAATGGTGGTATTCGAAGTGACCTAGTT


 


GTCAAAAATGACCGGACCATCACCTGGGGAGCTGCACAGGCTGTACAACCATTTGGTAATATCCTTCAAGTCA


 


TTCAAATGACTGGTCAACACATTTACGATGTCCTAAATCAGCAATACGATGAAAACCAGACCTATTTTCTTCA


 


AATGTCAGGTTTAACATACACTTATACAGATAATGATCCTAAGAACTCTGATACCCCCTTCAAGATAGTTAAG


 


GTTTATAAAGACAATGGTGAAGAAATTAACTTAACAACTACTTACACCGTTGTTGTCAACGACTTTCTTTATG


 


GTGGTGGTGATGGCTTTTCAGCATTTAAAAAAGCTAAATTAATCGGAGCTATTAACACAGATACTGAAGCTTT


 


CATCACATATATCACAAATTTAGAAGCATCAGGTAAAACTGTTAATGCTACTATAAAAGGGGTTAAAAATTAT


 


GTAACTTCAAACCTTGAAAGTTCGACAAAAGTTAATAGTGCTGGTAAACACAGTATCATTAGTAAGGTTTTTA


 


GAAATCGTGATGGCAATACAGTGTCTAGTGAAGTCATTTCAGACCTTTTGACTTCTACTGAAAACACTAATAA


 


CAGCCTTGGCAAAAAAGAAACAACAACAAACAAAAATACTATCTCTAGTTCCACTCTTCCAATAACA


 


4.3 Homologous sequences of other S. pyogenes isolates and/or serotypes


> Spy0872-2/Schmitz 1/7 (serotype 4); SEQ ID NO: 197


GCTATAATAAATCATGCTAATGATATTGTTAAAACAGTTACTGAACGAAAAATCGGAACTGCAACTAATTCTT


 


CAACTATTTCTAAAACAGAAAATATTGATAAAGAATCTCCTGTCGGTAACTTAGTAACAACGGCTCAGCTTAC


 


TATTGCTAAGAAAACTTTTCCAACTGTTGACTTTGCTATGACCAATAATGGTGGTATTCGAAGTGACCTAGTT


 


GTCAAAAATGACCGGACCATCACCTGGGAAGCTGCACAGGCTGTACAACCATTTGGTAATATCCTTCAAGTCA


 


TTCAAATGACTGGTCAACACATTTACGATGTCCTAAATCAGCAATACGATGAAAACCAGACCTATTTTCTTCA


 


AATGTCAGGTTTAACATACACTTATACAGATAATGATCCTAAGAACTCTGATACCCCCTTCAAGATAGTTAAG


 


GTTTATAAAGACAATGGTGAAGAAATTAACTTAACAACTACTTACACCGTTGTTGTCAACGACTTTCTTTATG


 


GTGGTGGTGATGGCTTTTCAGCATTTAAAAAAGCTAAATTAATCGGAGCTATTAACACAGATACTGAAGCTTT


 


CATCACATATATCACAAATTTAGAAGCATCAGGTAAAACTGTTAATGCTACTATAAAAGGGGTTAAAAATTAT


 


GTAACTTCAAACCTTGAAAGTTCGACAAAAGTTAATAGTGCTGGTAAACACAGTATCATTATCATTAGTAAGG


 


TTTTTAGAAATCGTGATGGCAATATAGTGTCTAGTGAAATCATTTCAGACCTTTTGACTTCTACTGAAAACAC


 


TAATAACAGCTTTGGCAAAAAAGAGATAACAACAAAcaAAAATACTATCTCTAATTCCACTCTTCCAATAACA


 


> Spy0872-2/Schmitz 1/39 (serotype 12); SEQ ID NO: 198


GCTATAATAAATCATGCTAATGATATTGTTAAAaCAGTTACTGAACGAAAAATCGGAACTGCAACTAATTCTT


 


CAACTATTTCTAAAACAGAAAATATTGATAAAGAATCTCCTGTCGGTAACTTAGTAACAACGGCTCAGCTTAC


 


TATTGCTAAGAAAACTTTTCCAACTGTTGACTTTGCTATGACCAATAATGGTGGTATTCGAAGTGACCTAGTT


 


GTCAAAAATGACCGGACCATCACCTGGGGAGCTGCACAGGCTGTACAACCATTTGGTAATATCCTTCAAGTCA


 


TTCAAATGACTGGTCAACACATTTACGATGTCCTAAATCAGCAATACGATGAAAACCAGACCTATTTTCTTCA


 


AATGTCAGGTTTAACATACACTTATACAGATAATGATCCTAAGAACTCTGATACCCCCATTCAAGATAGTTAAG


 


GTTTATAAAGACAATGGTGAAGAAATTAACTTAACAACTACTTACACCGTTGTTGTCAACGACTTTCTTTATG


 


GTGGTGGTGATGGCTTTTCAGCATTTAAAAAAGCTAAATTAATCGGAGCTATTAACACAGATACTGAAGCTTT


 


CATCACATATATCACAAATTTAGAAGCATCAGGTAAAACTGTTAATGCTACTATAAAAGGGGTTAAAAATTAT


 


GTAACTTCAAACCTTGAAAGCTCGACAAAAGTTAATAGTGCTGGTAAACACAGTATCATTAGTAAGGTTTTTA


 


GAATCGTGATGGCAATATAGTGTCTAGTGAAATCATTTCAGACCTTTTGACTTCTACTGAAAACACTAATAA


 


CAGCCTTGGCAAAAAAGAAACAACGACAAACAAAAATACTATCTCTAGTTCCACTCTTCCAATAACA


 


> Spy0872-2/Schmitz 1/55 (serotype 118); SEQ ID NO: 199


GCTATAATAAaTCATGCTAATGATATTGTTAAAACAGTTACTGAACGAAAAATCGGACTGCAACTAATTCTT


 


CAACTATTTCTAAAACAGAAAATATTGATAAAGAATCTCCTGTCGGTAACTTAGTAACAACGGCTCAGCTTAC


 


TATTGCTAAGAAAACTTTTCCAACTGTTGACTTTGCTATGACCAATAATGGTGGTATTCGAAGTGACCTAGTT


 


GTCAAAAATGACCGGACCATCACCTGGGGAGCTGCACAGGCTGTACAACCATTTGGTAATATCCTTCAAGTCA


 


TTCAAATGACTGGTCAACACATTTACGATGTCCTAAATCAGCAATACGATGAAAACCAGACCTATTTTCTTCA


 


AATGTCAGGTTTAACATACACTTATACAGATAATGATCCTAAGAACTCTGATATCCCCTTCAAGATAGTTAAG


 


GTTTATAAAGACAATGGTGAAGAAATTAACTTAACAACTACTTACACCGTTGTTGTCAACGACTTTCTTTATG


 


GTGGTGGTGATGGCTTTTCAGCATTTAAAAAAGCTAAATTAATCGGAGCTATTAATACAGATACTGAAGCTTT


 


CATCACATATATCACAAATTTAGAAGCATCAGGTAAAACTGTTAATGCTACTATAAAAGGGGTTAAAAATTAT


 


GTAACTTCAAACCTTGAAAGTTCGACAAAAGTTAATAGTGCTGGTAAACACAGTATCATTAGTAAGGTTTTTA


 


GAAATCGTGATGGCAATATAGTGTCTAGTGAAGTCATTTCAGACCTTTTGACTTCTACTGAAAACACTAATAA


 


CAGCCTTGGCAAAAAAGAAACAaCGACAAACAAAAATACTATCTCTAGTTCCACTCTTCCAATAACA


 


> Spy0872-2/Schmitz 1/56 (serotype 28); SEQ ID NO: 200


GCTATAATAAATCATGCTAATGATATTGTTAAAACAGTTACTGAACGAAAAATCGGAACTGCAACTAATTCTT


 


CAACTATTTCTAAAACAGAAAATATTGATAAAGAATCTCCTGTCGGTAACTTAGTAACAACAGCTCAGCTTAC


 


TATTGCTAAGAAAACTTTTCCAACTGTTGACTTTGCTATGACCAATAATGGTGGTATTCGAAGTGACCTAGTT


 


GTCAAAAATGATCGGACCATCACCTGGGGAGCTGCACAGGCTGTACAACCATTTGGTAATATCCTTCAAGTCA


 


TTCAAATGACTGGTCAACACATTTACGATGTCCTAAATCAGCAATACGATGAAAACCAGACCTATTTTCTTCA


 


AATGTCAGGTTTAACATACACTTATACAGATAATGATCCTAAGAACTCTGATACCCCCTTCAAGATAGTTAAG


 


GTTTATAAAGACAATGGTGAAGAAATTAACTTAACAACTACTTACACCGTTGTTGTCAACGACTTTCTTTATG


 


GTGGTGGTGATGGCTTTTCAGCATTTAAAAAAGCTAAATTAATTGGAGCTATTAACACAGATACTGAAGCTTT


 


CATCACATATATCACAAATTTAGAAGCATCAGGTAAAACTGTTAATGCTACTATAAAAGGGGTTAAAAATTAT


 


GTAACTTCAAACCTTGAAAGTTCGACAAAAGTTAATAGTGCTGGTAAACACAGTATCATTAGTAAGGTTTTTA


 


GAAATCGTGATGGCAATATAGTGTCTAGTGAGATCATTTCAGACCTTTTGACTTCTACTGAAAACACTAATAA


 


CAGCCTTGGCAAAAAAGAAACAACAACAAACAAAAATACTATCTCTAGTTCCACTCTTCCAATAACA


 


> Spy0872-2/Schmitz 1/94 (serotype 1); SEQ ID NO: 201


GCTATAATAAATCATGCTAATGATATTGTTAAAACAGTTACTGAACGAAAAATCGGAACTGCAACTAATTCTT


 


CAACTATTTCTAAAACAGAAAATATTGATAAAGAATCTCCTGTCGGTAACTTAGCAACAACGGCTCAGCTTAC


 


TATTGCTAAGAAAACTTTTCCAACTGTTGACTTTGCTATGACCAATAATGGTGGTATTCGAAGTGACCTAGTT


 


GTCAAAAATGACCGGACCATCACCTGGGGAGCTGCACAGGCTGTACAACCATTTGGTAATATCCTTCAAGTCA


 


TTCAAATGACTGGTCAACACATTTACGATGTCCTAAATCAGCAATACGATGAAAACCAGACCTATTTTCTTCA


 


AATGTCAGGTTTAACATACACTTATACAGATAATGATCCTAAGAACTCTGATACCCCCTTCAAGATAGTTAAG


 


GTTTATAAAGACAATGGTGAAGAAATTAACTTAACAACTACTTACACCGTTGTTGTCAACGACTTTCTTTATG


 


GTGGTGGTGATGGCTTTTCAGCATTTAAAAAAGCTAAATTAATCGGAGCTATTAACACAGATACTGAAGCTTT


 


CATCACATATATCACAAATTTAGAAGCATCAGGTAAAACTGTTAATGCTACTATAAAAGGGGTTAAAAATTAT


 


GTAACTTCAAACCTTGAAAGTTCGACAAAAGTTAATAGTGCTGGTAAACACAGTATCATTAGTAAGGTTTTTA


 


GAAATCGTGATGGCAATACAGTGTCTAGTGAAGTCATTTCAGACCTTTTGACTTCTACTGAAAACACTAATAA


 


CAGCCTTGGCAAAAAAGAAACAACAACAAACAAAAATACTATCTCTAGTTCCACTCTTCCAATAACA


 


> Spy0872-2/Schmitz 1/253 (serotype 49); SEQ ID NO: 202


GCTATAATAAATCATGCTAATGATATTGTTAAAaCAGTTACTGAACGAAAAATCGGAACTGCAACTAATTCTT


 


CAACTATTTCTAAAACAGAAAATATTGATAAAGAATCTCCTGTCGGTAACTTAGTAACAACAGCTCAGCTTAC


 


TATTGCTAAGAAAACTTTTCCAACTGTTGACTTTGCTATGACCAATAATGGTGGTATTCGAAGTGACCTAGTT


 


GTCAAAAATGATCGGACCATCACCTGGGGAGCTGCACAGGCTGTACAACCATTTGGTAATATCCTTCAAGTCA


 


TTCAAATGACTGGTCAACACATTTACGATGTCCTAAATCAGCAATACGATGAAAACCAGACCTATTTTCTTCA


 


AATGTCAGGTTTAACATTCACTTATACAGATAATGATCCTAAGAACTCTGATACCCCCTTCAAGATAGTTAAG


 


GTTTATAAAGACAATGGTGAAGAAATTAACTTAACAACTACTTACACCGTTGTTGTCAACGACTTTCTTTATG


 


GTGGTGGTGATGGCTTTTCAGCATTTAAAAAAGCTAAATTAATTGGAGCTATTAACACAGATACTGAAGCTTT


 


CATCACATATATCACAAATTTAGAAGCATCAGGTAAAACTGTTAATGCTACTATAAAAGGGGTTAAAAATTAT


 


GTAACTTCAAACCTTGAAAGCTCGACAAAAGTTAATAGTGCTGGTAAACACAGTATCATTAGTAAGGTTTTTA


 


GAAATCGTGATGGCAATATAGTGTCTAGTGAAATAATTTCAGACCTTTTGACTTCTACTGAAAACACTAATAA


 


CAGCCTTGGCAAAAAAGAAACAACGACaAACAAAAATACTATCTCTAGTTCCACTCTTCCAATAACA


 


> Spy0872-2/Schmitz 1/176 (serotype 83); SEQ ID NO: 203


GCTATAATAAATCATGCTAATGATATTGTTAAAACAGTTACTGAACGAAAAATCGGAACTGCAACTAATTCTT


 


CAACTATTTCTAAAACAGAAAATATTGATAAAGAATCCCCTGTCGGTAACTTAGTAACAACGGCTCAGCTTAC


 


TATTGCTAAGAAAACTTTTCCAACTGTTGACTTTGCTATGACCAATAATGGTGGTATTCGAAGTGACCTAGTT


 


GTCAAAAATGACCGGACCATCACCTGGGGAGCTGCACAGGCTGTACAACCATTTGGTAATATCCTTCAAGTCA


 


TTCAAATGACTGGTCAACACATTTACGATGTCCTAAATCAGCAATACGATGAAAACCAGACCTATTTTCTTCA


 


AATGTCAGGTTTAACATACACTTATACAGATAATGATCCTAAGAACTCTGATACCCCCTTCAAGATAGTTAAG


 


GTTTATAAAGACAATGGTGAAGAAATTAACTTAACAACTACTTACACCGTTGTTGTCAACGACTTTCTTTATG


 


GTGGCGGTGATGGCTTTTCAGCATTTAAAAAAGCTAAATTAGTCGGAGCTATTAACACAGATACTGAAGCTTT


 


CATCACATATATCACAAATTTACAAGCATCAGGTAAAACTGTTAATGCTACTATCAAAGGGGTTAAAAATTAT


 


GTAACTTCAAACCTTGAAAGATCAACAAAAATTAATAGTGCTGGCAAACACAGTATCATTAGTAAGGTTTTTA


 


GAAATCGTGATGGCAATATAGTGTCTAGTGAAGTCATTTCAGACCTTTTGACTTCTACTGAAAACACTAATAA


 


CAGCTTTGGCAAAaAAGAGACAACAACAAACAAAAATACTATCTCTAATTCCACTCTTCCAATAACA


 


> Spy0872-2/Schmitz 1/177 (serotype 22); SEQ ID NO: 204


GCTATAATAAATCATGCTAATGATATTGTTAAAACAGTTACTGAACGAAAAATCGGAACTGCAACTAATTCTT


 


CAACTATTTCTAAAACAGAAAATATTGATAAAGAATCTCCTGTCGGTAACTTAGTAACAACGGCTCAGCTTAC


 


TATTGCTAAGAAAACTTTTCCAACTGTTGACTTTGCTATGACCAATAATGGTGGTATTCGAAGTGACCTAGTT


 


GTCAAAAATGACCGGACCATCACGTGGGGAGCTGCACAGGCTGTACAACCATTTGGTAATATCCTTCAAGTCA


 


TTCAAATGACTGGTCAACACATTTACGATGTCCTAAATCAGCAATACGATGAAAACCAGACCTATTTTCTTCA


 


AATGTCAGGTTTAACATACACTTATACAGATAATGATCCTAAGAACTCTGATACCCCCTTCAAGATAGTTAAG


 


GTTTATAAAGACAATGGTGAAGAAATTAACTTAACAACTACTTACACCGTTGTTGTCAACGACTTTCTTTATG


 


GTGGTGGTGATGGCTTTTCAGCATTTAAAAAAGCTAAATTAATCGGAGCTATTAACACAGATACTGAAGCTTT


 


CATCACATATATCACAAATTTAGAAGCATCAGGTAAAACTGTTAATGCTACTATAAAAGGGGTTAAAAATTAT


 


GTAACTTCAAACCTTGAAAGCTCGACAAAAGTTAATAGTGCTGGTAAACACAGTATCATTAGTAAGGTTTTTA


 


GAAATCGTGATGGCAATATAGTGTCTAGTGAAATCATTTCAGACCTTTTGACTTCTACTGAAAACACTAATAA


 


CAGCCTTGGCAAAAAAGAAACaACGACAAACAAAAATACTATCTCTAGTTCCACTCTTCCAATAACA


 


> Spy0872-2/Schmitz 1/234 (serotype 44); SEQ ID NO: 205


GCTATAATAAATCATGCTAATGATATTGTTAAAACAGTTACTGAACGAAAAATCGGAACTGCAACTAATTCTT


 


CAACTATTTCTAAAACAGAAAATATTGATAAAGAATCTCCTGTCGGTAACTTAGTAACAACGGCTCAGCTTAC


 


TATTGCTAAGAAAACTTTTCCAACTGTTGACTTTGCTATGACCAATAATGGTGGTATTCGAAGTGACCTAGTT


 


GTCAAAAATGACCGGACCATCACCTGGGGAGCTGCACAGGCTGTACAACCATTTGGTAATATCCTTCAAGTCA


 


TTCAAATGACTGGTCAACACATTTACGATGTCCTAAATCAGCAATACGATGAAAACCAGACCTATTTTCTTCA


 


AATGTCAGGTTTAACATACACTTATACAGATAATGATCCTAAGAACTCTGATACCCCCTTCAAGATAGTTAAG


 


GTTTATAAAGACAATGGTGAAGAAATTAACTTAACAACTACTTACACCGTTGTTGTCAACGACTTTCTTTATG


 


GTGGTGGTGATGGCTTTTCAGCATTTAAAAAAACTAAATTAATCGGAGCTATTAACACAGATACTGAAGCTTT


 


CATCACATATATCACAAATTTAGAAGCATCAGGTAAAACTGTTAATGCTACTATAAAAGGGGTTAAAAATTAT


 


GTAACTTCAAACCTTGAAAGCTCGACAAAAGTTAATAGTGCTGGTAAACACAGTATCATTAGTAAGGTTTTTA


 


GAAATCGTGATGGCAATATAGTGTCTAGTGAAATCATTTCAGACCTTTTGACTTCTACTGAAAACACTAATAA


 


CAGCCTTGGCAAAAAAGAAACAACGACaAACAAAAATACTATCTCTAGTTCCACTCTTCCAATAACA


 


> Spy0872-2/Schmitz 1/22 (serotype 4); SEQ ID NO: 206


GCTATAATAAATCATGCTAATGATATTGTTAAAACAGTTACTGAACGAAAAATCGGAACTGCAACTAATTCTT


 


CAACTATTTCTAAAACAGAAAATATTGATAAAGAATCTCCTGTCGGTAACTTAGTAACAACGGCTCAGCTTAC


 


TATTGCTAAGAAAACTTTTCCAACTGTTGACTTTGCTATGACCAATAATGGTGGTATTCGAAGTGACCTAGTT


 


GTCAAAAATGACCGGACCATCACCTGGGAAGCTGCACAGGCTGTACAACCATTTGGTAATATCCTTCAAGTCA


 


TTCAAATGACTGGTCAACACATTTACGATGTCCTAAATCAGCAATACGATGAAAACCAGACCTATTTTCTTCA


 


AATGTCAGGTTTAACATACACTTATACAGATAATGATCCTAAGAACTCTGATACCCCCTTCAAGATAGTTAAG


 


GTTTATAAAGACAATGGTGAAGAAATTAACTTAACAACTACTTACACCGTTGTTGTCAACGACTTTCTTTATG


 


GTGGTGGTGATGGCTTTTCAGCATTTAAAAAAGCTAAATTAATCGGAGCTATTAACACAGATACTGAAGCTTT


 


CATCACATATATCACAAATTTAGAAGCATCAGGTAAAACTGTTAATGCTACTATAAAAGGGGTTAAAAATTAT


 


GTAACTTCAAACCTTGAAAGTTCGACAAAAGTTAATAGTGCTGGTAAACACAGTATCATTATCATTAGTAAGG


 


TTTTTAGAAATCGTGATGGCAATATAGTGTCTAGTGAAATCATTTCAGACCTTTTGACTTCTACTGAAAACAC


 


TAATAACAGCTTTGGCAAAAAAGAGATAACAACAAACAAAAATACTATCTCTAATTCCACTCTTCCAATAACA


 


5. Further Sequences


> Spy0488/SF370 (serotype 1); SEQ ID NO: 18


TTGCGGCAGATTCAGTCCATTCGTCTGATAGACGTTTTGGAGTTGGCTTTTGGAGTTGGCTATAAGGAAGAAA


 


CAACCTCTCAGTTTTCTTCGGATCAGCCCTCCCAAGTGGTTTTGTATCGAGGTGAGGCTAACACGGTTAGGTT


 


TGCCTATACCAATCAGATGTCTCTGATGAAAGATATTCGCATTGCTTTGGATGGTTCTGATAAGTCTTTGACC


 


GCTCAGATTGTTCCTGGTATGGGTCATGTTTATGAGGGCTTTCAAACTTCTGCTAGAGGGATTTTTACGATGT


 


CAGGAGTTCCTGAAAGCACTGTTCCCGTTGCTAACCCTAATGTACAAACCAAATATATAAGGTATTTCAAAGT


 


CATTGATGATATGCATAACACAATGTATAAAGGAACTGTTTTTCTTGTTCAACCGCAAGCTTGGAAATACACC


 


ATGAAATCTGTTGATCAGTTACCAGTAGATGACTTGAACCATATTGGCGTTGCTGGTATTGAACGAATGACAA


 


CTCTCATTAAAAATGCGGGTGCCCTTTTAACCACAGGAGGTAGTGGGGCTTTCCCAGACAATATTAAAGTATC


 


TATTAATCCAAAGGGGAGGCAGGCCACGATTACTTATGGGGACGGCTCTACGGATATTATTCCTCCAGCAGTT


 


TTATGGAAAAAAGGCTCCGTAAAAGAGCCTACTGAAGCCGATCAATCTGTCGGAACACCGACTCCTGGTATTC


 


CTGGTAAATTCAAACGAGACCAGAGCCTTAACGAGCATGAAGCTATGGTAAATGTCGAACCACTGTCTCATGT


 


AGTAAAAGACAATATAAAGGTCATAGATGAAAAATCAACAGGGCGGTTTGAGCCTTTTAGACCTAATGAAGAT


 


GAGAAGGAGAAGCCTGCCAGCGATGTTAAGGTAAGACCAGCAGAAGTTGGTAGCTGGCTAGAACCAGCGACAG


 


CTCTTCCTAGTGTTGAAATGAGCGCTGAGGACAGGTTAAAAAGT


 


> Spy0895/SF370 (serotype 1); SEQ ID NO: 19


ACTAATAATCAAACACTAGACATCCTTTTGGATGTCTATGCTTATAATCACGCCTTTAGAATTGCTAAAGCCT


 


TGCCAAATATCCCTAAAAGTGCCCTCTATTTACTAGAGATGTTAAAAGAGCGCAGAGAATTGAACCTTGCCTT


 


TCTAGCGGAACATGCAGCAGAGAATCGGACCATTGAAGACCAGTATCACTGTTCATTATGGCTTAACCAATCG


 


CTTGAAGATGAGCAGATTGCCAATTACATTTTGGATTTAGAAGTTAAAGTAAAAAACGGTGCTATTATTGATT


 


TCGTCAGGTCAGTGTCGCCTATTCTTTACCGACTTTTTCTCAGACTAATCACGTCAGAAATTCCAAACTTCAA


 


GGCTTATATTTTTGATACAAAGAATGACCAATATGATACCTGGCATTTTCAGGCCATGTTGGAATCTGATCAC


 


GAGGTTTTCAAGGCTTACCTGTCTCAAAAGCAGTCTCGCAATGTGACGACCAAAAGCTTAGCAGACATGTTGA


 


CGTTGACCTCCTTACCTCAGGAAATCAAGGACTTGGTTTTTTTGTTACGACATTTTGAAAAGGCTGTCCGTAA


 


TCCTCTGGCTCATTTGATTAAGCCTTTTGATGAAGAGGAACTGCATCGCACCACTCATTTTTCTTCTCAGGCT


 


TTTTTGGAAAACATTATCACCTTGGCGACTTTTTCTGGTGTAATCTACCGACGTGAGCCTTTTTACTTTGATG


 


ACATGAATGCCATTATTAAAAAGGAGTTGAGCCTTTGGAGACAATCTATTGTC


 


> Spy1536/SF370 (serotype 1); SEQ ID NO: 207


ATTGAAATGCCTGGAGGCGCTTACGATATTCGGACTGTCTTACAAGTCAATGGCAAAGAAGACAAACGAAAAG


 


GAGCTTACCAGTTTGTTGCAGTGGGCATTAGTCGTGCCAGCCTCGCTCAGCTATTATATGCTTGGCTGACACC


 


GTTTACTGAAATTAGTACAGCAGAAGATACAACAGGCGGATACAGCGATGCTGATTTCCTTCGAATTAATCAA


 


TTTTACATGGAAACATCACAAAATGCAGCTATTTATCAAGCTTTATCCTTAGCTGGAAAACCAGTTACATTAG


 


ATTATAAAGGCGTATATGTTTTAGACGTAAACAACGAATCTACTTTTAAAGGAACGCTACACTTAGCAGATAC


 


TGTAACAGGTGTAAATGGTAAACAGTTTACTAGTTCAGCAGAACTTATTGACTATGTTTCTCACCTAAAACTA


 


GGGGATGAAGTTACGGTTCAGTTTACGAGTGATAATAAGCCTAAAAAAGGAGTTGGCCGTATTATCAAACTGA


 


AAAATGGGAAAAATGGGATTGGCATTGCCTTGACTGATCATACAAGTGTCAATTCAGAAGACACAGTGATCTT


 


TAGTACTAAAGGAGTAGGAGGACCTAGTGCTGGTCTAATGTTTACTCTTGATATATATGATCAAATAACTAAA


 


GAAGATTTACGCAAGGGCCGTACAATTGCAGGTACAGGAACTATTGGCAAGGATGGCGAAGTAGGAGATATTG


 


GTGGTGCAGGTCTTAAAGTAGTTGCAGCAGCTGAAGCTGGTGCAGATATATTTTTTGTTCCGAATAATCCTGT


 


TGATAAGGAAATTAAAAAAGTTAATCCAAATGCTATAAGTAATTACGAAGAAGCCAAACGGGCAGCCAAACGA


 


CTAAAGACCAAAATGAAGATTGTTCCTGTTACGACTGTTCAAGAGGCACTGGTTTATCTTCGCAAA


 


> Spy1666/SF370 (serotype 1); SEQ ID NO: 208


ACAAAAGAATTTCATCACGTGACCGTACTCCTTCACGAAACAGTGGACATGCTTGACATAAAGCCTGATGGGA


 


TTTATGTTGATGCGACGCTAGGTGGCTCAGGCCACTCAGCTTATTTGTTGTCCAAACTTGGTGAAGAAGGGCA


 


CCTCTATTGTTTTGACCAAGACCAAAAGGCTATTGACAATGCACAAGTTACCCTCAAATCTTATATTGACAAA


 


GGACAGGTAACTTTTATTAAAGATAATTTTAGACACCTCAAAGCACGTTTAACAGCGCTTGGAGTTGATGAAA


 


TTGATGGTATCTTATATGACCTTGGTGTTTCCAGCCCGCAATTGGATGAAAGAGAACGAGGGTTTTCTTATAA


 


ACAAGATGCTCCATTGGATATGCGCATGGATCGTCAGTCGCTCTTAACAGCTTACGAAGTGGTGAATACCTAT


 


CCATTCAATGATTTGGTTAAGATTTTTTTCAAATATGGTGAAGATAAATTCTCCAAGCAGATCGCTCGAAAAA


 


TTGAACAAGCAAGAGCTATTAAGCCTATTGAGACAACAACAGAGTTGGCAGAATTGATTAAGGCAGCAAAGCC


 


AGCTAAAGAGTTGAAGAAAAAAGGCCACCCTGCTAAACAGATTTTTCAAGCTATTCGCATTGAAGTCAATGAT


 


GAATTGGGAGCGGCCGATGAATCTATTCAGGACGCTATGGAATTATTAGCCCTTGATGGTCGTATCTCAGTTA


 


TTACCTTCCATTCTCTGGAAGATCGCCTAACCAAGCAGTTGTTTAAAGAAGCTAGTACGGTGGATGTGCCAAA


 


AGGGCTTCCTCTAATTCCTGAAGATATGAAACCTAAGTTTGAACTTGTTTCACGTAAGCCGATCTTACCTAGT


 


CATTCAGAGTTAACAGCTAATAAAAGGGCACACTCAGCCAAGCTACGTGTTGCCAAAAAAATTCGGAAA


 


> Spy1727/SF370 (serotype 1); SEQ ID NO: 20


GTGACAACGACGGAACAAGAACTTACCTTGACTCCCTTACGTGGGAAAAGTGGCAAAGCTTATAAAGGCACTT


 


ATCCAAATGGGGAATGTGTCTTTATAAAATTAAATACGACCCCTATTCTACCTGCCTTAGCAAAAGAACAGAT


 


TGCGCCACAGTTACTTTGGGCCAAACGCATGGGCAATGGTGATATGATGAGTGCCCAAGAATGGCTTAACGGC


 


CGTACATTGACCAAAGAAGATATGAACAGTAAGCAAATCATTCATATTCTATTGCGCCTTCACAAATCTAAAA


 


AATTAGTCAATCAACTGCTTCAGCTCAATTATAAGATTGAAAACCCATACGATTTATTGGTTGATTTTGAGCA


 


AAATGCACCCTTGCAAATTCAGCAAAATTCATACTTACAAGCTATCGTTAAAGAATTAAAACGGAGCTTACCA


 


GAGTTCAAATCAGAAGTAGCAACGATTGTGCATGGAGATATTAAACATAGCAATTGGGTGATTACTACTAGTG


 


GTATGATTTTTTTAGTAGATTGGGATTCTGTTCGTCTAACTGATCGGATGTATGATGTTGCTTACCTGTTGAG


 


CCACTATATTCCACGGTCTCGTTGGTCAGAATGGCTGTCTTATTATGGCTATAAAAATAATGACAAGGTTATG


 


CAAAAAATTATTTGGTATGGTCAATTTTCTCACCTGACACAAATTCTCAAGTGTTTTGACAAGCGTGACATGG


 


AGCATGTGAATCAGGAGATTTATGCCCTCAGAAAATTTAGAGAAATATTTAGAAAGAAA

## Claims

1. An isolated protein consisting of
a) the amino acid sequence of SEQ ID NO: 4,
b) a fragment of SEQ ID NO: 4, wherein the fragment is at least 50 consecutive amino acids from SEQ ID NO: 4, or
c) an amino acid sequence with at least 95% sequence identity to the full length of the sequence of SEQ ID NO: 4.

2. The isolated protein of claim 1, wherein the amino acid sequence is from a serotype of S. pyogenes selected from the group consisting of M2, M3, M4, M5, M6, M11, M12, M14, M19, M22, M24, M25, M28, M44, M49, M57, M59, M60, M61, M76, M83, M84, M87, M89 and M118.

3. The isolated protein of claim 1, wherein the fragment consists of at least 95% of the amino acid sequence of SEQ ID NO:4.

4. The isolated protein of claim 1, wherein the amino acid sequence has at least 97% sequence identity to the sequence of SEQ ID NO:4.

5. The isolated protein of claim 1, wherein the amino acid sequence is selected from SEQ ID NOs: 90, 91, 92, 95, 96, 97 and 98.

6. The isolated protein of claim 1, wherein the fragment consists of SEQ ID NO: 5 or SEQ ID NO: 6.

7. A fusion protein comprising the isolated protein of claim 1, further comprising additional amino acid residue(s) from a heterologous amino acid sequence.

8. The fusion protein of claim 7, wherein the additional amino acid residue(s) is/are flanking the antigen C-terminally, N-terminally, or C- and N-terminally.

9. A fusion protein comprising at least two isolated proteins of claim 1.

10. The fusion protein of claim 7, wherein the amino acid sequence of said isolated protein is from a serotype of S. pyogenes selected from the group consisting of M2, M3, M4, M5, M6, M11, M12, M14, M19, M22, M24, M25, M28, M44, M49, M57, M59, M60, M61, M76, M83, M84, M87, M89 and M118.

11. The fusion protein of claim 7, wherein the fragment consists of at least 95% of the amino acid sequence of SEQ ID NO:4.

12. The fusion protein of claim 7, wherein the isolated protein has at least 97% sequence identity to the sequence of SEQ ID NO:4.

13. The fusion protein of claim 12, wherein the amino acid sequence differs from the sequence of SEQ ID NO:4 by at least one conservative amino acid substitution.

14. The fusion protein of claim 7, wherein said isolated protein is selected from SEQ ID NOs: 90, 91, 92, 95, 96, 97 and 98.

15. The fusion protein of claim 7, wherein said isolated protein consists of SEQ ID NO: 5 or SEQ ID NO: 6.

16. An immunogenic composition comprising at least one isolated protein according to claim 1 and a pharmaceutically acceptable carrier or excipient.

17. An immunogenic composition comprising at least one fusion protein according to claim 7 and a pharmaceutically acceptable carrier or excipient.

18. Method of inducing an immune response in a subject, the method comprising administering to the subject an effective amount of the protein of claim 1.